For those living with generalised #myastheniagravis (gMG), additional planning is necessary when preparing to spend time away from home for the holidays.
Deanna shares the extra steps she takes to travel safely.
youtu.be/3ADVz9CuVAY
Alexion Pharmaceuticals
Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in New Haven, Connecticut, specializing in orphan drugs for rare diseases. More on Wikipedia
-
Alexion
@AlexionPharma
-
Alexion
@AlexionPharma
Our kidneys work around the clock to filter waste from the blood.
For people living with #igan, a rare inflammatory kidney disease, abnormal IgA proteins set off a chain reaction that affects the kidney’s ability to function properly.
Learn more ⬇️ -
Alexion
@AlexionPharma
For people living with generalised #myastheniagravis, muscle weakness can mean more than feeling tired and may worsen as the day progresses.
Scroll through to learn more about the signs and symptoms of gMG to better understand the realities of this rare neuromuscular disorder. -
Alexion
@AlexionPharma
For Mario, getting diagnosed with #hypophosphatasia (HPP) brought clarity to symptoms he'd lived with since early childhood, like premature tooth loss and physical pain. Find out more in Rare Connections in HPP: rareconnectionsinhpp.com
-
Alexion
@AlexionPharma
On #worldhppday, and every day, we stand with the #hypophosphatasia (HPP) community.
In Rare Connections in HPP, Antje, Lisa and Mario share their experiences living with this complex #raredisease. Listen to their stories at rareconnectionsinhpp.com. -
Alexion
@AlexionPharma
This #worldamyloidosisday, we're shining a light on the profound impact amyloidosis can have on people living with this group of complex rare diseases and their families.
Continued collaboration, education and innovation are critical to driving progress for this community. -
Alexion
@AlexionPharma
While atypical haemolytic uraemic syndrome (#ahus) is often associated with kidney damage, its effects can extend beyond the kidneys, impacting multiple organs and contributing to serious, potentially life-threatening complications.
-
Alexion
@AlexionPharma
A person's late teens to forties are often marked by big life milestones.
They're also the same years that #igan is typically diagnosed.
Some people living with IgAN may face kidney failure within 10 years of diagnosis, often putting plans for the future on hold.
Learn more ⬇️ -
Alexion
@AlexionPharma
Did you know up to 67% of people living with neuromyelitis optica spectrum disorder (#nmosd) experience cognitive dysfunction, which can impact attention, memory and executive function, making everyday tasks, work and personal relationships more difficult to navigate.
-
Alexion
@AlexionPharma
How long would you search for answers if you spent your life in pain? For Lisa, it took more than 50 years of dental issues, muscle weakness and pain before her persistence paid off with a diagnosis. Watch her #hypophosphatasia (HPP) story at rareconnectionsinhpp.com.
-
Alexion
@AlexionPharma
Meaningful progress in #raredisease often starts with new insights into disease biology.
In #igan, ongoing research on the role of the complement system in driving kidney inflammation and damage is advancing our understanding of this disease. -
Alexion
@AlexionPharma
Where do new ideas in rare disease begin? Sometimes with research. Often with a conversation.
At the Joint @ACTRIMS and @ECTRIMS Meeting, we'll share our latest neuromyelitis optica spectrum disorder (#nmosd) research and engage in the discussions shaping the future of care. -
Alexion
@AlexionPharma
Living with generalised #myastheniagravis (gMG) is more than just managing muscle weakness.
Watch Deanna's story to learn how she manages.
www.youtube.com/watch?v=3ADVz9CuVAY. -
Alexion
@AlexionPharma
"Giving up is not an option."
Antje's story in Rare Connections in HPP highlights the deep emotional and physical toll of #hypophosphatasia (HPP), including fatigue and severe chronic pain, and the grit it takes to keep pushing forward: ▶️ rareconnectionsinhpp.com -
Alexion
@AlexionPharma
In recognition of #pnhawarenessday, we're proud to join the community in building greater understanding of paroxysmal nocturnal haemoglobinuria (#pnh).
Thank you to the patients, caregivers and advocates who inspire our ongoing commitment to improving outcomes. -
Alexion
@AlexionPharma
Three people. Three countries. One diagnosis. Today at #asbmr2026 in our hometown of Boston, we premiered Rare Connections in HPP, a new short film featuring Mario, Antje and Lisa who share the realities of living with #hypophosphatasia (HPP).
▶️ rareconnectionsinhpp.com -
Alexion
@AlexionPharma
For people living with #hypophosphatasia (HPP), it can take years — sometimes a decade — to get the correct diagnosis.
Earlier and accurate diagnosis has the potential to change what those years hold for people living with this rare metabolic disease. -
Alexion
@AlexionPharma
#hypoparathyroidism (HypoPT) is a rare endocrine disease that affects multiple body systems.
Signs and symptoms of HypoPT can vary widely and escalate over time, making early recognition an important step toward better outcomes and reduced complications.
Learn more below 👇 -
Alexion
@AlexionPharma
Lisa knew something wasn't right all along, and her persistent search for answers paid off when a #hypophosphatasia (HPP) diagnosis came.
Her full story is part of Rare Connections in HPP. Watch in person in Boston at @ASBMR 2026 and on our digital channels. -
Alexion
@AlexionPharma
Generalised #myastheniagravis (gMG) can affect an entire household
This level of support reflects the far-reaching effects gMG can have on daily life, not only for the people living with gMG but also for care partners. -
Alexion
@AlexionPharma
Antje lived for years with terrible pain and exhaustion. A #hypophosphatasia (HPP) diagnosis didn't just provide answers, it helped her feel seen.
Antje shares her story in Rare Connections in HPP, debuting at @ASBMR and on our channels in October. -
Alexion
@AlexionPharma
On #ahusday, we're taking an extra moment to recognise the resilience it takes to live with a rare disease like atypical haemolytic uraemic syndrome (aHUS).
At Alexion, we're proud to stand with the aHUS community, today and every day. #ahus24sept -
Alexion
@AlexionPharma
For Mario, a #hypophosphatasia (HPP) diagnosis meant relief and clarity after decades of unexplained pain.
Here's a glimpse of his journey. Watch the full Rare Connections in HPP short film at @ASBMR 2026 and on our digital channels this October. -
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is a rare autoimmune disease marked by unpredictable relapses that can cause permanent disability.
Improving our understanding of this rare disease is the first step to addressing that looming possibility. -
Alexion
@AlexionPharma
Non-specific symptoms like low platelet count, anaemia and shortness of breath can be easy to confuse with common causes or write off entirely.
Learn more about atypical haemolytic uraemic syndrome (#ahus), which can cause severe organ damage or death, if not diagnosed early. -
Alexion
@AlexionPharma
Paroxysmal nocturnal haemoglobinuria (#pnh) can affect people of all different ages, sexes and backgrounds.
Even though PNH is rare, awareness of this disease shouldn't be. -
Alexion
@AlexionPharma
Back to school is often exciting, but may also present challenges. Some teens may be navigating hurdles others can't see. At 13 years old, Nick was diagnosed with generalised #myastheniagravis (gMG). Learn more about his experience.
www.youtube.com/watch?v=DLDzFYU8QFQ. -
Alexion
@AlexionPharma
Swollen arms and legs, extreme shortness of breath and an abnormal heartbeat can all be signs and symptoms of light chain (AL) #amyloidosis.
Greater awareness of AL amyloidosis can help support earlier recognition and shorten the path to diagnosis.
Learn more ⬇️ -
Alexion
@AlexionPharma
Heading to Munich for the @escardio Congress 2026?
We'll be there presenting our latest research.
We look forward to connecting with the global cardiology community to help turn science into meaningful outcomes for patients with persistent unmet needs. -
Alexion
@AlexionPharma
The barriers are real. Gaps in diagnosis, treatment and support aren’t just statistics—they’re lived experiences that demand action. Together with patients, caregivers, researchers, advocates and communities, with a shared belief that rare never means forgotten. #raredisease
-
Alexion
@AlexionPharma
Taking the stairs. Reaching into a kitchen cabinet. Daily activities that most people don’t think twice about can be difficult, even painful for those living with #hypophosphatasia (HPP) and may require their careful consideration.
-
Alexion
@AlexionPharma
Know a nonprofit improving the rare disease diagnostic journey? Last day to submit a Alexion Charitable Foundation 2026 Grant application is Aug. 21.
Learn more → alexion.com/alexion-charitable-foundation
The ACF and Alexion, AstraZeneca Rare Disease, are separate legal entities. -
Alexion
@AlexionPharma
The early symptoms of generalised #myastheniagravis (gMG) can be easy to mistake for another cause, and because symptoms often fluctuate day to day, doctors may not get the full picture from a single exam.
Know the signs and symptoms of gMG. -
Alexion
@AlexionPharma
The rare disease diagnostic journey can take years. The ACF's 2026 is focused on changing that, and the 2026 grant cycle is now open.
Learn more → alexion.com/alexion-charitable-foundation
The ACF and Alexion, AstraZeneca Rare Disease, are separate legal entities. -
Alexion
@AlexionPharma
Because #nmosd is rare, it's possible to never meet another person with the same diagnosis.
Rare Connections in NMOSD brings together three strangers who exchange raw, personal letters about their experiences living with NMOSD.
www.youtube.com/watch?v=cfnE7cxfY3s&linkId=990363991. -
Alexion
@AlexionPharma
#neurofibromatosis Type 1 (#nf1) is rare, but did you know that it's also one of the most commonly inherited disorders?
While they are often identified in infancy or childhood, the impacts of PN can persist into adulthood. -
Alexion
@AlexionPharma
The Alexion Charitable Foundation's (ACF) 2026 Grant Cycle is now open.
Learn more → alexion.com/alexion-charitable-foundation?linkId=987892160
The ACF and Alexion, AstraZeneca Rare Disease, are separate legal entities. -
Alexion
@AlexionPharma
In paroxysmal nocturnal haemoglobinuria (#pnh) red blood cells are missing protective proteins, leaving them exposed to the complement system.
It’s important to understand how PNH impacts the body to properly manage this rare and potentially life-threatening blood disorder. -
Alexion
@AlexionPharma
Hypophosphatasia (#hpp) in adults can take a serious toll on physical, mental and emotional health, making everyday activities a challenge.
-
Alexion
@AlexionPharma
HSCT-TMA is a rare, severe and potentially life-threatening type of thrombotic microangiopathy (TMA) that occurs following haematopoietic stem cell transplantation, a procedure to treat some types of cancers and other diseases. Learn more about this condition below.
-
Alexion
@AlexionPharma
Timely and accurate diagnosis is critical for people living with atypical haemolytic uraemic syndrome (#ahus), an ultra-rare, rapidly progressive disease that may result in severe organ damage and death.
-
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is a rare autoimmune disease in which the body’s immune system mistakenly attacks the optic nerve, spinal cord and brain.
Early recognition is critical for timely diagnosis and appropriate management. Learn more: -
Alexion
@AlexionPharma
Slurred speech, double vision, droopy eyelids and loss of balance are all common symptoms of generalised #myastheniagravis (gMG), a rare autoimmune disorder.
Learn more about the breakdown of communication between nerves and muscles in people with gMG ⬇️ -
Alexion
@AlexionPharma
At the International Society for @childrensbones Health 2026 Conference, we’re proud to have presented our latest research in #hypophosphatasia (HPP) and connected with leaders in the bone metabolism space to deepen understanding of the unmet needs of those living with HPP.
-
Alexion
@AlexionPharma
Hypophosphatasia (#hpp) can take different forms for people of all ages, but pain is often reported.
-
Alexion
@AlexionPharma
At the Congress of the @EANeurology, we will be showcasing our latest research in generalised #myastheniagravis (gMG).
This premier congress is an important forum to foster collaboration and innovation within the rare neurology community to shape the future of patient care. -
Alexion
@AlexionPharma
We’re at the International Society for @childrensbones Health’s 2026 Conference, where we will be sharing our latest research in #hypophosphatasia, with the aim of improving understanding of this rare metabolic disease and its diverse impacts in paediatric patients.
-
Alexion
@AlexionPharma
Did you know up to 50% of people with #neurofibromatosis type 1 (NF1) may develop nonmalignant tumours on the nerve sheaths called plexiform neurofibromas (PN)? Some PN can grow fast and become large, which can progressively interfere with normal physical functions.
-
Alexion
@AlexionPharma
Generalised #myastheniagravis (gMG) is often called the “snowflake disease” because no two peoples’ experiences are the same. Deanna shares how her symptoms can fluctuate day-to-day and how she has learned to navigate the fluctuations: www.youtube.com/watch?v=3ADVz9CuVAY.
-
Alexion
@AlexionPharma
The symptoms and day-to-day impact of generalised #myastheniagravis (gMG) are often invisible, but constant for those living with gMG. Marta shares how life with gMG can feel isolating, but how she navigates her condition and regains a sense of control: www.youtube.com/watch?v=0Mi-wpZiaMg.
-
Alexion
@AlexionPharma
For many people, amyloid light chain (AL) amyloidosis is not accurately diagnosed until the later stages of the disease, when prognosis is poor. Education around signs and symptoms is critical to help shorten time to diagnosis for patients.
-
Alexion
@AlexionPharma
We’re at the 31st @EHA_Hematology Congress, where we’ll be showcasing our most recent research in light chain (AL) amyloidosis and PNH.
We look forward to engaging with the haematology community on our shared commitment to advancing care for people living with rare diseases. -
Alexion
@AlexionPharma
Navigating life with generalised #myastheniagravis (gMG) can mean overcoming invisible hurdles. Nick shares how support from loved ones help him navigate the daily, sometimes unpredictable, challenges of gMG: www.youtube.com/watch?v=DLDzFYU8QFQ.
-
Alexion
@AlexionPharma
As the 63rd @ERAkidney Congress concludes, we’re grateful to have connected with scientific, medical and patient communities to deepen the understanding of rare kidney diseases and help shape the future of care for these patient communities.
-
Alexion
@AlexionPharma
Immunoglobulin A nephropathy (IgAN) is a rare, inflammatory disease of the kidneys that can lead to chronic kidney disease and progress to end-stage kidney disease (ESKD). Learn more about this condition below.
-
Alexion
@AlexionPharma
aHUS is a type of thrombotic microangiopathy (TMA), a group of severe and potentially life-threatening rare disorders that cause blood clots and damage to blood vessels, which can lead to organ failure and death.
Learn more about TMAs ⬇️ -
Alexion
@AlexionPharma
Look for us at the 63rd @ERAkidney Congress, where we'll be presenting new research in IgAN and aHUS.
We're excited to join the scientific community at ERA, where new data and clinical insights converge to advance care for people living with rare kidney diseases. -
Alexion
@AlexionPharma
On #worldhypoparaday, we stand with the #hypoparathyroidism community to raise awareness, advance understanding and drive progress towards better outcomes for those impacted by this rare endocrine disease.
-
Alexion
@AlexionPharma
June is #mgawareness Month ─ an annual moment to elevate the voices of those living with generalised #myastheniagravis.
Behind every diagnosis is an individual journey. Learn from Marta, Deanna and Nick who share their experiences living with gMG: rareconnectionsfilms.com 🎥 -
Alexion
@AlexionPharma
#neurofibromatosis (NF) is a rare, genetic condition involving the development of nonmalignant tumours that may affect the brain, spinal cord and nerves. As the most common type of NF, neurofibromatosis type 1 (NF1) affects about 1 in 3,000 people worldwide.
-
Alexion
@AlexionPharma
Light chain (AL) #amyloidosis, also referred to as AL, is a rare, systemic and progressive disorder caused by defective plasma cells in the bone marrow.
-
Alexion
@AlexionPharma
We’re committed to advancing the understanding of paroxysmal nocturnal haemoglobinuria (PNH) and showing our support for the #pnh community. Learn about this rare, chronic, progressive and potentially life-threatening blood disorder below.
-
Alexion
@AlexionPharma
Now out: Tina’s Big Trip, the latest in our Inspired By series—celebrating resilience and inclusion in rare disease. [link: www.tinasbigtrip.com] #inspiredby #raredisease
-
Alexion
@AlexionPharma
IgAN is a rare, inflammatory disease of the kidneys that can lead to chronic kidney disease & progress to end-stage kidney disease. It begins when the body develops abnormal IgA proteins resulting in immune complexes that are deposited in the kidneys causing damage. #iganday
-
Alexion
@AlexionPharma
IgA Nephropathy Awareness Day is a powerful reminder of the urgent need for greater awareness and understanding of #igan.
Every day, we remain deeply committed to advancing research to support meaningful progress for people living with this rare kidney disease.
#iganday -
Alexion
@AlexionPharma
Today wraps the @ESEndocrinology’s Congress of Endocrinology (ECE) 2026, where we had the privilege to share our research in hypoparathyroidism and advance knowledge of the unmet needs of those impacted by this complex #raredisease.
-
Alexion
@AlexionPharma
At the @ESEndocrinology’s Congress of Endocrinology (ECE) 2026, we’ll be showcasing our latest research in hypoparathyroidism, reinforcing our commitment to advancing progress for patients affected by this #raredisease.
-
Alexion
@AlexionPharma
#neurofibromatosis (NF) is a rare, progressive genetic condition, with the most common type being neurofibromatosis type 1 (NF1). NF1 can impact every organ system and be involved in the development of non-malignant tumours that may affect the brain, spinal cord and nerves.
-
Alexion
@AlexionPharma
#nfawarenessmonth is a powerful reminder of the strength and resilience of those living with #neurofibromatosis.
This May—and every month—we’re dedicated to raising awareness and deepening understanding of this rare, progressive condition to advance outcomes for this community. -
Alexion
@AlexionPharma
Did you know up to 50% of people with #neurofibromatosis type 1 (NF1) may develop nonmalignant tumours on the nerve sheaths called plexiform neurofibromas (PN)? Some PN can grow fast and become large, which can progressively interfere with normal physical functions.
-
Alexion
@AlexionPharma
Immunoglobulin A Nephropathy (IgAN) is a rare, inflammatory disease of the kidneys that can lead to chronic kidney disease and progress to end-stage kidney disease (ESKD). Learn more about this condition below.
-
Alexion
@AlexionPharma
Symptoms of generalised #myastheniagravis (gMG) can mimic those of other disorders, often delaying diagnosis for years. Recognising these symptoms can lead to faster diagnoses and help ensure the best possible outcomes.
-
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is a rare and debilitating autoimmune disease characterised by unpredictable relapses, or attacks. Learn more about the condition below.
-
Alexion
@AlexionPharma
Today concludes the WCO-IOF-ESCEO Congress, where we had the pleasure of sharing our latest research, exchanging scientific insights and educating on the unmet needs of those living with hypophosphatasia (#hpp) and hypoparathyroidism (#hypopt).
-
Alexion
@AlexionPharma
The path to a hypophosphatasia (#hpp) diagnosis can be difficult. Vague, varied symptoms can often lead to missed signs, many doctor visits and uncertainty.
-
Alexion
@AlexionPharma
We’re excited to be attending WCO-IOF-ESCEO in Prague where we’ll present our latest research in hypophosphatasia (#hpp) and hypoparathyroidism (#hypopt) and engage with bone, joint and muscle health experts from across the globe to deepen understanding of these #rarediseases.
-
Alexion
@AlexionPharma
Fluctuating #gmg symptoms can sometimes make accomplishing daily activities such as brushing teeth feel like small victories. Hear how Deanna navigates the challenges of living with a rare disease where each day is unpredictable:
www.youtube.com/watch?v=3ADVz9CuVAY -
Alexion
@AlexionPharma
Hypophosphatasia (#hpp) is more than a bone disease. HPP can affect other parts of the body beyond the skeleton, leading to a range of symptoms that can be overlooked.
-
Alexion
@AlexionPharma
What happens when three people living with #nmosd exchange letters about their #raredisease journeys?
See what unfolds from these meaningful conversations in Rare Connections in NMOSD, a short film highlighting the importance of being seen.
🎬Watch here: www.youtube.com/watch?v=cfnE7cxfY3s -
Alexion
@AlexionPharma
For many people, amyloid light chain (AL) #amyloidosis is not accurately diagnosed until the later stages of the disease, when prognosis is poor. Education around signs and symptoms is critical to help shorten time to diagnosis for patients.
-
Alexion
@AlexionPharma
People living with paroxysmal nocturnal haemoglobinuria (#pnh) can experience a delayed diagnosis by 10 or more years due to diverse symptoms and varied clinical presentation. Explore the signs and symptoms of PNH below.
-
Alexion
@AlexionPharma
Haematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) is a type of thrombotic microangiopathy, commonly known as TMA. Learn more below.
-
Alexion
@AlexionPharma
Today marks the start of the 52nd Annual Meeting of @TheEBMT in Madrid.
We look forward to sharing our latest research in #pnh and #hscttma, highlighting our commitment to improving scientific understanding and outcomes for those living with these rare haematologic conditions. -
Alexion
@AlexionPharma
#nmosd is associated with unpredictable attacks, also known as relapses, which can lead to long-term disability like vision loss or paralysis.
Explore what other symptoms are associated with this #raredisease below. -
Alexion
@AlexionPharma
Immunoglobulin A nephropathy (IgAN) is a rare, chronic kidney disease that begins when the body develops abnormal IgA proteins resulting in immune complexes that are deposited in the kidneys causing damage. On #worldkidneyday, take some time to learn more about this rare disease.
-
Alexion
@AlexionPharma
In honour of @WorldKidneyDay, we stand alongside clinicians, caregivers, patients, advocates and everyone working to create meaningful impact for people living with rare kidney diseases.
Inspired by this community’s strength, we remain dedicated to advancing #kidneyhealthforall -
Alexion
@AlexionPharma
aHUS is a type of thrombotic microangiopathy (TMA), a group of severe and potentially life-threatening rare disorders that cause blood clots and damage to blood vessels, which can lead to organ failure and death. See the signs, symptoms & complications of TMA ⬇.
-
Alexion
@AlexionPharma
There are 10,000+ rare diseases affecting 400M+ people worldwide. 🌎
Yet less than 10% of rare diseases have an approved treatment option. We’re on a mission to continue innovating to discover, develop and deliver medicines to more people in need. alexion.com/about-us -
Alexion
@AlexionPharma
March is #nmoawarenessmonth - a time to honour the resilience, courage and unity of the #nmosd community.
This month and beyond, we’re committed to deepening understanding of this rare neurological disease and advancing scientific research to improve outcomes for patients. -
Alexion
@AlexionPharma
Today, we join hands with advocates, families and innovators everywhere to shine a light on rare diseases and move one step closer to a world where no one is left behind. #rarediseaseday
-
Alexion
@AlexionPharma
Together with the global rare disease community, we celebrate resilience, raise awareness and inspire hope for a brighter tomorrow. #rarediseaseday
-
Alexion
@AlexionPharma
Rare Disease Day is a call to act for more than 400 million people living with rare conditions and their caregivers. Learn how we are listening to and partnering with the rare disease community to speed up access to diagnosis and equitable care alexion.com/news-centre-resources/articles/pioneering-new…
-
Alexion
@AlexionPharma
90% of rare diseases do not have an approved treatment. That’s why we’re committed to advancing the next wave of rare disease innovation, co-creating with patients and caregivers and expanding access to life-changing medicines. Learn more www.alexion.com
#rarediseaseday -
Alexion
@AlexionPharma
Despite small patient populations, collectively hundreds of people globally are living with a rare disease.
It takes around five years to receive a diagnosis, often involving over seven specialists and several misdiagnoses.
#rarediseaseday #raredisease -
Alexion
@AlexionPharma
Through the empowering stories of Marta, Deanna and Nick, Rare Connections in gMG spotlights the emotional and physical challenges faced by those living with generalised #myastheniagravis (gMG).
Learn more about their journeys at rareconnectionsfilms.com! -
Alexion
@AlexionPharma
Newborn screening & genetic testing are vital for faster diagnosis and easing the burden of rare diseases—but access remains limited. Expanding these tools can help detect rare diseases early. Learn more: alexion.com/news-centre-resources/articles/newborn-screening
-
Alexion
@AlexionPharma
Atypical haemolytic uraemic syndrome (#ahus) is a rare disease that often presents suddenly with potentially severe complications and frequently develops into a progressive, chronic condition with relapses. Learn more below about aHUS, a type of thrombotic microangiopathy (TMA).
-
Alexion
@AlexionPharma
Did you know that 7 in 10 rare diseases begin in childhood? At Alexion, we are dedicated to supporting children and families affected by rare conditions, while working to drive early diagnosis and transform lives.
-
Alexion
@AlexionPharma
HSCT-TMA is a rare, severe and potentially life-threatening type of thrombotic microangiopathy (TMA) that occurs following haematopoietic stem cell transplantation, a procedure to treat some types of cancers and other diseases. Learn more about this condition below.
-
Alexion
@AlexionPharma
For millions, living with a rare disease means waiting ~5 years or more for a diagnosis. Every patient deserves equitable and timely access to the resources and care they need.
alexion.com/news-centre-resources/articles/pioneering-new…
#rarediseaseday #raredisease -
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is a rare and debilitating autoimmune disease characterised by unpredictable relapses, or attacks. Learn more about the condition below.
-
Alexion
@AlexionPharma
Paroxysmal nocturnal haemoglobinuria (#pnh) is a rare, chronic, progressive, and potentially life-threatening blood disorder that is characterised by red blood cell destruction within blood vessels and white blood cell and platelet activation, which may lead to blood clots.
-
Alexion
@AlexionPharma
Typically diagnosed in early childhood, #neurofibromatosis type 1 (NF1) is a rare, progressive, genetic condition that involves the development of nonmalignant tumours that may affect the brain, spinal cord and nerves.
-
Alexion
@AlexionPharma
For some people, signs and symptoms of hypophosphatasia (#hpp) aren’t just disruptive, they can worsen over a person’s lifetime and lead to impaired mobility and disability that can significantly change how they live.
-
Alexion
@AlexionPharma
Atypical haemolytic uraemic syndrome is a rare disease that often presents suddenly with potentially severe complications and frequently develops into a progressive, chronic condition with relapses. Learn more below about #ahus, a type of thrombotic microangiopathy (TMA).
-
Alexion
@AlexionPharma
Generalised #myastheniagravis (gMG) is a debilitating rare autoimmune disorder characterised by loss of muscle function and severe muscle weakness. Learn how this occurs below.
-
Alexion
@AlexionPharma
#nmosd is associated with unpredictable attacks, also known as relapses, which can lead to long-term disability like vision loss or paralysis. Explore what other symptoms are associated with this #raredisease below.
-
Alexion
@AlexionPharma
Generalised #myastheniagravis can feel invisible to others due to its rapidly fluctuating symptoms. Our short film, Rare Connections in gMG, highlights the importance of being seen. Watch the full film at rareconnectionsfilms.com!
-
Alexion
@AlexionPharma
Light chain (AL) #amyloidosis, also referred to as AL, is a rare, systemic and progressive disorder caused by defective plasma cell in the bone marrow.
-
Alexion
@AlexionPharma
HSCT-TMA is a rare, severe and potentially life-threatening type of TMA that occurs following haematopoietic stem cell transplantation, a procedure to treat some types of cancers and other diseases. Learn more about this condition below.
-
Alexion
@AlexionPharma
We’re committed to advancing the understanding of paroxysmal nocturnal haemoglobinuria (PNH) and showing our support for the #pnh community. Learn about this rare, chronic, progressive and potentially life-threatening blood disorder below.
-
Alexion
@AlexionPharma
Did you know up to 50% of children with #neurofibromatosis type 1 (NF1) may develop nonmalignant tumours on the nerve sheaths called plexiform neurofibromas (PN)? Some PN can grow fast and become large, which can progressively interfere with normal physical functions.
-
Alexion
@AlexionPharma
Meg was 15 years old when she began experiencing weight loss, hair loss, and fatigue–symptoms which were initially dismissed by doctors. Eventually, she was diagnosed with #nmosd, a #raredisease. Learn about her journey and why Meg is raising awareness of NMOSD.
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
#neurofibromatosis (NF) is a rare, progressive genetic condition, with the most common type being neurofibromatosis type 1 (NF1). NF1 can impact every organ system and be involved in the development of non-malignant tumours that may affect the brain, spinal cord and nerves.
-
Alexion
@AlexionPharma
Rare Connections in gMG offers a powerful look into the personal stories of Marta, Deanna and Nick – three individuals living with generalised #myastheniagravis (gMG).
Discover their strength and resilience at rareconnectionsfilms.com 🎥 -
Alexion
@AlexionPharma
Amyloid light chain (AL) #amyloidosis often occurs from ages 50-80 with the median age of diagnosis occurring between 60-67 years. Learn more about this systemic and progressive disease below.
-
Alexion
@AlexionPharma
Atypical haemolytic uraemic syndrome (#ahus) is a rare disease that often presents suddenly with potentially severe complications and frequently develops into a progressive, chronic condition with relapses. Learn more below about aHUS, a type of thrombotic microangiopathy (TMA).
-
Alexion
@AlexionPharma
Immunoglobulin A (IgA) nephropathy is a rare, chronic kidney disease that begins when the body develops abnormal IgA proteins resulting in immune complexes that are deposited in the kidneys causing damage. Take some time to learn more about this rare disease.
-
Alexion
@AlexionPharma
On #stemday, we celebrate the brilliant minds driving scientific innovation and transforming the rare disease landscape. Recently, we shared this commitment with budding scientists at our US R&D sites in New Haven, Connecticut and Kendall Square, Massachusetts.
-
Alexion
@AlexionPharma
Every year on #worldhppday we shine a light on the inspiring #hypophosphatasia (HPP) community and educate on the daily challenges of this rare metabolic condition. By listening to and learning from this patient community, together we can transform the future of HPP care.
-
Alexion
@AlexionPharma
Hypophosphatasia (#hpp) can take different forms for people of all ages, but pain is often reported.
-
Alexion
@AlexionPharma
Patient registries are helping us shape the future of R&D in rare diseases.
Learn how registries help open new avenues for therapeutic innovation: alexion.com/news-centre-resources/articles/shaping-the-fu… -
Alexion
@AlexionPharma
For some people, signs and symptoms of hypophosphatasia (#hpp) aren’t just disruptive, they can worsen over a person’s lifetime and lead to impaired mobility and disability that can significantly change how they live.
-
Alexion
@AlexionPharma
Hypophosphatasia (#hpp) is more than a bone disease. HPP can affect other parts of the body beyond the skeleton, leading to a range of symptoms that can be overlooked.
-
Alexion
@AlexionPharma
On #worldamyloidosisday and every day, we’re dedicated to raising awareness of this group of complex #rarediseases. Guided and inspired by those impacted, we strive to bring new hope to this community through advances in diagnosis and care. Like this post to show your support!
-
Alexion
@AlexionPharma
2025 marks 10 years of the Alexion-sponsored Global HPP Registry (#hpp). As the largest observational study in this #raredisease, the registry helps to increase understanding of HPP and inform the science leading to new innovations for this community.
-
Alexion
@AlexionPharma
Hypophosphatasia (#hpp) in adults can take a serious toll on physical, mental and emotional health, making everyday activities a challenge.
-
Alexion
@AlexionPharma
The path to a hypophosphatasia (#hpp) diagnosis can be difficult. Vague, varied symptoms can often lead to missed signs, many doctor visits and uncertainty.
-
Alexion
@AlexionPharma
Due to the unpredictability and fluctuating symptoms of generalised #myastheniagravis (gMG), those living with this #raredisease may feel invisible.
Learn about the power of feeling seen while navigating life with gMG in Rare Connections in gMG. Watch at rareconnectionsfilms.com -
Alexion
@AlexionPharma
People living with paroxysmal nocturnal haemoglobinuria (PNH) can experience a delayed diagnosis by 10 or more years due to diverse symptoms and varied clinical presentation. Explore the signs and symptoms of PNH below.
#pnhday2025 #pnhawareness2025 -
Alexion
@AlexionPharma
On Global #pnhday2025, we’re joining the rare disease community to bring attention to paroxysmal nocturnal haemoglobinuria (PNH).
By deepening awareness and understanding, we’re committed to improving outcomes for those living with PNH.
#pnhawareness2025 #togetherforpnh -
Alexion
@AlexionPharma
What is generalised #myastheniagravis (gMG)? Learn more about this #raredisease below.
-
Alexion
@AlexionPharma
On Sept 23, we united virtually for Rare Conversations with the global rare disease community—sharing experiences, insights and the power of data to drive change. Thank you to all who joined! #rareconversations #rarediseasecommunity
-
Alexion
@AlexionPharma
Like many rare diseases, there’s limited awareness of generalised #myastheniagravis, a rare autoimmune disorder characterised by loss of muscle function and severe muscle weakness. We’re committed to advancing understanding of this #raredisease to benefit patients across the 🌎.
-
Alexion
@AlexionPharma
We’re pleased to wrap up this year’s Congress of the @ECTRIMS , where we engaged in meaningful conversations with researchers and clinicians to advance care for those living with neuromyelitis optica spectrum disorder (#nmosd).
-
Alexion
@AlexionPharma
aHUS is a type of thrombotic microangiopathy (TMA), a group of severe and potentially life-threatening rare disorders that cause blood clots and damage to blood vessels, which can lead to organ failure and death. See the signs, symptoms & complications of TMA ⬇️ #ahusday
-
Alexion
@AlexionPharma
We’re proud to be at the 41st Congress of the @ECTRIMS , showcasing our latest research in neuromyelitis optica spectrum disorder (#nmosd) and screening Rare Connections in NMOSD to elevate patient voices and deepen understanding of this rare neuromuscular disease.
-
Alexion
@AlexionPharma
Today on #ahusday, we recognise those living with atypical haemolytic uraemic syndrome. We are inspired by the strength and resilience of the aHUS community and remain dedicated to improving care for those affected by this severe and devastating disease. #ahus24sept
-
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is a rare and debilitating autoimmune disease characterised by unpredictable relapses or attacks. Discover more about this condition and its impact below.
-
Alexion
@AlexionPharma
Hypophosphatasia (#hpp) can affect males and females of all ages, with certain symptoms more common based on a person’s age.
-
Alexion
@AlexionPharma
Genomic newborn screening holds the potential to transform the diagnostic journey for families by enabling early action to make a meaningful difference. Learn how: alexion.com/news-centre-resources/articles/newborn-screening
-
Alexion
@AlexionPharma
Learn how we’re advancing newborn screening through genetic research: alexion.com/news-centre-resources/articles/newborn-screening
-
Alexion
@AlexionPharma
With more than 400 million people worldwide living with a rare disease, and 10,000 rare diseases known to exist today, rare diseases are not as rare as we may think.
Learn more alexion.com/living-in-rare -
Alexion
@AlexionPharma
Haematopoietic stem cell transplant-associated thrombotic microangiopathy is a type of TMA, a group of severe and potentially life-threatening rare disorders that cause blood clots & damage to the walls of the smallest blood vessels, that occurs following HSCT. Learn more below.
-
Alexion
@AlexionPharma
The severity of hypophosphatasia (#hpp) can be wide-ranging. Signs and symptoms of the disease may present in many different ways and accumulate or worsen over time.
-
Alexion
@AlexionPharma
Are you passionate about making a difference in patients' lives? At Alexion, we're pioneering groundbreaking therapies for rare and devastating diseases and looking for top-tier talent to join us. Could you be up for the challenge? Let’s find out: careers.alexion.com
-
Alexion
@AlexionPharma
Join RareConversations on Sept 23! Hear patient advocates and experts discuss the real impact of rare diseases and new ways to drive change.
Rare disease patients, caregivers and members of patient advocacy groups can register now webapp.spotme.com/login/alexionevents/rareconversations
#rarediseases -
Alexion
@AlexionPharma
Last week, Alexion, AstraZeneca Rare Disease joined the Global Genes RARE Drug Development Symposium in Boston. Grateful for the chance to connect, share and learn from the rare disease community as we work together to drive innovation and support those affected.
-
Alexion
@AlexionPharma
Hypophosphatasia (#hpp) is a rare, inherited and progressive metabolic disease characterised by defective mineralisation, impaired calcium and phosphate regulation and non-skeletal manifestations, such as muscle weakness, generalised fatigue and pain.
-
Alexion
@AlexionPharma
What happens when three people living with neuromyelitis optica spectrum disorder (#nmosd) write and exchange letters about their individual journeys and read them for the first time on camera? Watch our short film “Rare Connections in NMOSD” to see it unfold:
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is associated with unpredictable attacks, also known as relapses, which can lead to long-term disability like vision loss or paralysis. Learn more about the symptoms of this #raredisease below.
-
Alexion
@AlexionPharma
Apply to join our talented team of individuals looking to make a difference in the lives of #raredisease patients: careers.alexion.com
-
Alexion
@AlexionPharma
We are committed to leveraging data science and Artificial Intelligence to improve the disease journey for patients and caregivers. Explore how we are speeding the journey to diagnosis: alexion.com/innovation/data-science-and-ai
-
Alexion
@AlexionPharma
People living with neuromyelitis optica spectrum disorder (#nmosd) often experience relapses, which can be severe and result in permanent disability. We’re committed to educating around the impact of relapses and the importance of timely diagnosis and treatment for patients.
-
Alexion
@AlexionPharma
Are you passionate about making a difference in patients' lives? At Alexion, we're pioneering groundbreaking therapies for rare and devastating diseases and looking for top-tier talent to join us. Could you be up for the challenge? Let’s find out: careers.alexion.com
-
Alexion
@AlexionPharma
Generalised #myastheniagravis can feel invisible to others due to its rapidly fluctuating symptoms. Our short film, Rare Connections in gMG, highlights the importance of being seen. Watch the full film at rareconnectionsfilms.com!
-
Alexion
@AlexionPharma
On average, it takes nearly five years and visits to seven different specialists to receive a correct rare disease diagnosis. Alexion is helping shorten the diagnostic journey for people living with rare disease. Learn more: alexion.com/innovation/diagnostics
-
Alexion
@AlexionPharma
Symptoms of hypophosphatasia (#hpp) can appear at any age and accumulate or worsen over time, they can cause significant disability or impaired mobility.
-
Alexion
@AlexionPharma
Like many #rarediseases, symptoms of generalised #myastheniagravis (gMG) can easily masquerade as many disorders, often delaying diagnosis for years to come. Recognising these symptoms can lead to faster diagnoses and help ensure the best possible outcomes.
-
Alexion
@AlexionPharma
What makes regulatory affairs a unique group in rare disease R&D? Watch to learn more from Sarah Rhee.
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
Our mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all that we do. Learn more about who we are at Alexion, AstraZeneca #raredisease: alexion.com/about-us
-
Alexion
@AlexionPharma
For many people, amyloid light chain (AL) #amyloidosis is not accurately diagnosed until the later stages of the disease, when prognosis is poor. Education around signs and symptoms is critical to help shorten time to diagnosis for patients.
-
Alexion
@AlexionPharma
#icymi: we launched Rare Connections in gMG to showcase the impact of generalised #myastheniagravis − a rare, often invisible, disease − on three people living with this condition. Click below to learn about the power that comes with being seen 👇 www.youtube.com/watch?v=Jvq0gLWGAEI&list=PLJQx_6LtucSB9GG…
-
Alexion
@AlexionPharma
Meet our diagnostics team working to advance the field to improve outcomes in #raredisease.
-
Alexion
@AlexionPharma
At Alexion, we’re fueled by one purpose: to transform the lives of people living with #rarediseases. Does this sound like you? Apply today: careers.alexion.com
-
Alexion
@AlexionPharma
Pioneering innovation means being willing to push the boundaries of science to address areas of high unmet need. Learn more about this philosophy from Gianluca and how Alexion’s patient-centered approach is innovating rare disease clinical trial design. alexion.com/news-centre-resources/articles/patient-centri…
-
Alexion
@AlexionPharma
Dive into our research and development approach at Alexion, where science meets dedication to address rare diseases. Read more: alexion.com/our-approach
-
Alexion
@AlexionPharma
aHUS is a type of thrombotic microangiopathy (TMA), a group of severe and potentially life-threatening rare disorders that cause blood clots and damage to blood vessels, which can lead to organ damage and death. See the signs, symptoms & complications associated with TMAs⬇️
-
Alexion
@AlexionPharma
Apply to join our talented team of individuals looking to make a difference in the lives of #raredisease patients: careers.alexion.com
-
Alexion
@AlexionPharma
Rare Connections in gMG sheds light on the emotional and physical toll of generalised #myastheniagravis (gMG) through the voices of three individuals living with gMG. Watch the film at www.youtube.com/watch?v=Jvq0gLWGAEI&list=PLJQx_6LtucSB9GG… to learn about the strength and resilience of Marta, Deanna and Nick.
-
Alexion
@AlexionPharma
Developing transformative therapies for rare diseases means overcoming unique challenges and reimagining foundational elements of research and development. Learn more about Alexion's Research and Development: alexion.com/rare-disease-research-and-development
-
Alexion
@AlexionPharma
Symptoms of hypophosphatasia (#hpp) can appear at any age and accumulate or worsen over time, they can cause significant disability or impaired mobility.
-
Alexion
@AlexionPharma
We’re excited to be at the @TheEndoSociety’s Annual Meeting in Endocrinology presenting new research in #hypophosphatasia (HPP) that could help improve understanding of this rare disease for endocrine and bone metabolism researchers and clinicians from around the globe.
-
Alexion
@AlexionPharma
Navigating the complex regulatory environment for #raredisease requires innovation thinking and collaboration.
Learn how we’re paving regulatory pathways using a patient-first mindset: alexion.com/news-centre-resources/articles/paving-regulat… -
Alexion
@AlexionPharma
Our mission is to transform the lives of people affected by rare diseases and devastating conditions by continuously innovating and creating meaningful value in all that we do. Learn more our unwavering commitment to the #raredisease community: alexion.com/about-us
-
Alexion
@AlexionPharma
We’re committed to advancing the understanding of paroxysmal nocturnal haemoglobinuria (#pnh) and showing our support for the PNH community. Learn about this rare, chronic, progressive and potentially life-threatening blood disorder below.
-
Alexion
@AlexionPharma
What is amyloid light chain (AL) #amyloidosis? Learn more about this #raredisease below.
Amyloid light chain (AL) #amyloidosis, also referred to as AL, is a rare, systemic and progressive disorder caused by defective plasma cell in the bone marrow. -
Alexion
@AlexionPharma
Are you passionate about making a difference in patients' lives? At Alexion, we're pioneering groundbreaking therapies for rare and devastating diseases and looking for top-tier talent to join us. Could you be up for the challenge? Let’s find out: careers.alexion.com
-
Alexion
@AlexionPharma
We recently screened our Rare Connections short film collection at @EANeurology. Our latest addition, Rare Connections in gMG, shares the powerful stories of three individuals living with generalised #myastheniagravis. Watch the film at rareconnectionsfilms.com 🎬
-
Alexion
@AlexionPharma
Generalised #myastheniagravis can feel invisible to others due to its rapidly fluctuating symptoms. Our recently premiered short film, Rare Connections in gMG, highlights the importance of being seen. Watch the full film here: www.youtube.com/watch?v=xDphLrcdpwo
-
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is a rare and debilitating autoimmune disease characterised by unpredictable relapses, or attacks. Learn more about the condition below.
-
Alexion
@AlexionPharma
Excited to be in Helsinki, Finland at the 11th Congress of the European Academy of Neurology @EANeurology. We are proud to be highlighting the latest from our neuromyelitis optica spectrum disorder (#nmosd) and generalised #myastheniagravis (gMG) research!
-
Alexion
@AlexionPharma
HSCT-TMA is a rare, severe and potentially life-threatening type of TMA that occurs following haematopoietic stem cell transplantation, a procedure to treat some types of cancers and other diseases. Learn more about this condition below.
-
Alexion
@AlexionPharma
#bio2025 kicks off today in Boston, right near our Seaport HQ. Together with @AstraZeneca, we are excited for dynamic discussions about the policies needed to foster drug development, support access to care, and drive meaningful change for the #raredisease community.
-
Alexion
@AlexionPharma
Today, we wrap up an inspiring few days at the European Hematology Association @EHA_Hematology 2025 Congress! It was an exciting opportunity to gather with experts in the field whose insights help inform our work to improve care for people living with rare haematologic diseases.
-
Alexion
@AlexionPharma
Paroxysmal nocturnal haemoglobinuria (#pnh) is a rare, chronic, progressive, and potentially life-threatening blood disorder that is characterised by red blood cell destruction within blood vessels and white blood cell and platelet activation, which may lead to blood clots.
-
Alexion
@AlexionPharma
Hello from Milan! We’re excited to be attending the European Hematology Association @EHA_Hematology 2025 Congress. We look forward to presenting our latest advancements in #pnh and #hsct-TMA research and engaging with the scientific community.
-
Alexion
@AlexionPharma
-
Alexion
@AlexionPharma
IgA Nephropathy (#igan) is a rare, chronic kidney disease that begins when the body develops abnormal IgA proteins that then result in immune complexes that are deposited in the kidneys causing damage. Take some time to learn more about this rare disease.
-
Alexion
@AlexionPharma
Atypical haemolytic uraemic syndrome (#ahus) is a rare, progressive, chronic disease with relapses. It’s a type of thrombotic microangiopathy, a group of severe and potentially life-threatening rare disorders that cause blood clots and damage to small blood vessels.
-
Alexion
@AlexionPharma
Greetings from Vienna! We’re proud to be attending the 62nd European Renal Association [@ERAkidney] Congress where we will be showcasing our latest research in atypical haemolytic uraemic syndrome (#ahus) and immunoglobulin A nephropathy (#igan).
-
Alexion
@AlexionPharma
This #mgawarenessmonth we’re proud to introduce Rare Connections in gMG, a powerful short film underscoring the strength and resilience of three people living with generalised #myastheniagravis. Watch the film here: www.youtube.com/watch?v=xDphLrcdpwo
-
Alexion
@AlexionPharma
June is #mgawarenessmonth! Now and always, our commitment to advancing research and awareness for generalised #myastheniagravis remains unwavering. Join us as we spotlight the stories of those living with this rare disease and educate around gMG throughout the month!
-
Alexion
@AlexionPharma
Today is #worldhypoparaday, dedicated to raising awareness of #hypoparathyroidism and the ongoing needs of those impacted by it. Join us in helping to educate on this rare endocrine disease.
-
Alexion
@AlexionPharma
At Alexion, we’re fueled by one purpose: to transform the lives of people living with #rarediseases. Does this sound like you? Apply today: careers.alexion.com
-
Alexion
@AlexionPharma
Symptoms of hypophosphatasia (#hpp) can appear at any age and accumulate or worsen over time, they can cause significant disability or impaired mobility.
-
Alexion
@AlexionPharma
Pioneering innovation means being willing to push the boundaries of science to address areas of high unmet need.
Learn more about this philosophy from Gianluca and how Alexion’s patient-centered approach is innovating rare disease clinical trial design. alexion.com/news-centre-resources/articles/patient-centri… -
Alexion
@AlexionPharma
While commonly recognized in early childhood, #neurofibromatosis type 1 (NF1) is a lifelong, progressive condition that can vary in severity. From initial signs like café au lait spots to neurofibromas, see how this disease can manifest below. #nfawarenessmonth
-
Alexion
@AlexionPharma
Individually rare, these diseases still affect millions across Europe, creating major challenges for patients, families and healthcare systems.
Explore @News_CRA's findings on the economic and emotional impacts: www.crai.com/insights-events/publications/the-economic-co…
#raredisease -
Alexion
@AlexionPharma
Our teams are working to advance genomic medicine by building upon prime editing tech. Learn about this powerful approach, published recently in @NatureComms, which holds potential to treat the underlying cause of many rare diseases: www.astrazeneca.com/what-science-can-do/topics/next-gener…
#whatsciencecando -
Alexion
@AlexionPharma
Hypophosphatasia (#hpp) can affect males and females of all ages, with certain symptoms more common based on a person’s age.
-
Alexion
@AlexionPharma
Clinical trials are investments for the future of healthcare, research, innovation & the rare disease community. This #clinicaltrialsday learn about our aim to drive innovation & advance science to support clinical trials for patients: www.astrazeneca.com/what-science-can-do/topics/clinical-i…
#whatsciencecando -
Alexion
@AlexionPharma
#neurofibromatosis (NF) is a rare genetic disorder involving the development of tumors that may affect the brain, spinal cord and nerves. As the most common type of NF, neurofibromatosis type 1 (NF1) affects about 1 in 3,000 people worldwide. #nfawarenessmonth
-
Alexion
@AlexionPharma
#neurofibromatosis Type 1, also known as #nf1, affects about 1 in 3,000 people globally. Learn more about this rare genetic disorder below. #nfawarenessmonth
-
Alexion
@AlexionPharma
As a clinician, industry veteran and parent to a child with a #raredisease, Gianluca’s unique perspectives help to shape Alexion’s approach to clinical development and foster meaningful advancements for people impacted by rare diseases.
Learn more: alexion.com/news-centre-resources/articles/patient-centri… -
Alexion
@AlexionPharma
IgA Nephropathy (#igan) is a rare, chronic kidney disease that begins when the body develops abnormal IgA proteins that then result in immune complexes that are deposited in the kidneys causing damage. Take some time to learn more about this rare disease. #iganaware
-
Alexion
@AlexionPharma
Today and every day, we proudly stand with the @IGANFoundation to raise awareness of IgA Nephropathy. By listening to and learning from people living with this rare kidney disease, we aim to bring hope to this resilient community. Show your support by liking this post!❤️#iganday
-
Alexion
@AlexionPharma
As the Joint Congress of ESPE and ESE comes to a close, we are grateful for opportunity to engage with experts across the community and educate on our dedication to increasing understanding of certain rare metabolic and endocrine diseases.
-
Alexion
@AlexionPharma
Apply to join our talented team of individuals looking to make a difference in the lives of #raredisease patients: careers.alexion.com
-
Alexion
@AlexionPharma
At the @ESEndocrinology & @EuroSPE Joint Congress, we’re reinforcing our commitment to advancing research of rare bone metabolic and endocrine diseases and contributing to discussions to improve understanding of conditions like #hypophosphatasia and #hypoparathyroidism.
-
Alexion
@AlexionPharma
Typically diagnosed in early childhood, #neurofibromatosis (NF) is a rare genetic disorder that involves the development of tumors that may affect the brain, spinal cord, and nerves. This #nfawarenessmonth, learn about NF1, the most common type of NF.
-
Alexion
@AlexionPharma
Are you passionate about making a difference in patients' lives? At Alexion, we're pioneering groundbreaking therapies for rare and devastating diseases and looking for top-tier talent to join us. Could you be up for the challenge? Let's find out: careers.alexion.com
-
Alexion
@AlexionPharma
We're committed to raising awareness of #neurofibromatosis during #nfawarenessmonth in May and throughout the year. Re-share this post to join us in recognising this #raredisease and celebrating the strength of the #nf community.
-
Alexion
@AlexionPharma
Individually rare, these diseases still affect millions across Europe, creating major challenges for patients, families and healthcare systems.
Explore @News_CRA's findings on the economic and emotional impacts: www.crai.com/insights-events/publications/the-economic-co…
#raredisease -
Alexion
@AlexionPharma
At Alexion, every team member plays a crucial role in advancing our mission to serve patients in need. Are you driven by purpose and ready to make a difference for the #raredisease community? Explore our job openings and join our team today: careers.alexion.com
-
Alexion
@AlexionPharma
Ready to join a team dedicated to transforming the lives of people living with rare diseases? Look no further. Explore our career opportunities to help deliver breakthrough therapies and make a difference in the lives of those in need: careers.alexion.com
-
Alexion
@AlexionPharma
Understanding the challenges of a rare diagnosis and the journey that follows is critical to the work we do. That's why we partner so closely with patients and caregivers to our research and development.
Learn more: alexion.com/living-in-rare -
Alexion
@AlexionPharma
Generalised #myastheniagravis (gMG) is a debilitating rare autoimmune disorder characterized by loss of muscle function and severe muscle weakness. Learn how this occurs below.
-
Alexion
@AlexionPharma
We’re committed to advancing the understanding of paroxysmal nocturnal haemoglobinuria (#pnh) and showing our support for the #pnh community. Learn about this rare, chronic, progressive and potentially life-threatening blood disorder below.
-
Alexion
@AlexionPharma
Hello from Florence! We’re excited to be at the 51st Annual Meeting of the European Society for Blood and Marrow Transplantation @TheEBMT! Looking forward to presenting our latest research in PNH and advancing scientific exchange with the haematology community.
-
Alexion
@AlexionPharma
Today and every day, we are committed to supporting patients affected by rare kidney diseases. This #worldkidneyday, learn how you can show your support and get involved: www.worldkidneyday.org
-
Alexion
@AlexionPharma
March is #nmoawarenessmonth, an important time to support education and recognise the neuromyelitis optica spectrum disorder (#nmosd) community. This year, we are proud to elevate the voices of those living with the disease and educate around NMOSD throughout the month.
-
Alexion
@AlexionPharma
We proudly stand with the rare disease community, highlighting their resilience and inspiring our continued efforts to tackle the long diagnosis timeline and life-changing treatments. #rarediseaseday
-
Alexion
@AlexionPharma
The crucial role of diagnosis and treatment availability for rare diseases can't be overstated. ⏰ Discover the impact of treatment unavailability and misdiagnosis for rare disease patients in this new report from @News_CRA: www.crai.com/insights-events/publications/the-economic-co… .
#raredisease -
Alexion
@AlexionPharma
Millions of people live with a #raredisease, yet less than 10% of the 10,000+ rare diseases have approved treatment options. Advancing the development of and providing greater access to innovative therapies are critical to fulfilling this unmet need.
-
Alexion
@AlexionPharma
Did you know? People with rare diseases face a 32% decrease in quality of life, incur costs 6x higher, and lose 78 workdays a year. Swipe through to learn more and read the latest report from @News_CRA: www.crai.com/insights-events/publications/the-economic-co…
-
Alexion
@AlexionPharma
Annually, rare diseases cost Europe an impressive €249.3 billion, impacting individuals, families, and healthcare systems financially.
Learn more in the latest report from @News_CRA: www.crai.com/insights-events/publications/the-economic-co… -
Alexion
@AlexionPharma
While the definition of a rare disease differs across countries, one thing is certain: the number of people living with a #raredisease is high. We’re committed to improving equitable access to healthcare for those living with rare.
-
Alexion
@AlexionPharma
Individually rare, these diseases still affect millions across Europe, creating major challenges for patients, families and healthcare systems.
Explore @News_CRA's findings on the economic and emotional impacts: www.crai.com/insights-events/publications/the-economic-co…
#raredisease -
Alexion
@AlexionPharma
Over 400 million people worldwide live with a #raredisease. But did you know 1 of 2 patients diagnosed with a rare disease is a child?
-
Alexion
@AlexionPharma
DYK that amyloidosis is a group of rare disease that is often misdiagnosed, because its signs and symptoms can mimic other diseases? Learn more: alexion.com/news-centre-resources/articles/addressing-the…
-
Alexion
@AlexionPharma
Why is a group of rare diseases, called amyloidosis, known as a “great pretender”? Learn more about this disease from Cristina Quarta: alexion.com/news-centre-resources/articles/addressing-the…
-
Alexion
@AlexionPharma
We spoke with Seng Cheng, Head of Research and Product Development about what creativity, serial innovation and passion looks like in rare disease R&D. Watch the video to learn more.
-
Alexion
@AlexionPharma
#raredisease #clinicaltrials present many challenges–small patient populations, few diagnostic tools available, if any, and limited understanding to name some. Learn how we continue to overcome these challenges and drive innovation forward in rare disease R&D.
-
Alexion
@AlexionPharma
Overcoming the unique challenges in #raredisease clinical trials requires a deep understanding of what those challenges are. We explore some of those hurdles and what makes rare disease trials so impactful in this video ⬇️
-
Alexion
@AlexionPharma
New research in @NatureComms shows how our ePsCas9 gene editing system offers greater precision. This specificity represents an important advancement in #genomicmedicine with potential for many rare diseases. Learn more: www.astrazeneca.com/what-science-can-do/topics/clinical-i…
-
Alexion
@AlexionPharma
Meet our diagnostics team working to advance the field to improve outcomes in #raredisease.
-
Alexion
@AlexionPharma
When we say we work tirelessly to better understand the patient experience—we mean it. Hear from Adrian Kielhorn on how his Health Economics & Outcomes Research team puts this belief into practice every day to learn more about patient needs & how we can help improve their lives.
-
Alexion
@AlexionPharma
More than 90% of #rarediseases have no approved treatment option. We’re determined to change that. Learn how we’re working tirelessly to deliver on that promise for the millions of rare disease patients worldwide: alexion.com
-
Alexion
@AlexionPharma
We truly believe Alexion is a great place to work. But don’t just take our word for it – hear perspectives from a few of our very own: www.youtube.com/watch?v=2AsAvq15CsI #lifeatalexion
-
Alexion
@AlexionPharma
For us, patient centricity isn't just a goal—it's our guiding principle. If you’re passionate about improving the lives of people affected by #rarediseases, we’d love to have you on our team. Apply now: careers.alexion.com
-
Alexion
@AlexionPharma
Amyloid light chain (AL) amyloidosis is the most common form of systemic #amyloidosis.
AL can result in significant organ damage and organ failure that can ultimately be fatal. -
Alexion
@AlexionPharma
Meet our diagnostics team working to advance the field to improve outcomes in #raredisease.
-
Alexion
@AlexionPharma
Since 2013, our Blanchardstown, Dublin facility has been Alexion’s Global Supply Chain and Operations headquarters. Hear from our Site Lead Maureen Larkin about our onsite operations and vibrant team culture: www.youtube.com/watch?v=WMyZY20sGxg&list=PLJQx_6LtucSBngZ…
-
Alexion
@AlexionPharma
We’re committed to fostering a culture of continuous learning and development by offering ample opportunities for our people to thrive in their careers. Hear from two colleagues who were able to grow their careers at Alexion in ways they could never have imagined elsewhere.
-
Alexion
@AlexionPharma
What’s next in the advancement of genomic medicine for rare disease? Read to learn more: alexion.com/news-centre/
-
Alexion
@AlexionPharma
What gets our Head of Patient Experience and Insights excited about coming to work at Alexion? The shared sense of purpose. Listen to Wendy’s inspiring journey to patient advocacy and how it has led her to become a passionate advocate for patients today. www.youtube.com/watch?v=Fl0o0rDjXEA
-
Alexion
@AlexionPharma
“We have this fantastic opportunity to use an expanding toolbox of therapeutic modalities to unlock transformative medicines for patients.”
-Nick France -
Alexion
@AlexionPharma
Many patients who may be eligible to participate in a #raredisease #clinicaltrial don’t, mostly due to a lack of awareness or misconceptions about clinical trials. This leads to many patients not receiving optimal care. We’re on a mission to change that.
-
Alexion
@AlexionPharma
New research in @NatureComms shows how our ePsCas9 gene editing system offers greater precision. This specificity represents an important advancement in #genomicmedicine with potential for many rare diseases. Learn more: www.astrazeneca.com/what-science-can-do/topics/clinical-i…
-
Alexion
@AlexionPharma
#raredisease poses its own set of unique challenges for patients—this also extends to those who care for them too. But caregivers don’t have to do it alone. Check out www.caregiver.org for helpful resources
-
Alexion
@AlexionPharma
We are steadfast in our commitment to the #hypophosphatasia (HPP) community—today, and every day. This #worldhppday, join us in raising awareness and showing your support for those affected by this rare, inherited, metabolic disease characterised by defective mineralisation.
-
Alexion
@AlexionPharma
In recognition of #worldamyloidosisday on October 26, we stand together with the #amyloidosis community to raise awareness and shine a light on the unique challenges of this #raredisease.
-
Alexion
@AlexionPharma
At Alexion, we're not just hiring employees; we're building a team of passionate individuals committed to making a difference for the #raredisease community. Hear from a few of our colleagues what makes #lifeatalexion so special. ✨
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
Living with paroxysmal nocturnal haemoglobinuria (#pnh) can be debilitating. On this first-ever Global PNH Awareness Day, take some time to learn about the signs and symptoms of this rare, chronic, progressive and potentially life-threatening blood disorder.
-
Alexion
@AlexionPharma
This year, October 12th marks the very first Global Paroxysmal Nocturnal Haemoglobinuria (PNH) Awareness Day. Today, and every day, we’re proud to support @GlobalPnh and the entire community to raise awareness of this rare blood disorder and advocate for those living with #pnh.
-
Alexion
@AlexionPharma
Discover the powerful journey of three individuals living with neuromyelitis optica spectrum disorder (#nmosd) as they exchange and read letters about their personal experiences in our short film, “Rare Connections in NMOSD”: www.youtube.com/watch?v=cfnE7cxfY3s
-
Alexion
@AlexionPharma
For 30+ years, our pioneering science in #raredisease research and development has paved the way for life-changing medicines. Are you looking to be part of a team that's redefining what's possible in the rare disease treatment landscape? Look no further: careers.alexion.com
-
Alexion
@AlexionPharma
Digital biomarkers have the potential to help researchers more effectively study #rarediseases by providing a better understanding of symptoms and their response to therapy. Learn more about how these data can accelerate the discovery and development of new medicines here:
-
Alexion
@AlexionPharma
On #ahusday, explore atypical haemolytic uraemic syndrome (aHUS), a rare, progressive, chronic disease with relapses and a type of thrombotic microangiopathy (TMA). Learn more about the signs, symptoms and complications of TMAs below.
-
Alexion
@AlexionPharma
Today, we stand with the @aHUSAllianceAct and recognise #ahusday—a time to honour people living with atypical haemolytic uraemic syndrome, shed light on the unique challenges of living with this rare disease and celebrate the resilience of this community. RT to show your support!
-
Alexion
@AlexionPharma
Each year, we unite with the global community to recognise aHUS Awareness Day. Ahead of #ahusday, view “A Day with Nurse Jen,” a heartfelt story dedicated to young patients and families
affected by aHUS, a progressive, chronic, rare disease with relapses:www.youtube.com/watch?v=d1W-OUd8A9A -
Alexion
@AlexionPharma
We are grateful for the opportunity to gather with the medical, advocacy and patient communities at ECTRIMS 2024 to help advance care for people living neuromyelitis optica spectrum disorder (NMOSD).
-
Alexion
@AlexionPharma
Delighted to be at ECTRIMS 2024! 🇩🇰 Building on our commitment to people living with neuromyelitis optica spectrum disorder (NMOSD), we’re proud to share our latest research and engage with the global community to help increase understanding of this rare neurological disease.
-
Alexion
@AlexionPharma
Aimee battled for an answer for 7 long years before receiving her diagnosis of generalised myasthenia gravis (gMG), a rare neurological disease. While she was relieved to finally have an answer, she still needed to process the reality of her diagnosis. This is her story.
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
We’re excited to share that an accessible version of our “Rare Connections in NMOSD” short film is now available with audio description. Our hope is that those who are visually impaired can experience the film in a new, meaningful way: www.youtube.com/watch?v=dwKpZQSZuZ0
-
Alexion
@AlexionPharma
We’re seeking talented individuals who are driven to push the boundaries of scientific discovery and bring life-changing therapies to those in need. If you’re ready to be part of a dynamic team that committed to making a difference, apply now: careers.alexion.com
-
Alexion
@AlexionPharma
Patient centricity isn’t a buzzword for us — it’s embedded in our DNA. Learn from several of our colleagues as they discuss how we act with a sense of urgency and intention to help address patient barriers. #lifeatalexion
-
Alexion
@AlexionPharma
Having navigated neuromyelitis optica spectrum disorder (#nmosd) for nearly 8 years, Craig has many lessons from living with this #raredisease. Hear from him on the importance of speaking up and advocating for yourself.
-
Alexion
@AlexionPharma
Curious about #lifeatalexion? Our Director of Global Medical Sciences Katherine Garlo shares how our commitment to bringing together diverse perspectives creates a positive and thriving workplace.
-
Alexion
@AlexionPharma
#rarediseases affect more children than you might think. In fact, 50% of those diagnosed with a rare disease are children. Share this post to drive awareness and education for children impacted by a rare disorder.
-
Alexion
@AlexionPharma
We’re committed to raising visibility of #nmosd by amplifying the stories of people living with this rare neurological disease. Learn more from Marie about her experience in our “Rare Connections in NMOSD” short film.
-
Alexion
@AlexionPharma
We're proud to partner with @EUneurology and other global stakeholders to develop The Rare Neurology Charter. Sign the Call to Action today to support the development of action plans aiding EU policy change for rare neurological diseases: www.efna.net/rnc-cta/
-
Alexion
@AlexionPharma
Raj joined Alexion because he was inspired by the mission to find solutions for devastating conditions that have few or no available treatment options. Watch to hear more about the challenges that motivate Raj to follow the science every day. #lifeatalexion
-
Alexion
@AlexionPharma
At Alexion, every team member plays a crucial role in advancing our mission to serve patients in need. Are you driven by purpose and ready to make a difference for the #raredisease community? Explore our job openings and join our team today: careers.alexion.com
-
Alexion
@AlexionPharma
Living with a #raredisease like neuromyelitis optica spectrum disorder (#nmosd) can be challenging, and patients often feel alone on their journey. Hear from Alex, who shares the importance of connection and community.
-
Alexion
@AlexionPharma
Today, @AstraZeneca completed the acquisition of @AmolytPharma. This acquisition bolsters the Alexion, AstraZeneca Rare Disease pipeline and expands on its bone metabolism franchise as we work to serve more #raredisease patients around the world.
-
Alexion
@AlexionPharma
For those living with #rarediseases, the path to diagnosis can feel like an endless odyssey, marked by countless challenges. Millions navigate a maze of misdiagnoses, unanswered questions, and relentless uncertainty. We’re hoping to change that through education and awareness.
-
Alexion
@AlexionPharma
We spoke with Seng Cheng, Head of Research and Product Development about what creativity, serial innovation and passion looks like in rare disease R&D. Watch the video to learn more.
-
Alexion
@AlexionPharma
At Alexion, we’re fueled by one purpose: to transform the lives of people living with #rarediseases. Does this sound like you? Apply today: careers.alexion.com
-
Alexion
@AlexionPharma
The complement system is a strong and powerful tool that protects the body against harmful invaders – but when thrown out of balance, its proteins can trigger a dangerous, uncontrolled cascade of reactions that attack cells and tissues. Watch the video to learn more.
-
Alexion
@AlexionPharma
What is a rare disease? It’s defined as a condition that affects a small population of people, but the definition can vary by region. Swipe to learn how the definition of “rare disease” differs in various countries across the globe.
-
Alexion
@AlexionPharma
It was a privilege to meet with experts at the EAN Congress as we work toward our shared goal of improving patient outcomes for rare neurological diseases.
-
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease characterised by unpredictable relapses. Learn why relapse prevention is critical for patients.
-
Alexion
@AlexionPharma
Generalised #myastheniagravis (gMG) can be challenging to diagnose because its symptoms often mimic other conditions. Continued research and awareness are critical to help patients receive an earlier diagnosis. #mgawarenessmonth
-
Alexion
@AlexionPharma
We're excited to mark a decade of the Congress of the European Academy of Neurology (EAN) at this year's meeting in Helsinki, Finland. Looking forward to presenting research in gMG and NMOSD, two rare neurological diseases.
-
Alexion
@AlexionPharma
“It takes a village to bring an AI to real world,” says Chathuri Daluwatte, Head of AI Diagnostics. Learn about the AI Diagnostic work she leads at Alexion.
-
Alexion
@AlexionPharma
Since 1992, our mission is, and always has been, to pioneer breakthrough therapies and make a meaningful difference in the lives of patients with #rarediseases. Interested? Explore our opportunities: careers.alexion.com
-
Alexion
@AlexionPharma
At #hltheurope? Join us for a panel session with Soraya Bekkali, SVP, EUCAN & International Business, as she explores how technology could be the answer to addressing the healthcare inequities that plague our healthcare systems and disproportionately impact rare disease patients.
-
Alexion
@AlexionPharma
People living with generalised #myastheniagravis (gMG) may experience a range of symptoms that can take an immense toll on daily life. Education around signs and symptoms is critical to help shorten time to diagnosis for patients. #mgawarenessmonth
-
Alexion
@AlexionPharma
What an exciting few days at the European Hematology Association 2024 Annual Congress! We’re thankful for the opportunity to engage with the scientific community and educate on our commitment to drive innovation forward for certain rare haematologic diseases.
-
Alexion
@AlexionPharma
Paroxysmal nocturnal haemoglobinuria (PNH) can lead to blood clots and/or damage to vital organs, which can result in an overall impaired quality of life and potentially premature death, making timely diagnosis and treatment critical. Learn how PNH is diagnosed and monitored.
-
Alexion
@AlexionPharma
Diagnosis of amyloid light chain (AL) amyloidosis is often delayed and can take more than 6 months after symptoms begin. Learn how this condition can be diagnosed below.
-
Alexion
@AlexionPharma
Greetings from Madrid! 🇪🇸 We’re excited to be attending the European Hematology Association’s 2024 Hybrid Congress, where we’ll present our latest research in PNH and AL amyloidosis. We look forward to engaging with the haematology community to advance scientific exchange.
-
Alexion
@AlexionPharma
Many people living with neuromyelitis optica spectrum disorder (#nmosd) suffer from relapses that can result in vision loss and paralysis. That was the case for Marie, whose eyes and spinal cord were impacted significantly.
-
Alexion
@AlexionPharma
This #mgawarenessmonth, we're shining a light on generalised myasthenia gravis, also known as gMG. Learn more about this rare disease and how it impacts patients in the video below.
-
Alexion
@AlexionPharma
What is the potential impact of the Inflation Reduction Act on #raredisease R&D and patient access to medicines? Join us today for a panel with Katie Jones, Senior Director, Federal Affairs, @rarediseases, @IVI_Health and Rare & Black to learn more.
-
Alexion
@AlexionPharma
We're a proud sponsor of this year's @BioConvention, where we'll gather with leaders from across the global biotech ecosystem. If you're attending, don't miss our panel session on the Inflation Reduction Act and its impact on #raredisease research & development.
-
Alexion
@AlexionPharma
As we continue our long-standing efforts to research and raise awareness of generalised #myastheniagravis (gMG), a rare autoimmune disease, we are proud to recognise #mgawarenessmonth in June. Join us in showing your support for the MG community!
-
Alexion
@AlexionPharma
This #womenshealthmonth, we're proud to sponsor the latest edition of @RareRevolutionM, which celebrates and amplifies the lived experiences of women in the #raredisease community. Check out the full edition here: editions.rarerevolutionmagazine.com/cookie_check.aspx?pub…
-
Alexion
@AlexionPharma
#icymi: As part of our commitment to advancing understanding of #nmosd, we launched “Rare Connections in NMOSD,” a powerful short film that tells the stories of three people living with the condition through letters. Get a sneak peek of the film below.
-
Alexion
@AlexionPharma
At the XIX International Symposium on Amyloidosis this year, we’re proud to be presenting our latest research in amyloidosis, a group of rare diseases caused by abnormal proteins that misfold and clump together to form toxic amyloids.
-
Alexion
@AlexionPharma
From insightful research presentations to thought-provoking discussions, each moment at the European Renal Association (ERA) Congress has been a step forward in advancing our mission to improve care for the rare disease community, including people living with aHUS or IgAN.
-
Alexion
@AlexionPharma
With approximately 25-30% of people with IgA nephropathy progressing to kidney failure, there is an urgent need to bring new options that can prevent disease progression and improve quality of life. We’re working to bring innovation through our research in complement science.
-
Alexion
@AlexionPharma
Hello from Stockholm! We’re at the 61st European Renal Association (ERA) Congress, where we’ll be presenting our latest research in atypical haemolytic uraemic syndrome (aHUS) and immunoglobulin A (IgA) nephropathy.
-
Alexion
@AlexionPharma
Patient perspectives play an essential role in rare disease research and development (R&D). In this Q&A, Sophia Zilber discusses her passion for statistical programming and her personal connection to #raredisease research. www.youtube.com/watch?v=xoGx355nuDE
-
Alexion
@AlexionPharma
IgA Nephropathy is a rare, chronic kidney disease that begins when the body develops abnormal IgA proteins that result in immune complexes that build up in the kidneys causing damage. This #iganawareday, take some time to learn more about this rare disease.
-
Alexion
@AlexionPharma
Today, we stand together with the @IGANFoundation to raise awareness for people living with IgA Nephropathy, a rare, chronic kidney disease. Show your support for this community by liking this post! ❤️ #iganawareday
-
Alexion
@AlexionPharma
Are you passionate about making a difference in patients' lives? At Alexion, we're pioneering groundbreaking therapies for rare and devastating diseases and looking for top-tier talent to join us. Could you be up for the challenge? Let’s find out: careers.alexion.com
-
Alexion
@AlexionPharma
#raredisease patients often face a long and difficult path to diagnosis, a journey called the “diagnostic odyssey.” Learn how we’re developing innovative diagnostic solutions with the potential to help patients get care and the right diagnosis faster: www.youtube.com/watch?v=gLvb9vai18o
-
Alexion
@AlexionPharma
We're looking for talented individuals who share our dedication to improving patient outcomes. Every role at Alexion contributes to our shared goal: delivering life-changing therapies to those who need them most. Could this be you? Apply now: careers.alexion.com
-
Alexion
@AlexionPharma
Immunoglobulin A (IgA) nephropathy is a rare, chronic kidney disease. Approximately 25-30% of people with IgA nephropathy will progress to end-stage kidney disease, or kidney failure, requiring long-term dialysis or a kidney transplant. Learn more about this condition below.
-
Alexion
@AlexionPharma
Haematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) is a type of TMA–a group of severe and potentially life-threatening rare disorders that cause blood clots & damage to the walls of the smallest blood vessels–triggered by HSCT. Learn more below.
-
Alexion
@AlexionPharma
Hello from Buenos Aires! 👋 We’re excited to be joining the global kidney care community at the World Congress of Nephrology, where we’ll be presenting our latest research in Immunoglobulin A (IgA) Nephropathy, a rare, chronic kidney disease.
-
Alexion
@AlexionPharma
We’re excited to announce Rare Connections in NMOSD. This powerful short film weaves together the stories of Craig, Alex & Marie as told in letters. Watch below to see the power of finding support and community. www.youtube.com/watch?v=cfnE7cxfY3s
-
Alexion
@AlexionPharma
We're pleased to be attending the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in London, where we'll be presenting our latest research in hypophosphatasia (HPP).
-
Alexion
@AlexionPharma
Paroxysmal nocturnal hemoglobinuria (#pnh) is a rare, chronic, progressive, and potentially life-threatening blood disorder that is characterized by red blood cell destruction within blood vessels and white blood cell and platelet activation, which may lead to blood clots.
-
Alexion
@AlexionPharma
People living with #rarediseases are faced with unique challenges, which often require unique solutions. We are committed to leading the way by applying a deep understanding of the patient experience to our clinical trial design. Learn how: www.astrazeneca.com/what-science-can-do/topics/clinical-i…
-
Alexion
@AlexionPharma
#nmoawarenessmonth may be coming to an end, but our work never stops. We remain committed to the #nmosd community and strive to help the countless people whose lives are impacted by this rare disease.
-
Alexion
@AlexionPharma
Without collaboration, there would be no progress. Just ask SungKwon Kim, a driven research investigator based at our New Haven Center of Excellence in CT. Hear why he’s passionate about scientists partnering to drive complement research forward.
-
Alexion
@AlexionPharma
This #nmoawarenessmonth, we’re launching a new storytelling approach to share what living with a #raredisease like neuromyelitis optica spectrum disorder (#nmosd) means. Hear from Alex, who has been living with the condition since she was a teenager.
-
Alexion
@AlexionPharma
The journey to diagnosis for #nmosd can be long, and patients can feel isolated and alone. This #nmoawarenessmonth, we are highlighting the patient experience and the power of the community to raise awareness - and will be sharing a new storytelling approach soon. Stay tuned!
-
Alexion
@AlexionPharma
Tackling #rarediseases is an ambitious goal – but one we embrace head-on. As we work towards closing the gap of unmet need for people living with rare diseases, we’re hiring top-tier talent to join us. Apply now: careers.alexion.com
-
Alexion reposted
AstraZeneca
@AstraZeneca
Intended for investors:
We have entered into a definitive agreement to acquire @AmolytPharma, further expanding our late-stage rare disease pipeline. Learn more about the financial considerations here: learn.az/6019kTK63 -
Alexion
@AlexionPharma
Today and every day, we are committed to supporting patients affected by rare kidney diseases. This #worldkidneyday, learn how you can show your support and get involved: www.worldkidneyday.org
-
Alexion
@AlexionPharma
#nmosd is associated with unpredictable attacks, also known as relapses, which can lead to long term disability like vision loss or paralysis. Explore what other symptoms are associated with this #raredisease below. #nmoawarenessmonth
-
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is a rare and debilitating autoimmune disease characterised by unpredictable relapses, or attacks. In honour of #nmoawarenessmonth, learn more about the condition below ⬇️
-
Alexion
@AlexionPharma
March is #nmoawarenessmonth, an important time to support education and recognise the neuromyelitis optica spectrum disorder (#nmosd) community. This year, we are proud to elevate the voices of those living with the disease and educate around NMOSD throughout the month.
-
Alexion
@AlexionPharma
People with #rarediseases often experience a lengthy diagnostic journey, lack of treatment options, and limited awareness of their conditions. On #rarediseaseday, learn how we are making a meaningful impact for people living with rare diseases every day: www.astrazeneca.com/media-centre/articles/rare-disease-da…
-
Alexion
@AlexionPharma
Rare is many. Rare is strong. Rare is proud.
Today, on #rarediseaseday, we stand tall, strong, and proud as one of many in support of the broader rare community. Join us in amplifying the needs of people living with #rarediseases on this incredibly important day. 🦓 -
Alexion
@AlexionPharma
Tune in LIVE for The @WhiteHouse Rare Disease Forum on Wednesday, 2/28 at 5:30 pm ET. Tamar Thompson, VP, Global Corporate Affairs, will join a panel to highlight the need for #raredisease health equity & a regulatory environment that fosters innovation: www.youtube.com/live/uG43oLZzeBE?cbrd=1&ucbcb=1
-
Alexion
@AlexionPharma
While each of the 400 million people worldwide living with #raredisease is on their own journey, together, they share a collective journey. In honour of #rarediseaseday this week, learn about the shared challenges of this community and why we will never stop delivering for them.
-
Alexion
@AlexionPharma
In honour of #rarediseaseday next week, we’re thrilled to share that our 3rd book in the Inspired By series, “Zara Shares Her Stripes,” is more widely available! Find out how you can secure a copy for you and your loved ones: zarasharesherstripes.com
-
Alexion
@AlexionPharma
Over 400 million people worldwide live with a #raredisease. But did you know 1 of 2 patients diagnosed with a rare disease is a child? Learn more about the high burden of rare diseases: globalgenes.org
-
Alexion
@AlexionPharma
Newborn screenings and genetic testing play a huge role in speeding up diagnosis & reducing health care costs—but access is limited. Broadening the availability of these diagnostic tools can aid early diagnosis of #rarediseases.
-
Alexion
@AlexionPharma
There are 10,000+ #rarediseases affecting 400M+ people worldwide. 🌎
Yet less than 10% of rare diseases have an approved treatment option. We’re on a mission to continue innovating to discover, develop, and deliver medicines to more people in need. -
Alexion
@AlexionPharma
It takes an average of 5 years to receive a rare disease diagnosis, a journey that often involves multiple doctors, specialists, and misdiagnoses along the way. It’s time to shorten the diagnostic odyssey for the #raredisease community. RT this post if you agree!
-
Alexion
@AlexionPharma
Did you know over 400 million people worldwide are living with a #raredisease? Ahead of #rarediseaseday, share this post to raise awareness for the community 📣
-
Alexion
@AlexionPharma
#rarediseases impact over 400M+ people worldwide, yet their needs often go overlooked. This #rarediseaseday, we must work together to make rare disease a public health priority and support the millions of people living with rare diseases. RT this post to show your support!
-
Alexion
@AlexionPharma
In the days leading up to #rarediseaseday, we’ll be shining a light on the bold steps that we can take to make a difference in the lives of people who are living with a rare disease. Learn more about our efforts: www.astrazeneca.com/media-centre/articles/rare-disease-da…
-
Alexion
@AlexionPharma
On February 29, we’ll be recognising #rarediseaseday: a globally coordinated movement driving equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with #rarediseases. Follow along for updates throughout the month!
-
Alexion
@AlexionPharma
⏰ 30 more days until #rarediseaseday! This year, it falls on the rarest day of the year: February 29th. We can’t wait to come together with the #raredisease community in support of patients across the globe. See how you can get involved: www.rarediseaseday.org
-
Alexion
@AlexionPharma
Like many #rarediseases, diagnosis of amyloid light chain (AL) #amyloidosis is often delayed because its symptoms often mimic other diseases. Find out how AL amyloidosis can ultimately be diagnosed below.
-
Alexion
@AlexionPharma
For Media/Investors: Today, we’re excited to announce that our add-on treatment for certain adults with #pnh has been granted its first-ever regulatory approval in Japan. Learn more: www.astrazeneca.com/media-centre/press-releases/2024/voyd…
-
Alexion
@AlexionPharma
Did you know? #amyloidosis can result in significant organ damage and failure that can be fatal. We're proud to be advancing research of this devastating condition.
-
Alexion
@AlexionPharma
As pioneers in #raredisease, we know patients are counting on us to deliver. In this video, Mary Kunjappu, Medical Director, US Medical Affairs, explains how to explore the possibilities in #raredisease research by challenging the status quo and following the science.
-
Alexion
@AlexionPharma
New year, fresh start! 🎉Apply to join our talented team of individuals looking to make a difference in the lives of #raredisease patients: careers.alexion.com
-
Alexion
@AlexionPharma
What’s our “why”? Easy. It’s the 400+ million people affected by #rarediseases around the world. Care to make an impact in the lives of patients? Join our team: careers.alexion.com
-
Alexion
@AlexionPharma
More than 90% of #rarediseases have no approved treatment option. We’re determined to change that. Learn how we’re working tirelessly to deliver on that promise for the millions of rare disease patients worldwide: alexion.com
-
Alexion
@AlexionPharma
When we say we work tirelessly to better understand the patient experience—we mean it. Hear from Adrian Kielhorn on how his Health Economics & Outcomes Research team puts this belief into practice every day to learn more about patient needs & how we can help improve their lives.
-
Alexion
@AlexionPharma
#raredisease #clinicaltrials present many challenges–small patient populations, few diagnostic tools available, if any, and limited understanding to name some. Learn how we continue to overcome these challenges and drive innovation forward in rare disease R&D.
-
Alexion
@AlexionPharma
We work tirelessly to deliver innovative medicines to a community with high unmet medical need: the #raredisease community. Interested in supporting our mission? Check out careers.alexion.com for open roles.
-
Alexion
@AlexionPharma
Overcoming the unique challenges in #raredisease clinical trials requires a deep understanding of what those challenges are. We explore some of those hurdles and what makes rare disease trials so impactful in this video ⬇️
-
Alexion
@AlexionPharma
At Alexion, our employees are fueled by a desire to make a real difference for patients living with #raredisease. If this sounds like you, check out our open roles: careers.alexion.com
-
Alexion
@AlexionPharma
What does our Head of Global Medical Affairs love most about #lifeatalexion? That we all strive towards one singular purpose: helping patients with #raredisease. Tune in below to learn more.
-
Alexion
@AlexionPharma
While commonly recognized in early childhood, #neurofibromatosis type 1 (NF1) is a lifelong, progressive condition that can vary in severity. From initial signs like café au lait spots to neurofibromas, see how this disease can manifest below.
-
Alexion
@AlexionPharma
#neurofibromatosis (NF) is a rare genetic disorder involving the development of tumors that may affect the brain, spinal cord and nerves. As the most common type of NF, neurofibromatosis type 1 (NF1) affects about 1 in 3,000 people worldwide. Learn more about NF1 below.
-
Alexion
@AlexionPharma
Our mission to transform the lives of patients living with #raredisease wouldn’t be possible without the right people. Could that be you? Let’s find out: careers.alexion.com
-
Alexion
@AlexionPharma
Many patients who may be eligible to participate in a #raredisease #clinicaltrial don’t, mostly due to a lack of awareness or misconceptions about clinical trials. This leads to many patients not receiving optimal care. We’re on a mission to change that.
-
Alexion
@AlexionPharma
For people living with AL #amyloidosis, diagnosis is often delayed and can take < 6 months after symptoms begin. In honor of #worldamyloidosisday, learn about the symptoms associated with this #raredisease. @AmyloidosisA
-
Alexion
@AlexionPharma
Faster diagnoses and treatment of #amyloidosis can only be achieved by more widespread knowledge of the disease. In honor of #worldamyloidosisday, we explore amyloid light chain (AL) amyloidosis. @AmyloidosisA
-
Alexion
@AlexionPharma
Today is #worldamyloidosisday 📣 Join us in our efforts to raise awareness of #amyloidosis, a group of rare, complex diseases caused by abnormal proteins that misfold and clump together to form toxic amyloids and support the amyloidosis patient community. @AmyloidosisA
-
Alexion
@AlexionPharma
We believe our focus on patient centricity is unrivaled, but don’t just take our word for it–hear from our very own Cristina Quarta, Senior Medical Director, on what makes Alexion a great place to work. #lifeatalexion
-
Alexion
@AlexionPharma
Meet Christophe, our Head of Global Medical Affairs. In this video, he explains the role of Medical Affairs in #raredisease R&D, his leadership philosophy and what he loves most about working at Alexon. #lifeatalexion
-
Alexion
@AlexionPharma
Today, we’re wrapping up our time at MSMilan2023 where we had the privilege of presenting new data and connecting with those who share our commitment to making a difference for patients with neuromyelitis optica spectrum disorder (NMOSD).
-
Alexion
@AlexionPharma
“NMOSD Your Way” global podcast🎙️, an educational series hosted by people living with NMOSD, is now featured at MSMilan2023! It features interviews with clinicians, researchers & patients to discuss and better understand this rare disease. Listen here: nmosdyourway.com
-
Alexion
@AlexionPharma
We’re at MSMilan2023 with global experts who are committed to advancing care for neuromyelitis optica spectrum disorder (NMOSD), a rare and debilitating autoimmune disease that affects the central nervous system. Learn more about the science behind NMOSD below.
-
Alexion
@AlexionPharma
Day 1 of MSMilan2023 is here! We’re excited to be onsite at the 9th Joint ECTRIMS-ACTRIMS Meeting, where we’ll be presenting our latest real-world and clinical research in neuromyelitis optica spectrum disorder (NMOSD), a rare neurological disease.
-
Alexion
@AlexionPharma
This year at SIOP Congress, we’re proud to be presenting our latest research in neurofibromatosis type 1 (NF1), a rare genetic disorder that involves the development of tumors.
-
Alexion
@AlexionPharma
For more than 30 years, we’ve explored uncharted territory in the 🌎 of #raredisease. Now, together with @AstraZeneca, we’re rapidly hiring. Do you have what it takes to help transform the lives of patients with #raredisease? Let’s find out: careers.alexion.com
-
Alexion
@AlexionPharma
Unbeknownst to many, #rarediseases are not that rare. In fact, more than 400 million people worldwide live with a rare disease. That’s more people than cancer and Alzheimer’s combined.
-
Alexion
@AlexionPharma
We’re in it to make a real difference in the lives of people living with #rarediseases–and we’re looking for top-tier talent to join us along the way. Sound like a good fit? Apply to our open roles: careers.alexion.com
-
Alexion
@AlexionPharma
When 65% of #rarediseases result in a shorter life span, faster diagnoses and treatments are critical. We’re working tirelessly to address these challenges for people with rare diseases. Learn about our work for the community: alexion.com
-
Alexion
@AlexionPharma
This #ahusday, follow Nurse Jen 👩⚕️ through her day as she cares for paediatric patients living with atypical haemolytic uraemic syndrome (#ahus), a rare, progressive, chronic condition with relapses that is a type of thrombotic microangiopathy. #ahus24sept www.youtube.com/watch?v=d1W-OUd8A9A
-
Alexion
@AlexionPharma
Every year on September 24, we’re inspired by the strength of the #ahus community. Today on #ahusday, we shine a spotlight on this #raredisease and celebrate the capabilities and possibilities that exist for this resilient community. #ahus24sept
-
Alexion
@AlexionPharma
Curious about what #lifeatalexion is like? 🧐 Our VP, Global Clinical Development, sums it up quite nicely.
-
Alexion
@AlexionPharma
Each year, @PharmaVoice recognizes life sciences industry trailblazers. This year, we’re proud to announce that Gianluca Pirozzi, SVP, Head of Development, Regulatory and Safety, is a #pharmavoice100 honoree! Learn more: www.pharmavoice.com/news/pharmavoice100-pv100-pharma-lead…
-
Alexion
@AlexionPharma
While the definition of a #raredisease varies around the 🌎, people living with these conditions have much in common. Our CEO Marc Dunoyer explains some of the unique challenges they face and how we’re working to address them.
-
Alexion
@AlexionPharma
Our commitment to serving patients means many things–one of which is to deliver medicines with a proven safety & efficacy profile to patients around the globe. Our VP of Patient Safety shares why he’s proud to lead the Global Patient Safety team at Alexion. #worldpatientsafetyday
-
Alexion
@AlexionPharma
#rarediseases are some of the world’s toughest diseases to tackle, and often where there is the highest unmet need. Of the 7,000+ rare diseases that exist globally, 80% of them are genetic. Learn more below.
-
Alexion
@AlexionPharma
#pnhawarenessweek may be drawing to a close, but our work never stops. We continue to support the PNH community, today and every day. Anita Hill, VP, Global Medical Affairs Leader, Haematology, Nephrology, shares how we’re working tirelessly to advance patient care.
-
Alexion
@AlexionPharma
15 years ago, we opened our doors in Japan to bring transformative medicines to even more people living with #rarediseases. Since then, we’ve made significant progress in delivering innovation where progress is rare. Here’s to many more years!
-
Alexion
@AlexionPharma
People living with paroxysmal nocturnal haemoglobinuria (#pnh) can experience a delayed diagnosis of up to 10 years due to diverse symptoms and varied clinical presentation. Explore the signs & symptoms of PNH below. #pnhawarenessweek
-
Alexion
@AlexionPharma
Every year, members of the #pnh community stand together to recognise #pnhawarenessweek, a time dedicated to educating and elevating the experiences of patients, family members & caregivers affected by this #raredisease. Follow along as we raise awareness throughout the week! 📣
-
Alexion
@AlexionPharma
Atypical haemolytic uraemic syndrome (#ahus) is a rare, progressive, chronic disease with relapses. It’s a type of thrombotic microangiopathy, a group of severe and potentially life-threatening rare disorders that cause blood clots and damage to small blood vessels. Learn more ⬇️
-
Alexion
@AlexionPharma
As we endeavor to transform the lives of patients living with #rarediseases around the world, we’re hiring top talent to join us. Are you up for the challenge? Explore our open roles: login.microsoftonline.com/af8e89a3-d9ac-422f-ad06-cc4eb42…
-
Alexion
@AlexionPharma
What’s your "why"? For Gianluca Pirozzi, SVP, Head of Development, Regulatory and Safety, his "why" is his daughter. Hear how his daughter’s #raredisease diagnosis fueled his professional passions. #lifeatalexion
-
Alexion
@AlexionPharma
Amyloid light chain (AL) #amyloidosis is a #raredisease that can result in significant organ damage and organ failure that may ultimately be fatal. See what symptoms are associated with this condition below.
-
Alexion
@AlexionPharma
Join us in giving a warm welcome to our 7 new postdoctoral PharmD fellows! In partnership with @MCPHS, this program enhances PharmD graduates understanding of the biopharma industry. These 7 fellows join 5 second-year fellows working across various departments at Alexion.
-
Alexion
@AlexionPharma
Raj joined Alexion because he was inspired by our mission to find solutions for devastating conditions that have few or no available treatment options. Hear about the scientific challenges that motivate Raj every single day. #lifeatalexion
-
Alexion
@AlexionPharma
Our mission is simple—to help create a 🌎 with better outcomes for people afflicted by #rarediseases. Sound like a mission you’d want to be a part of? Join our talented team: login.microsoftonline.com/af8e89a3-d9ac-422f-ad06-cc4eb42…
-
Alexion
@AlexionPharma
People with #rarediseases often wait years to receive an accurate diagnosis. As a leader in rare disease, we’re committed to helping shorten this diagnostic odyssey for patients who have been searching for answers.
-
Alexion
@AlexionPharma
Ever think of scientific communications as an art form? 🎨 Well, for Sarah, it is. Learn how she brings her passion for storytelling to her work at Alexion to further the understanding of treating and targeting disease. #lifeatalexion
-
Alexion
@AlexionPharma
Over 30 years ago, we ventured into the unknown to deliver innovation where progress was rare: in the 🌎 of #raredisease R&D. Since then, our work in complement research has led to the development of life-changing therapies. Our R&D colleagues explain what this journey entailed.
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
Poor growth and development, weakness and deformity of bones, and premature loss of teeth with the root intact are just a few of the symptoms of #hypophosphatasia (HPP). Explore the many ways in which this #raredisease can present in the body below.
-
Alexion
@AlexionPharma
Kerstin is passionate about data visualisation 📊 and breaking down complex information in meaningful ways. Get to know Kerstin and her work in biostatistics in our “people behind the science” video. #lifeatalexion
-
Alexion
@AlexionPharma
Ever wonder what it’s like to work at Alexion? Katherine, Director, Global Medical Sciences, shares how our emphasis on uniting people from different backgrounds & all walks of life fosters a positive workplace environment. #lifeatalexion
-
Alexion
@AlexionPharma
Proud to share, connect and learn alongside industry-leading experts at the European Academy of Neurology (EAN) 2023 Congress. Together, we can make an impact for people living with rare neurological diseases.
-
Alexion
@AlexionPharma
People living with neuromyelitis optica spectrum disorder (#nmosd) often experience relapses, which can be severe and result in permanent disability. We’re committed to educating around the impact of relapses and the importance of timely diagnosis and treatment for patients.
-
Alexion
@AlexionPharma
Like many rare diseases, there’s limited awareness of generalised #myastheniagravis, a rare autoimmune disorder characterised by loss of muscle function and severe muscle weakness. We’re committed to advancing understanding of this #raredisease to benefit patients across the 🌎.
-
Alexion
@AlexionPharma
At the European Academy of Neurology (EAN) Congress, we’re proud to be presenting research across our portfolio for generalised myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD), two rare neurological diseases.
-
Alexion
@AlexionPharma
In recognition of #pridemonth this year, we found meaningful ways to celebrate – from our Pride happy hour to hosting bingo & more. Thank you to AZ Pride, our #lgbtq+ employee resource group, for helping keep Alexion wonderfully diverse & proud!🌈
-
Alexion
@AlexionPharma
What does #pridemonth mean to you? 🏳️🌈 For Genevieve, it’s a time to spread love and create a warm community that not only accepts members of the #lgbtq+ community but celebrates them too.
-
Alexion
@AlexionPharma
Tenacity. Grit. Energy. Motivation. These are just a few of the qualities needed to succeed at Alexion.
Simone shares what makes her proud to work here. (Spoiler 🚨: it’s her team, the culture, and our rapidly expanding portfolio). #lifeatalexion -
Alexion
@AlexionPharma
#pridemonth celebrations are back and in full swing! 🏳️🌈 Louis shares his exciting plans to recognize this month – in-person and out loud.
-
Alexion
@AlexionPharma
#icymi: We partnered with @RareRevolutionM to spotlight #newbornscreening programmes in America, Europe and Australia and raise awareness of the vital role they play. Read more: edition.pagesuite-professional.co.uk/cookie_check.aspx?pu…
-
Alexion
@AlexionPharma
“Pride is a time to commit to live the only way possible–as the best, most authentic version of myself.” 🌈 As we continue with our #pridemonth celebrations throughout the month, Rich reflects on this time of year and what it means to him.
-
Alexion
@AlexionPharma
Thanks to all who joined us at #era2023! We’re leaving the meeting feeling inspired by the meaningful conversations had and wealth of #nephrology data presented. We look forward to building upon this forward momentum for patients living with rare nephrology diseases like #ahus.
-
Alexion
@AlexionPharma
Atypical haemolytic uraemic syndrome (#ahus) is a rare, progressive, chronic disease with relapses. It’s a type of thrombotic microangiopathy, a group of severe and potentially life-threatening rare disorders that cause blood clots and damage to small blood vessels.
-
Alexion
@AlexionPharma
We’re thrilled to be attending the European Renal Association (ERA) Congress, the largest annual nephrology congress in Europe, to learn about the latest research in the prevention, detection, and management of rare kidney diseases.
-
Alexion
@AlexionPharma
Regardless of sexuality or background, we believe that everyone deserves to be treated with equal respect and dignity. This #pridemonth, Jonathan reflects on what this time of year can mean for many in the #lgbtq+ community.
-
Alexion
@AlexionPharma
People living with the rare autoimmune disorder gMG may experience a wide range of symptoms that can become more severe as the disease progresses. Show your support for #mgawarenessmonth by learning about the symptoms below.
-
Alexion
@AlexionPharma
Thank you to @EHA_Hematology for an incredible conference! We enjoyed connecting with the haematology community to advance scientific exchange across multiple rare, haematological diseases.
-
Alexion
@AlexionPharma
How can a rare, chronic, and progressive blood disorder like paroxysmal nocturnal haemoglobinuria (#pnh) manifest in patients? View the possible signs and symptoms below.
-
Alexion
@AlexionPharma
In individuals living with #pnh, the complement system mistakenly destroys red blood cells which can lead to serious complications, like damage to vital organs and life-threatening blood clots. Learn about this below.
-
Alexion
@AlexionPharma
Today at the European Hematology Association 2023 Hybrid Congress, we are proud to present data which continues to advance the understanding of PNH.
-
Alexion
@AlexionPharma
We’re excited to be at the European Hematology Association (EHA) 2023 Hybrid Congress in Frankfurt, Germany this year to connect with haematologists from around the world. We’ll be presenting our latest research across four rare haematologic diseases.
-
Alexion
@AlexionPharma
In recognition of #mgawarenessmonth, we’re raising awareness of generalized #myastheniagravis (gMG), a severe form of this #raredisease. Learn more about this condition below.
-
Alexion
@AlexionPharma
Today marks the start of #pridemonth – a month-long celebration of the #lgbtq+ community. Throughout the month, we’ll be participating in events led by our LGBTQ+ ERG, AZ Pride, and amplifying the voices of colleagues around the globe. Stay tuned for updates! 👀
-
Alexion
@AlexionPharma
Every year in June, the #mgcommunity unites to raise awareness of the impact of #myastheniagravis (MG) and the experiences of those living with this rare neurological disease. Follow along as we show our support throughout #mgawarenessmonth.
-
Alexion
@AlexionPharma
For Medical Media/Investors: A message from SVP, Head of Development, Regulatory and Safety Gianluca Pirozzi on today’s news.
-
Alexion
@AlexionPharma
We’re honored to be named a @LinkedIn 25 Best Workplaces to Grow Your Career in Ireland! Our College Park site was ranked #7 on the list, which recognizes companies that are helping their employees build careers that will set them up for long-term success. #linkedintopcompanies
-
Alexion
@AlexionPharma
Behind every medicine stands a team of patients who have volunteered for the greater good. Without them, our work in #raredisease wouldn’t be possible. Hear how we go the extra mile to incorporate a patient-centric mindset, even in clinical trial design. #clinicaltrialsday
-
Alexion
@AlexionPharma
We’re leading the way in workplace culture and opportunity 🏆 Our College Park site recently made @ibec_irl Top 100 Companies Leading in Wellbeing Index, recognising the top businesses who are prioritising employee mental health and wellbeing. #workplacewellbeing100
-
Alexion
@AlexionPharma
This #nfawarenessday, we honor this resilient community and support them in their fight against this #raredisease. Learn about #nf1, the most common type of NF. #makenfvisible
-
Alexion
@AlexionPharma
Today, we announced that we will present new data at the European Hematology Association Annual Congress, across PNH, aHUS, amyloidosis, and sickle cell disease, demonstrating how we continue to follow the science and innovate for people living with rare diseases.
-
Alexion
@AlexionPharma
How can patients and the pharmaceutical industry partner together to evolve the rare disease ecosystem? In a co-authored manuscript written in partnership with #raredisease patient advocates, we dive into the topic of patient centricity. Key insights below.
-
Alexion
@AlexionPharma
We’re celebrating #internationalnursesday through the launch of our animated video: A Day with Nurse Jen. Follow Nurse Jen through her day as she cares for pediatric patients living with atypical haemolytic uraemic syndrome (#ahus). youtu.be/d1W-OUd8A9A
-
Alexion
@AlexionPharma
People living with #rarediseases, their caregivers, and families face fears of the unknown with courage, tenacity, and grace that inspire us to continue to push forward in our mission to transform patient lives. Learn more about those who inspire us: alexion.com/living-in-rare
-
Alexion
@AlexionPharma
Our mission to transform the lives of patients with #raredisease wouldn’t be possible without our team of passionate, driven, and dedicated individuals who make up Alexion. Interested in making an impact? Join us: login.microsoftonline.com/af8e89a3-d9ac-422f-ad06-cc4eb42…
-
Alexion
@AlexionPharma
“The possibilities are endless.” At Alexion, we truly believe that investing in our people is paramount to our success as an organization. A few of our employees share how they were able to grow in their careers by exploring different opportunities. #lifeatalexion
-
Alexion
@AlexionPharma
Regardless of background or circumstance, every patient should be able to have an equal opportunity to live the healthiest life possible. On #worldhealthday, our leaders share a few of the hurdles people living with #raredisease face and how we can achieve #healthforall.
-
Alexion
@AlexionPharma
Behind each #raredisease patient lies a person who carries a story of resilience and hope. As we close out March, we’re reminded of the countless people living with #nmosd, #wilsondisease & AL #amyloidosis whose stories fuel our purpose every single day.
-
Alexion
@AlexionPharma
We are proud to support the José Baselga Research Fund (JBRF) honoring the late physician-scientist. José Baselga, EVP Oncology R&D at @AstraZeneca passed away in 2021. To continue his legacy, JBRF is now accepting applications for its first-ever research grant.
-
Alexion
@AlexionPharma
Imagine receiving one wrong diagnosis after another for 2 to 3 years with a #raredisease. That’s what people with #wilsondisease often encounter in their journey to diagnosis. Hear more on this from Brian Meltzer, VP, Global Medicine Team Lead. #wilsondiseaseawarenessmonth
-
Alexion
@AlexionPharma
Last week during #rarediseaseday, we joined together with the global community of 400 million strong to drive awareness of #rarediseases and ignite change for a future with equitable access to care. Check out a recap of our activities below.
-
Alexion
@AlexionPharma
Like many people with #raredisease, those with #nmosd may experience a long journey to diagnosis – receiving delayed or even misdiagnoses – due to limited awareness of their condition. Can you guess whether this is fact or fiction?
-
Alexion
@AlexionPharma
Faster diagnosis and treatment are critical to tackling #rarediseases like atypical hemolytic uremic syndrome (#ahus). This #worldkidneyday, we are proud to be supporting @ISNkidneycare and @ikfk_wka in their efforts to make #kidneyhealthforall a reality.
-
Alexion
@AlexionPharma
Today is #internationalwomensday. At Alexion, we are strengthened by a diverse workforce. By embedding inclusive behaviors through our shared values, we strive to create an equitable environment where everyone can thrive. #embraceequity
-
Alexion
@AlexionPharma
#wilsondisease is a rare, progressive, and even potentially fatal disorder that can be challenging to diagnose due to the wide range of symptoms patients experience. We break this #raredisease down below ⬇️ #wilsondiseaseawarenessmonth
-
Alexion
@AlexionPharma
Every day, we are inspired by the resilience of the #nmosd community. During #nmoawarenessmonth, we’re shining a light on NMOSD and the journeys of all those diagnosed with this #raredisease. Follow along as we raise awareness of this devastating condition throughout the month.
-
Alexion
@AlexionPharma
Last week, we announced the winners and nominees of the 2023 CEO Awards, which recognizes the best of the best across @Astrazeneca. Of the 12 nominated projects, 3 of them were from Alexion! Congrats to our colleagues for their incredible contributions this past year.
-
Alexion
@AlexionPharma
Happy #employeeappreciationday! To our global colleagues, we say thank you – you are the key to our success and without your contributions, we would not be the company we are today.
-
Alexion
@AlexionPharma
What is neuromyelitis optica spectrum disorder (#nmosd)? NMOSD is an autoimmune disorder in which the immune system mistakenly attacks healthy tissues and cells in the central nervous system.
-
Alexion
@AlexionPharma
Imagine a world where #rarediseases weren’t considered rare. 💭 That is the future we aspire to create. Our CEO Marc Dunoyer shares his thoughts on how we can improve care, accelerate access, and expand our reach to more people across the world. #rarediseaseday
-
Alexion
@AlexionPharma
Every day, we are inspired by the perseverance and strength of the 400 million people worldwide living with #raredisease. Join us as we raise our voices to drive awareness on #rarediseaseday.
-
Alexion
@AlexionPharma
When it comes to managing a #raredisease, patients are the true experts. Lauren shares how being diagnosed with a #raredisease has helped her become more in-tune with her own body.
-
Alexion
@AlexionPharma
When Alyssa was diagnosed with a #raredisease, she was scared of what it could mean for her future. After months of uncertainty, she finally received a diagnosis. Hear her thoughts on the importance of never giving up on finding the right doctor for you 🔊
-
Alexion
@AlexionPharma
People with #rarediseases face significant challenges in reaching diagnosis, often due to limited awareness of their conditions. We’re working to bridge that gap through education and meaningful conversations with stakeholders. #rarediseaseday
-
Alexion
@AlexionPharma
While the definition of a rare disease differs across countries, one thing is certain: the number of people living with a #raredisease is high. We’re committed to improving equitable access to healthcare for those living with rare. #rarediseaseday
-
Alexion
@AlexionPharma
Every #raredisease patient has a unique story, but many share a common journey: challenges in reaching a diagnosis and accessing care. We’re on a mission to change that. Next week on #rarediseaseday, join us in raising awareness for the global community.
-
Alexion
@AlexionPharma
Rare is many. Rare is strong. Rare is proud. In honor of #rarediseaseday next week, we’re excited to unite as a global community to raise awareness for the 400 million people living with a #raredisease around the world. #shareyourcolours
-
Alexion
@AlexionPharma
When it comes to living with a #raredisease, the burden on siblings and their role as carers is often overlooked. In partnership with @RareRevolutionM, we’re proud to share a new report that highlights the real impact of rare disease on the sibling experience.
-
Alexion reposted
AstraZeneca
@AstraZeneca
We asked some of our #womeninscience what they hope women and girls can achieve in #stem. Watch to reveal their vision for the future. #february11 #womeninstem www.astrazeneca.com/r-d/our-approach/stem-at-astrazeneca.…
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
“If not science, what else?”
On International Day of Women and Girls in Science, hear from a few of our talented #womeninscience as they share some words of wisdom for women interested in pursuing a career in #stem. #idwgs2023 -
Alexion reposted
RARE Revolution Magazine®
@RareRevolutionM
We are delighted to launch “The impact of RARE disease on sibling experience” report. Supported by @AlexionPharma and undertaken by us, the report aims to give a voice to RARE siblings.
Read now : rarerevolutionmagazine.com/rare-revolution-magazine-publi…
#raredisease #siblings #raresiblings -
Alexion
@AlexionPharma
Paroxysmal Nocturnal Hemoglobinuria (#pnh) is a rare, chronic, progressive, debilitating, and potentially life-threatening blood disorder characterized by complement-mediated intravascular hemolysis and thrombosis. For further advice and support: pnhglobalalliance.org
-
Alexion
@AlexionPharma
We’re #hiring! Our passion drives us to continuously innovate and create meaningful value in all we do. Are you devoted to changing the outlook for people affected by rare diseases? Join us! jobs.alexion.com
-
Alexion
@AlexionPharma
To serve the #raredisease community, creating a purpose-driven and rewarding culture is critical. This is why we strive to cultivate an environment in which every team member is equipped to perform at their personal best. #lifeatalexion
-
Alexion
@AlexionPharma
Today marks the 40th anniversary of the Orphan Drug Act, a U.S. law that spurred tremendous progress in the development of treatments for rare diseases. Tamar Thompson reflects on this significant milestone and what it means for the #raredisease community.
-
Alexion
@AlexionPharma
Thank you to all who followed along as we celebrated the end of our 30th year. We look forward to continuing our legacy in rare disease in the New Year. #alexion30
-
Alexion
@AlexionPharma
This year, we expanded our global R&D footprint through the creation of our new Development Hub in Barcelona, Spain. We are committed to #followingthescience to help patients and families affected by #rarediseases live their best lives. #alexion30
-
Alexion
@AlexionPharma
We were proud to sponsor a special edition of @RareRevolutionM focused on the impact of long-term caregiving. A special thank you to the patients and caregivers who generously shared their stories. edition.pagesuite-professional.co.uk/cookie_check.aspx?pu… #alexion30
-
Alexion
@AlexionPharma
We invest in and value people who believe in our purpose and understand what it takes to deliver on it. In 2022, we welcomed close to 1,400 new employees across the globe and are excited to continue expanding our team in 2023! #alexion30 Join us: jobs.alexion.com
-
Alexion
@AlexionPharma
For the past 30 years, Alexion has been among the first to tackle scientific challenges for #rarediseases by following the science and leading in collaboration. r.socialstudio.radian6.com/3e09117e-f8fc-406d-876a-7cb7d0… #alexion30
-
Alexion
@AlexionPharma
To commemorate our first anniversary as Alexion, AstraZeneca Rare Disease in July, patients, caregivers, and colleagues gathered across the globe to honor our legacy and celebrate our future in #raredisease. #alexion30
-
Alexion
@AlexionPharma
We are attending the @ASH_hematology American Society of Hematology Annual Meeting and Exposition December 10-13 in New Orleans, Louisiana. #ash22
-
Alexion
@AlexionPharma
This year, in celebration of #internationaldayofthegirl, we hosted Aanya Patel, a senior in high school, at our New Haven site where she met with our CEO, toured our lab, and presented to a number of our leaders to show that #girlsbelonghere. #alexion30
-
Alexion
@AlexionPharma
On #rarediseaseday earlier this year, our CEO, Marc Dunoyer, discussed #healthequity and what we are doing to close the gaps in our healthcare systems that affect people living with #rarediseases. Read what he had to say: brand-studio.fortune.com/alexion/rare-disease-inequities-… #alexion30
-
Alexion
@AlexionPharma
Yelena Pinkhasik, Vice Chair of Alexion’s ‘No Limits, No Labels’ resource group shares her thoughts on fostering a truly inclusive culture. #idpwd #inclusion #diversity
-
Alexion
@AlexionPharma
2022 was a year of celebration for us. We marked our first year as Alexion, AstraZeneca Rare Disease and reflected on 30 years of transforming the lives of people affected by rare diseases. Follow along as we highlight some of our favorite moments of this year. #alexion30
-
Alexion
@AlexionPharma
Our passion drives us to continuously innovate and create meaningful value in all we do. Join us to change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day. jobs.alexion.com
-
Alexion
@AlexionPharma
Interested in transforming the lives of people affected by #rarediseases? Join our team of growing innovators, leaders, and collaborators: jobs.alexion.com
-
Alexion
@AlexionPharma
DYK… there are over 7,000 known #rarediseases in the world. Most of these diseases are genetic, and of those 70% start in childhood. For further advice and support: globalgenes.org/rare-disease-facts/
-
Alexion
@AlexionPharma
Our science wouldn’t be possible without our team of passionate, driven, and dedicated individuals who make up Alexion R&D. Interested in a career where you can help transform patients' lives? Join us: jobs.alexion.com
-
Alexion
@AlexionPharma
Today, we are excited to announce the official opening of our new Barcelona Development Hub in Spain. This new facility will support the expansion of our global R&D footprint and accelerate the clinical development of transformative medicines for #rarediseases
-
Alexion
@AlexionPharma
Today at #wodc, our CEO, Marc Dunoyer, will deliver a keynote presentation on Building a Sustainable Rare Disease Ecosystem. #raredisease
-
Alexion
@AlexionPharma
We are attending the @orphan_drugs World Orphan Drug Congress November 14-17 in Sitges, Barcelona. #wodc
-
Alexion
@AlexionPharma
On #worldqualityday, and every day, we are committed to working with a quality mindset and acting with integrity to earn the trust of patients, physicians, and our communities. #wqd22
-
Alexion
@AlexionPharma
We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Join us! jobs.alexion.com
-
Alexion
@AlexionPharma
Paroxysmal Nocturnal Hemoglobinuria (#pnh) is a rare, chronic, progressive, debilitating, and potentially life-threatening blood disorder characterized by complement-mediated intravascular hemolysis and thrombosis. For further advice and support: pnhglobalalliance.org
-
Alexion
@AlexionPharma
November is #nationalfamilycaregiversmonth, a time to celebrate, honor, and empower all family #caregivers. For further advice and support: www.caregiving.org/rare/. #caregiversupport
-
Alexion
@AlexionPharma
Some opportunities happen only once in a lifetime – like a job where you have the chance to change lives. Learn more about #lifeatalexion. careers.alexion.com
-
Alexion
@AlexionPharma
DYK… #hypophosphatasia (HPP) is a rare, genetic, metabolic disease characterized by impaired mineralization, the process that hardens and strengthens bones and teeth. For further advice and support: www.metabolicsupportuk.org. #worldhppday #hppaware
-
Alexion
@AlexionPharma
Sharing research with the scientific community is essential to drive innovation for patients.
-
Alexion
@AlexionPharma
At Alexion, we are passionate about driving research forward to transform the lives of patients living with debilitating #rarediseases.
-
Alexion
@AlexionPharma
Today is #worldamyloidosisday! #amyloidosis is a group of rare diseases caused by abnormal proteins that misfold and clump together to form toxic amyloids, and deposit in tissues or organs. For further advice and support: www.worldamyloidosisday.org.
-
Alexion
@AlexionPharma
We’re attending the 38th Congress of the @ECTRIMS October 26-28 in Amsterdam. 2022.ectrims-congress.eu #ectrims2022
-
Alexion
@AlexionPharma
Curious about #lifeatalexion? Get to know us and check out our open #careeropportunities. alexion.com/your-career/career-opportunities #raredisease
-
Alexion
@AlexionPharma
We'll be attending the Out & Equal Workplace Summit, kicking off today in Las Vegas. For more info on the Summit: outandequal.org and to check out our open career opportunities: careers.alexion.com
-
Alexion
@AlexionPharma
Don’t miss today’s Rare Conversations Conference and a robust discussion around which future #raredisease policies can lead the way toward a resilient ecosystem. Not in Brussels? Join virtually! sciencebusiness.eventsair.com/rare-conversations-2022/reg… @eurordis @EUCOPE @EuropaBio @EFPIA
-
Alexion
@AlexionPharma
Today, on #internationaldayofthegirl, we recognize the importance of supporting and promoting women and girls as leaders and invaluable contributors in the rare disease space and across all industries. #girlsbelonghere2022
-
Alexion
@AlexionPharma
Join us this Thursday for our next Rare Conversations Conference, bringing together Alexion leaders & those from research, regulatory, and patient & industry organizations to develop inspiring ideas to advance the future of #rarediseases. Register today! sciencebusiness.eventsair.com/rare-conversations-2022/reg…
-
Alexion
@AlexionPharma
We’ll be hosting our next Rare Conversations Conference on 13 October virtually and in Brussels to discuss which future rare disease policies can lead the way toward a resilient ecosystem. Register: sciencebusiness.eventsair.com/rare-conversations-2022/reg… @eurordis @EUCOPE @EuropaBio @EFPIA #raredisease
-
Alexion
@AlexionPharma
Looking for a change? Want to change the world for people living with #rarediseases? Join us! Check out our open positions: jobs.alexion.com
-
Alexion
@AlexionPharma
October is #liverawarenessmonth. #lald is a genetic and progressive ultra-rare metabolic disease in which people have an uncontrolled buildup of fatty material in their liver and other organs. For further advice and support: www.globalliver.org
-
Alexion
@AlexionPharma
Why choose Alexion? There are many factors that set us apart but above all is our connection to the rare disease patients we serve. They inspire us every day to find answers to the most complex scientific challenges. Join us! jobs.alexion.com
-
Alexion
@AlexionPharma
DYK… atypical hemolytic uremic syndrome (#ahus) is a #raredisease caused by complement dysregulation. For further advice and support visit: ahusallianceaction.org
-
Alexion
@AlexionPharma
Want to learn more about paroxysmal nocturnal hemoglobinuria (#pnh)? Check out the link below for information and resources for patients and caregivers. www.pnhinterestgroup.org/resources/pnh-patient-organizati… #pnhweek
-
Alexion
@AlexionPharma
In people living with #pnh, the complement system mistakenly destroys red blood cells. PNH can lead to serious health complications, including damage to vital organs, such as kidneys and lungs. For further advice and support: www.pnhinterestgroup.org/resources/pnh-patient-organizati…
#pnhweek -
Alexion
@AlexionPharma
Today kicks off #pnhweek. Paroxysmal nocturnal hemoglobinuria, or #pnh, is a rare, chronic, progressive, and potentially life-threatening blood disorder. Learn more: www.pnhinterestgroup.org/resources/pnh-patient-organizati…
-
Alexion
@AlexionPharma
Developing medicines takes a village, especially in rare disease. Learn why collaboration with the community, including patients, advocacy groups, physicians, site investigators, health authorities and more, is critical to our success. #alexion30
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
The World Health Organization estimates that one out of 15 people worldwide could be affected by a rare disease. For more information: www.who.int/medicines/areas/priority_medicines/Ch6_19Rare…
-
Alexion
@AlexionPharma
We’re attending the @ipna2022 Congress September 7-11 in Calgary. www.ipna2022.org #pedneph
-
Alexion
@AlexionPharma
We’re attending the XVIII Meeting of the International Society of Amyloidosis September 4-8 in Heidelberg, Germany. www.isaheidelberg2022.org @ISA_Amyloidosis #isa_2022 #amyloidosis
-
Alexion
@AlexionPharma
Learn how we put patient centricity into action every day through our people, innovative processes, and metrics that keep people living with rare diseases at the heart of our work and hold us accountable to those who matter most.
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
We’re attending the European Society of Cardiology 2022 Congress August 26-29 in Barcelona, Spain. r.socialstudio.radian6.com/3de3ab1b-e92c-415c-a6c1-a709a1… @escardio #esccongress #amyloidosis
-
Alexion
@AlexionPharma
Generalized myasthenia gravis (#gmg) is a rare autoimmune disorder characterized by loss of muscle function and severe muscle weakness. For further advice and support: myasthenia.org #raredisease
-
Alexion
@AlexionPharma
We strive to ignite an inclusive environment where people belong because of their uniqueness and unleash their individuality and diversity to spur innovative breakthroughs for patients. Join us: jobs.alexion.com #hiring
-
Alexion
@AlexionPharma
To transform the lives of rare disease patients, we must listen, learn and incorporate their insights into our research and development. Watch to hear why the patient voice is essential for innovation.
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
Navigating regulatory pathways in #raredisease can be challenging as we often need to build our own roadmap. Learn about how we collaborate and pioneer creative solutions to transform patient lives. #alexion30
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
Patient centricity is at the forefront of all that we do. In our efforts to remain steadfast in this commitment we introduced LEAP, a series of experiential learning sessions designed to immerse employees in the patient journey. Learn more: r.socialstudio.radian6.com/93eda9c2-cf13-4a87-81bb-b4768f…
-
Alexion
@AlexionPharma
DYK… 80% of #rarediseases are genetic, while others are the result of infection, allergies, and environmental causes, or are rare cancers. For more information and support, visit r.socialstudio.radian6.com/42e164d2-62c3-495d-901a-358a03…
-
Alexion
@AlexionPharma
The work we do is guided by people living with rare and devastating diseases. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. Hear from our employees about #lifeatalexion.
-
Alexion
@AlexionPharma
At Alexion, you’re encouraged to take on the most daunting of challenges, settle for nothing less than transformation, and push the boundaries of what science has traditionally offered. Check out our career opportunities: jobs.alexion.com #hiring
-
Alexion
@AlexionPharma
This year we celebrate our 30th anniversary of pioneering leadership in designing and executing clinical trials for rare diseases. Hear how we’ve done this with a focus on listening to and learning from patients. #alexion30
-
Alexion
@AlexionPharma
To commemorate our first anniversary as Alexion, AstraZeneca Rare Disease, patients and colleagues gathered across the globe to honor our legacy and celebrate our future in #raredisease. #alexion30
-
Alexion
@AlexionPharma
DYK… most #raredisease caregivers are providing care to a child under the age of 18. For more information and resources, visit r.socialstudio.radian6.com/377dfa18-d1cd-419a-9505-b568de… #caregiversupport
-
Alexion
@AlexionPharma
There are over 7,000 known #rarediseases in the world. Most of these diseases are genetic, and of those 70% start in childhood. For further advice and support: r.socialstudio.radian6.com/a2e44197-567f-4084-8f77-cdb05a…
-
Alexion
@AlexionPharma
In everything we do, we are empowered and committed to speak up and perform at our personal best to accelerate our collective impact for people living with #rarediseases. Check out our career opportunities: r.socialstudio.radian6.com/48d0445e-9202-445c-8b15-77a133… #hiring
-
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is a #raredisease in which the immune system is inappropriately activated to target healthy tissues and cells in the central nervous system. For further advice and support: www.sumairafoundation.org
-
Alexion
@AlexionPharma
This month marks the one-year anniversary of our acquisition by @AstraZeneca. Together, we have the opportunity to add more value for more patients worldwide across a full spectrum of care. Hear from our employees about #lifeatalexion.
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
Gianluca Pirozzi, Head of Development & Safety, shares his journey and tips as the parent of a child with an ultra-rare disease in the latest issue of @RareRevolutionM focused on long-term caregiving. edition.pagesuite-professional.co.uk/cookie_check.aspx?pu…
-
Alexion
@AlexionPharma
Austen Eadie-Friedman, a member of our Patient & Employee Experience Team, shares his journey with ALS and how he and his partner are managing his care in the latest edition of @RareRevolutionM focused on long-term caregiving. edition.pagesuite-professional.co.uk/cookie_check.aspx?pu…
-
Alexion
@AlexionPharma
“Science is what you do, but it’s not everything that you are”. Hear from Sharon Barr, our Head of Research & Product Development, and other colleagues about life as working parents. #lifeatalexion
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
We’re proud to sponsor this special edition of RARE Revolution Magazine focused on long-term caregiving. A special thank you to the patients and caregivers who generously shared their stories. edition.pagesuite-professional.co.uk/cookie_check.aspx?pu… @RareRevolutionM
-
Alexion
@AlexionPharma
DYK… #nmosd primarily affects the optic nerve and the spinal cord. The most common symptoms of NMOSD are optic neuritis and transverse myelitis. For further advice and support: r.socialstudio.radian6.com/7c094a15-7dcc-40f9-9c3e-6f99b4… #ean2022
-
Alexion
@AlexionPharma
We’re attending the 8th Congress of the @EANeurology June 25-28 in Vienna. r.socialstudio.radian6.com/02482a48-cd4c-499e-b3ad-ab841d… #ean2022
-
Alexion
@AlexionPharma
Today we were honored to welcome Deputy Prime Minister (Tánaiste) of Ireland, @LeoVaradkar, to our College Park campus. We’re thrilled to further expand our global capabilities to accelerate innovation and transform the lives of people affected by #rarediseases.
-
Alexion
@AlexionPharma
Wilson disease is a rare and progressive genetic condition in which the body’s pathway for removing excess copper is compromised. For further advice and support: www.globalliver.org #ilc2022
-
Alexion
@AlexionPharma
We’re attending the @EASLnews International Liver Congress June 22-26 in London. r.socialstudio.radian6.com/e7e34df3-088d-4cf3-9bba-23929e… #ilc2022
-
Alexion
@AlexionPharma
We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Watch this video and visit jobs.alexion.com to learn more about our career opportunities and #lifeatalexion.
-
Alexion
@AlexionPharma
Congrats to our Global Head of Patient Experience, Wendy Erler, on her @GlobalGenes RARE Champions of Hope nomination, recognizing partners who display collaborative efforts in engaging with rare disease communities while driving change. globalgenes.org/event/rare-champion-of-hope-celebration/
-
Alexion
@AlexionPharma
For Rich Welch, Global Regulatory Affairs, #pride is a reminder of the importance of showing up every day as your most authentic self. #pridemonth #pride2022
-
Alexion
@AlexionPharma
Initial symptoms of #gmg may include slurred speech, double vision, droopy eyelids, and a lack of balance. This can often lead to more severe symptoms as the disease progresses. For further advice and support: r.socialstudio.radian6.com/ed793984-a51c-42e6-a2f3-471053… #mgawareness
-
Alexion
@AlexionPharma
In people living with #pnh, the complement system mistakenly destroys red blood cells. PNH can lead to serious health complications, including damage to vital organs, such as kidneys and lungs. For further advice and support: r.socialstudio.radian6.com/ce1327d2-59ea-4ee2-8521-8e84c9… #eha2022 #hematology
-
Alexion
@AlexionPharma
We’re attending the @EHA_Hematology Hybrid Congress June 9-12 in Vienna. r.socialstudio.radian6.com/14b27a9d-e1dc-4e5b-a6b1-9da7a3… #eha2022 #hematology
-
Alexion
@AlexionPharma
DYK… myasthenia gravis (#mg) is a #raredisease that occurs across all racial and ethnic groups. For further advice and support: r.socialstudio.radian6.com/ed793984-a51c-42e6-a2f3-471053… #mgawareness
-
Alexion
@AlexionPharma
Laura Kennedy, Corporate Affairs, reflects on the many milestones that #pride has marked in her life as she and her wife celebrate their first #pridemonth with their new baby. #pride2022
-
Alexion
@AlexionPharma
June is #mgawareness Month. Generalized myasthenia gravis (#gmg) is a rare autoimmune disorder characterized by loss of muscle function and severe muscle weakness. For further advice and support: r.socialstudio.radian6.com/ed793984-a51c-42e6-a2f3-471053…
-
Alexion
@AlexionPharma
Happy #pridemonth! We proudly stand with the LGBTQ+ community and in celebration this month, our global colleagues are sharing their perspectives on what #pride truly means. #pride2022
-
Alexion
@AlexionPharma
Navigating regulatory pathways in #raredisease can be challenging as we often need to build our own roadmap. Learn about how we collaborate and pioneer creative solutions to transform patient lives. #alexion30
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
Submission deadline approaching! Finalize your proposal to advance scientific discovery for a chance to be awarded a fully funded #postdoc position at @AstraZeneca by May 26: r.socialstudio.radian6.com/e4331377-adf3-4f23-9610-004795… #whatsciencecando
-
Alexion
@AlexionPharma
We are innovators, leaders, and collaborators. And at the heart of everything we do is an intense desire to change the world for people living with rare and devastating diseases. Watch this video to learn more about our collective spirit.
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
DYK… atypical hemolytic uremic syndrome (#ahus) is a #raredisease caused by complement dysregulation. For more information and support visit: www.ahusallianceaction.org
-
Alexion
@AlexionPharma
This year we celebrate our 30th anniversary of pioneering leadership in designing and executing clinical trials for rare diseases. Hear how we’ve done this with a focus on listening to and learning from patients. #clinicaltrialsday #ictd22
-
Alexion
@AlexionPharma
We’re attending the 59th European Renal Association Congress May 19-22 in Paris. @ERAkidney #era22 r.socialstudio.radian6.com/34ef60e9-b85e-4503-8f94-71fb74…
-
Alexion
@AlexionPharma
In celebration of World #nfawareness Day, we were proud to join the NF community to #makenfvisible by shining a light on this #raredisease. For further advice and support: www.nf-patients.eu/about/
-
Alexion
@AlexionPharma
Thank you to @MyastheniaOrg for hosting the 14th International Conference on #myasthenia and Related Disorders.
-
Alexion
@AlexionPharma
Happy #internationalnursesday! We are so grateful for nurses around the world for their tireless dedication and deep commitment to patient safety. #ind2022 #nurses2022
-
Alexion
@AlexionPharma
Generalized myasthenia gravis (#gmg) is a rare autoimmune disorder characterized by loss of muscle function and severe muscle weakness. For further advice and support: r.socialstudio.radian6.com/2e76a5d6-63b6-45fd-9463-2aa3fa… or r.socialstudio.radian6.com/9954f258-6527-49da-b3af-a8fffc… #raredisease
-
Alexion
@AlexionPharma
We’re attending the 14th @MyastheniaOrg International Conference on #myasthenia and Related Disorders May 10-12 in Miami. r.socialstudio.radian6.com/efc1bedf-99c8-4797-bb63-17e34c…
-
Alexion
@AlexionPharma
We’re thrilled for our colleagues in Ireland who are celebrating several recent honors including two Pharma Industry Awards and inclusion in the @ibec_irl and @BandF #workplacewellbeing100 index.
-
Alexion
@AlexionPharma
The work we do is guided by people living with rare and devastating diseases. Hear from some of our colleagues about how this passion drives and inspires them each day. #lifeatalexion
-
Alexion
@AlexionPharma
Interested in exploring #whatsciencecando? Participate today in the R&D Postdoctoral Challenge and turn your innovative ideas into reality: r.socialstudio.radian6.com/6386790d-c8a9-491e-9bd9-c92277…. #postdoc @AstraZeneca
-
Alexion
@AlexionPharma
May is #mentalhealthmonth. Hear from Angela Giannantonio, our Head of Human Resources, as she reflects on the importance of focusing on mental wellbeing and ending the stigma related to #mentalhealth.
-
Alexion
@AlexionPharma
Our new corporate headquarters in Kendall Square will bring together our Boston-area Alexion and AstraZeneca colleagues in a vibrant new space, designed to support collaboration and innovation and deliver advances for patients.
The Boston Globe
@BostonGlobe
AstraZeneca to open major research center in Kendall Square www.bostonglobe.com/2022/04/29/business/astrazeneca-open-…
-
Alexion
@AlexionPharma
Happy #administrativeprofessionalsday! We’re so grateful for our administrative professionals across the globe and their unwavering commitment to transforming patient lives.
-
Alexion
@AlexionPharma
Our innovation is driven by a sense of urgency and a relentless quest for answers. Join the R&D #postdoc Challenge and explore #whatsciencecando for some of the world’s most complex diseases: r.socialstudio.radian6.com/d5550dfa-1396-4389-96b1-aefd94… @AstraZeneca
-
Alexion
@AlexionPharma
Paroxysmal Nocturnal Hemoglobinuria (#pnh) is a rare, chronic, progressive, debilitating, and potentially life-threatening blood disorder characterized by complement-mediated intravascular hemolysis and thrombosis. For further advice and support: pnhglobalalliance.org
-
Alexion
@AlexionPharma
In everything we do, we are empowered and committed to speak up and perform at our personal best to accelerate our collective impact for people living with #rarediseases. Check out our career opportunities: r.socialstudio.radian6.com/48d0445e-9202-445c-8b15-77a133… #hiring
-
Alexion
@AlexionPharma
For 30 years, our mission has been to transform the lives of people affected by #rarediseases. Hear from our CEO, Marc Dunoyer, on the health inequities in this space and our efforts to close these gaps: brand-studio.fortune.com/alexion/rare-disease-inequities-… #alexion30
-
Alexion
@AlexionPharma
DYK… atypical hemolytic uremic syndrome (#ahus) is a #raredisease caused by complement dysregulation. For further advice and support visit: r.socialstudio.radian6.com/2be00a14-805f-434b-ab5a-a4134e…
-
Alexion
@AlexionPharma
We were honored to welcome @GovNedLamont to our New Haven campus earlier this year & are thrilled to expand our footprint to further drive our ability to innovate and transform the lives of people affected by rare diseases. View our career opportunities: jobs.alexion.com
-
Alexion
@AlexionPharma
This #worldhealthday, we’re reminded of the connection between a healthy planet and healthy communities. We’re committed to sustaining our planet and serving the communities where we work.
-
Alexion
@AlexionPharma
There are over 7,000 known #rarediseases in the world. Most of these diseases are genetic, and of those 70% start in childhood. For further advice and support: r.socialstudio.radian6.com/a2e44197-567f-4084-8f77-cdb05a…
-
Alexion
@AlexionPharma
Are you passionate about advancing scientific discovery? Join the R&D Postdoctoral Challenge where innovative ideas will be critiqued by a world-leading judging panel with the potential to secure a fully-funded postdoctoral position: r.socialstudio.radian6.com/9fe7147d-cd90-4790-b1fe-4df82b… #postdoc @AstraZeneca
-
Alexion
@AlexionPharma
Our Global Culture Forum brought together colleagues from across the world, representing 10 countries and 21 functions, to share ideas and build connections as we bring our culture values to life. #lifeatalexion
-
Alexion
@AlexionPharma
We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Want to change the world for people living with rare diseases and devastating conditions? Check out our career opportunities: jobs.alexion.com #hiring
-
Alexion
@AlexionPharma
#nmosd is a rare and devastating disorder that affects the central nervous system. Patients with NMOSD can experience unpredictable attacks that can lead to long-term disability. For further advice and support: r.socialstudio.radian6.com/6f13a0a6-a80d-4a85-bda9-39f8da… #nmoawarenessmonth
-
Alexion reposted
AstraZeneca
@AstraZeneca
Our postdocs gain valuable industry experience with the room to remain on the academic track. They have the autonomy to undertake their own research to advance scientific discovery. Help accelerate drug development through the R&D Postdoctoral Challenge. know.az/3qsykXQ
-
Alexion
@AlexionPharma
Congratulations to Sharon Barr, SVP, Head of Research and Product Development, on her @HBAnet Luminary recognition! We’re so grateful for Sharon’s transformational leadership and passion for mentoring those around her.
-
Alexion
@AlexionPharma
Patients living with Wilson disease can develop a wide range of symptoms, including liver disease and/or psychiatric or neurological symptoms. For further advice and support: www.wilsonsdisease.org #wilsondiseaseawarenessmonth
-
Alexion reposted
AstraZeneca
@AstraZeneca
Tomorrow we’re launching an ambitious challenge where outstanding candidates can secure fully funded postdoctoral research positions to transform future treatments. Register to join the live launch event. #postdoc know.az/3JtlDTK
-
Alexion
@AlexionPharma
Most people living with #nmosd experience unpredictable attacks, known as relapses, that can result in cumulative disability, including vision loss and paralysis. For further advice and support: r.socialstudio.radian6.com/8086ac04-92a0-4332-86e1-9239a1… #nmoawarenessmonth
-
Alexion
@AlexionPharma
We are proud to announce the creation of our new Development Hub in Barcelona, Spain, supporting the expansion of our global R&D footprint. We are committed to continuing to advance our science to help patients and families fully live their best lives. #rarediseases
-
Alexion
@AlexionPharma
DYK… #nmosd primarily affects the optic nerve and the spinal cord. The most common symptoms of NMOSD are optic neuritis and transverse myelitis. For further advice and support: r.socialstudio.radian6.com/7c094a15-7dcc-40f9-9c3e-6f99b4… #nmoawarenessmonth
-
Alexion reposted
AstraZeneca
@AstraZeneca
Do you share our passion for advancing scientific discovery? Then register to hear about our new R&D Postdoctoral Challenge, launching on 17 March. It’s your opportunity to explore #whatsciencecando for some of the world’s most complex diseases. #postdoc know.az/3tWkXA7
-
Alexion
@AlexionPharma
Our CEO, Marc Dunoyer, reflects on his commitment to #breakthebias. #iwd2022
-
Alexion
@AlexionPharma
Happy #internationalwomensday! In celebration, our colleagues are reflecting on the importance of #womeninscience and sharing their advice for those interested in pursuing a scientific career. #iwd2022 #womenshistorymonth
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
March is #wilsondiseaseawarenessmonth. Wilson disease is a rare and progressive genetic condition in which the body’s pathway for removing excess copper is compromised. For further advice and support: www.wilsonsdisease.org
-
Alexion
@AlexionPharma
We are deeply grateful for the dedication of our employees worldwide. It is our mission to transform the lives of people living with rare diseases, and we could not accomplish it without each and every one of you! #employeeappreciationday
-
Alexion
@AlexionPharma
Patient centricity is at the forefront of all that we do. In our efforts to remain steadfast in this commitment we introduced LEAP, a series of experiential learning sessions designed to immerse employees in the patient journey. Learn more: r.socialstudio.radian6.com/6acce5a7-66cb-4734-ab5a-30bace…
-
Alexion reposted
AstraZeneca
@AstraZeneca
We are deeply troubled by the events unfolding in #ukraine and the tragic loss of life. We condemn any unprovoked attack and have been working to assist the people affected by this tragedy — protecting employees, ensuring medicines reach patients, and assisting relief efforts.
-
Alexion
@AlexionPharma
Today kicks off #nmoawarenessmonth. #nmosd is a rare, autoimmune disorder of the central nervous system that affects the optic nerve and spinal cord. For further advice and support: r.socialstudio.radian6.com/3a618d9b-9787-4cd1-8938-9d4f8c… #nmo #raredisease
-
Alexion
@AlexionPharma
65% of rare diseases are associated with a reduced lifespan. For more information and support, visit globalgenes.org/rare-disease-facts/ #rarediseaseday
-
Alexion
@AlexionPharma
Today we proudly celebrate #rarediseaseday, a day to raise awareness and generate change for the hundreds of millions of people worldwide living with a rare disease.
-
Alexion
@AlexionPharma
We’re proud to support Rare Diseases: A Global Priority for Equity at Expo2020 Dubai on #rarediseaseday. Join us this morning for a discussion on the impact & implementation of the first UN Resolution for People Living with Rare Disease. events.eurordis.org/rarediseases #resolution4rare
-
Alexion
@AlexionPharma
This year #rarediseaseday is focused on the topic of health equity. Hear from our CEO, Marc Dunoyer, on what we are doing to close the gaps in healthcare systems that affect people living with rare diseases. brand-studio.fortune.com/alexion/rare-disease-inequities-…
-
Alexion
@AlexionPharma
Join us for “Rare Diseases: A Global Priority for Equity” at Expo2020 Dubai on #rarediseaseday. This full-day event focuses on rare diseases as a global priority for equity. To view the full agenda and register: events.eurordis.org/rarediseases #resolution4rare
-
Alexion
@AlexionPharma
We’re proud to support Rare Diseases: A Global Priority for Equity at Expo2020 Dubai on #rarediseaseday. Our CEO, Marc Dunoyer, joins a roundtable discussion on the impact of the first UN Resolution for People Living with Rare Disease. events.eurordis.org/rarediseases #resolution4rare
-
Alexion
@AlexionPharma
The World Health Organization estimates that one out of 15 people worldwide could be affected by a rare disease. For more information: www.who.int/medicines/areas/priority_medicines/Ch6_19Rare… #rarediseaseday
-
Alexion
@AlexionPharma
The work we do is guided by people living with rare and devastating diseases. Hear from a few of our leaders on how they’re working to help patients and their families fully live their best lives. #rarediseaseday
-
Alexion
@AlexionPharma
80% of rare diseases are genetic, while others are the result of infection, allergies, and environmental causes, or are rare cancers. For more information and support, visit globalgenes.org/rare-disease-facts/ #rarediseaseday
-
Alexion
@AlexionPharma
Half of all people affected by a rare disease are children. For more information and support, visit globalgenes.org/rare-disease-facts/ #rarediseaseday
-
Alexion
@AlexionPharma
We believe it's our responsibility to listen to, understand, & change the lives of rare disease patients & those who work tirelessly to help them. Hear from a few of our employees on the critical connection between employees & patients & how that informs our work. #rarediseaseday
-
Alexion
@AlexionPharma
The World Health Organization estimates that 400 million people worldwide (30 million in Europe and 25 million in the US) could be affected by a rare disease. For more information: www.who.int/medicines/areas/priority_medicines/Ch6_19Rare… #rarediseaseday
-
Alexion
@AlexionPharma
Tomorrow we kick off a full week of activities with a focus on health equity leading up to #rarediseaseday on February 28th. Follow us for updates! www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Next week we’ll begin celebrating #rarediseaseday, joining the rare disease community in raising awareness for patients, families, & caregivers around the world & highlighting this year’s theme of health equity. Rare is many, Rare is strong. Rare is proud. www.rarediseaseday.org
-
Alexion
@AlexionPharma
Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. Make your next career move and check out our job openings: r.socialstudio.radian6.com/f3935824-d331-4fe4-ad76-0c6d5b… #hiring #careers
-
Alexion
@AlexionPharma
Today is the 7th International Day of Women and Girls in Science. Hear from Sharon Barr, Head of R&D, about the importance of #womeninscience and her advice for those interested in pursuing a career in the field. #february11
-
Alexion
@AlexionPharma
DYK… most #rarecaregivers live in the same household as their care recipient. Self-care can be hard for caregivers, but resources are available. Visit r.socialstudio.radian6.com/c430e859-f129-4ab6-b08e-97d62b… or r.socialstudio.radian6.com/4db8e006-3a52-4f8b-aa73-96a34a… for more information. #caregiversupport
-
Alexion
@AlexionPharma
In everything we do, we are empowered and committed to speak up and perform at our personal best to accelerate our collective impact for people living with #rarediseases. Check out our career opportunities: r.socialstudio.radian6.com/48d0445e-9202-445c-8b15-77a133… #hiring
-
Alexion reposted
AstraZenecaUS
@AstraZenecaUS
.@AstraZenecaUS is committed to supporting a diverse workforce. We are proud to be recognized as one of the Best Places To Work For LGBTQ+ Equality in @HRC Foundation’s Corporate Equality Index! #cei2022
-
Alexion
@AlexionPharma
DYK… most #raredisease caregivers are providing care to a child under the age of 18. For more information and resources, visit r.socialstudio.radian6.com/377dfa18-d1cd-419a-9505-b568de… #caregiversupport
-
Alexion
@AlexionPharma
Generalized myasthenia gravis (#gmg) is a rare autoimmune disorder characterized by loss of muscle function and severe muscle weakness. For further advice and support: r.socialstudio.radian6.com/ed793984-a51c-42e6-a2f3-471053… or r.socialstudio.radian6.com/12bfe36c-082b-418c-af8d-c9fd37… #raredisease
-
Alexion
@AlexionPharma
Neuromyelitis optica spectrum disorder (#nmosd) is a #raredisease in which the immune system is inappropriately activated to target healthy tissues and cells in the central nervous system. For further advice and support: r.socialstudio.radian6.com/5afd8992-ffce-4c64-bc26-b52e86…
-
Alexion
@AlexionPharma
DYK… there are over 7,000 known #rarediseases in the world. Most of these diseases are genetic, and of those 70% start in childhood. For further advice and support: r.socialstudio.radian6.com/a2e44197-567f-4084-8f77-cdb05a…
-
Alexion
@AlexionPharma
At Alexion, you’re encouraged to take on the most daunting of challenges, settle for nothing less than transformation, and push the boundaries of what science has traditionally offered. Join us! r.socialstudio.radian6.com/8b42bba0-a6c9-4a0c-b3cc-d5ba5e… #hiring #careers
-
Alexion
@AlexionPharma
Creating a purpose-driven, rewarding culture is critical to our collective success and our mission to serve the #raredisease community. This is why we strive to cultivate an environment in which every team member is equipped to perform at their personal best. #lifeatalexion
-
Alexion
@AlexionPharma
Looking to make a change in the new year? We’re #hiring! At the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for people living with #rarediseases. Join us! r.socialstudio.radian6.com/63a10847-afc9-4f80-a2ba-e07fb7…
-
Alexion
@AlexionPharma
Thank you to all who followed along to celebrate our #proudmoments2021. Wishing everyone a happy, healthy New Year!
-
Alexion
@AlexionPharma
In March, Tsveta Milanova and Tamar Thompson were recognized by @HBAnet as Luminary and Rising Star. #proudmoments2021
-
Alexion
@AlexionPharma
This year we launched our inaugural Diversity, Inclusion & Belonging Impact Report chronicling our journey to ignite an inclusive environment and shine light on #rarediseases. alexion.com/-/media/alexion_comredesign/documents/alexion… #proudmoments2021
-
Alexion
@AlexionPharma
Our colleagues in Ireland were honored with several awards this year, including @NISOIreland Healthy Workplace and Biopharmaceutical awards for best-in-class safety standards and the @IbecKeepWell Mark for commitment to employee wellbeing. #proudmoments2021
-
Alexion
@AlexionPharma
We celebrated PRIDE Month in June with perspectives from our employees and were honored to be among the recipients of the Swiss LGBTI-Label, recognizing companies in Switzerland that are actively fostering a diverse and inclusive workplace culture. #proudmoments2021
-
Alexion
@AlexionPharma
In February we were honored to welcome Yann le Cam, founder and CEO of @eurordis, for a discussion on our shared goal of supporting continued research and innovation to address the significant unmet needs of people living with rare diseases around the world. #proudmoments2021
-
Alexion
@AlexionPharma
We were proud to publish our 2020 Corporate Social Responsibility (#csr) Report, outlining our efforts to transform the lives of people affected by #rarediseases and devastating conditions while creating value for all our stakeholders. csr.alexion.com #proudmoments2021
-
Alexion
@AlexionPharma
We found many moments in 2021 to focus on health equity, including internal events with outside guest speaker perspectives and sharing our own expertise at events focused on this critical topic. #proudmoments2021
-
Alexion
@AlexionPharma
We were proud to be named to @Newsweek’s America's Most Responsible Companies. Corporate social responsibility is an inherent part of our mission to transform the lives of people affected by rare diseases & devastating conditions. r.socialstudio.radian6.com/459080ba-b0d1-4195-b6c5-6c93a1… #proudmoments2021
-
Alexion
@AlexionPharma
We hosted Rohini in our Boston office as part of our International Day of the Girl celebrations. Rohini met with Alexion leaders and shared a presentation on the #girlsbelonghere campaign. #proudmoments2021
-
Alexion
@AlexionPharma
In July, @AstraZeneca completed its acquisition of Alexion, marking the creation of Alexion, AstraZeneca Rare Disease. Together we are better positioned to ensure the ongoing discovery and development of medicines for rare diseases and devastating conditions. #proudmoments2021
-
Alexion
@AlexionPharma
As the end of 2021 approaches, we are reflecting on our achievements, milestones, and proudest moments over the past 12 months. Join us over the next ten days as we celebrate #proudmoments2021.
-
Alexion
@AlexionPharma
Our colleagues gathered across the globe to celebrate our proudest moments of the year and our Alexion Excellence Award winners. We were so proud to present this award, our highest employee recognition, to over 130 incredible employees! #lifeatalexion
-
Alexion
@AlexionPharma
DYK… atypical hemolytic uremic syndrome (#ahus) is a #raredisease caused by complement dysregulation. For more information and support visit: r.socialstudio.radian6.com/2be00a14-805f-434b-ab5a-a4134e…
-
Alexion
@AlexionPharma
The #rareconversations Conference brought together thought leaders to develop inspiring ideas to advance the future of #raredisease. Watch this video and be part of the solution by joining us for Rare Conversations 2022. @eurordis @EUCOPE @EuropaBio @EJPRD
-
Alexion
@AlexionPharma
#sustainability is at the forefront of everything we do to minimize negative environmental impacts while conserving energy and natural resources. Learn more about the #futureofmanufacturing2021: www.businessnews.ie/manufacturing/how-manufacturing-can-c… @MediaplanetIE
-
Alexion
@AlexionPharma
Patient centricity is at the forefront of all that we do. In our efforts to remain steadfast in this commitment we introduced LEAP (Learn, Evolve, Activate, and deliver for Patients). Learn more about how LEAP aids us in remaining grounded in our mission: www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Tamar Thompson, VP and Head of Corporate Affairs, will join the @MilkenInstitute Partnering for Patients Forum for a robust discussion on improving access to testing and treatment for #rarediseases. Learn more: r.socialstudio.radian6.com/5bd6d3e3-30e3-414d-a163-668b0a…
-
Alexion
@AlexionPharma
On this International Day of Persons with Disabilities and every day, we strive to foster a true sense of belonging – a pact to ensure that every person feels included because of their uniqueness, not despite it. #idpwd #inclusion #diversity
-
Alexion
@AlexionPharma
The Alexion Charitable Foundation was recognized by @AngelFlightNE at the Evening of Angels Gala, an event celebrating 25 years of arranging free flights and ground transportation for those requiring access to medical care. Learn more about their mission: www.angelflightne.org
-
Alexion
@AlexionPharma
At Alexion, you’re encouraged to take on the most daunting of challenges, settle for nothing less than transformation, and push the boundaries of what science has traditionally offered. Visit r.socialstudio.radian6.com/fcd640f5-ca37-45eb-b468-031ec3… to find out what we’re really about. #hiring
-
Alexion
@AlexionPharma
November is #nationalcaregiversmonth and today especially we are thankful for the generous gift of caregiving that so many provide. Toni Gitles, CEO of Caregiver Empowerment, shares her advice for caregivers. #happythanksgiving #thankacaregiver
-
Alexion
@AlexionPharma
In the last month, we’re proud to have been recognized as one of the world’s top employers, earning places alongside our colleagues at @AstraZeneca on the @Forbes World’s Top Female Friendly Employers lists and the @biospace Best Places to Work list.
-
Alexion
@AlexionPharma
Our internship programs are designed to ensure students gain valuable industry and functional experience, work on meaningful and challenging assignments and build partnerships within their professional networks. Learn more:
r.socialstudio.radian6.com/790e1f6e-9966-433e-8c9e-7562e8… #hiring -
Alexion reposted
EFPIA
@EFPIA
1 in 17 people in Europe live with a rare disease. #wewontrest until we make treatments for rare diseases less rare efpia.eu/about-medicines/development-of-medicines/intelle…
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Want to change the world for people living with rare diseases and devastating conditions? Check out our open positions: r.socialstudio.radian6.com/f0da8cbd-c32c-4f12-a6b8-e8ab97… #hiring
-
Alexion reposted
AstraZeneca
@AstraZeneca
Congratulations to Aradhana Sarin, Executive Director & CFO, for being named one of @FiercePharma's Fiercest Women in Life Sciences 2021. Aradhana’s diverse experience has always aligned with her mission of positively impacting the health of others. www.fiercepharma.com/special-report/women-life-sciences-2…
-
Alexion
@AlexionPharma
We’re proud to be named among the top #lifesciences employers on the inaugural @biospace Best Places to Work list. www.biospace.com/article/biospace-s-best-places-to-work-w…
-
Alexion
@AlexionPharma
Constantine Velentzas, Steering Committee member of our Veterans & Allies in Service Council and U.S. Naval Officer ‘02-’06, shares his thoughts on the complexities of “Happy Veterans Day.” #veteransday www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
On #worldqualityday, and every day, we are committed to working with a quality mindset and acting with integrity to earn the trust of patients, physicians, and our communities. #wqd21
-
Alexion
@AlexionPharma
We’re looking forward to the Women of Color in Pharma 5th Annual Conference. @wocip2015’s mission is to empower women of color to excel in their personal & professional development and to transform their path in the pharmaceutical industry. r.socialstudio.radian6.com/ef02edc6-3143-4b0f-9831-ce5979… #projecther2021
-
Alexion
@AlexionPharma
Today is #nationalsteamday in the U.S. and we’re proud to support organizations working to inspire the next generation of scientists, engineers, mathematicians, and artists! #steamday #steam #stem
-
Alexion
@AlexionPharma
Is R&D your area of expertise? Join us as we continue to discover and deliver transformative medicines, technologies, and healthcare services for people living with rare diseases and devastating conditions. r.socialstudio.radian6.com/fe8ddaef-853b-4e43-aa81-4033ee… #researchjobs #hiring #rarediseases
-
Alexion reposted
Alexion Pharmaceuticals U.S.
@AlexionPharmaUS
We are proud to sponsor tonight’s Schwartz Center for Compassionate Healthcare 26th Annual Dinner to raise money for programs to support the mental & emotional well-being of all caregivers. r.socialstudio.radian6.com/c2cb3b0b-25fb-4491-858c-2e0b18… #nationalfamilycaregiversmonth @theSCCH
-
Alexion
@AlexionPharma
We were honored to receive special mentions by @GalienFdn in Italy. #prixgalien
-
Alexion
@AlexionPharma
On 9 Nov. we’ll be hosting our Rare Conversations Conference, virtually bringing together leaders from research, regulatory, and patient & industry organizations to develop inspiring ideas to advance the future of #rarediseases. Register today! @eurordis @EUCOPE @EuropaBio @EJPRD
-
Alexion
@AlexionPharma
November is #nationalfamilycaregiversmonth – a time to recognize, support, and empower #caregivers. Self-care can be hard for caregivers but resources are available. Check out this guide from @CaregiverAlly: r.socialstudio.radian6.com/3eb02e42-96a5-4fe7-9459-e10d40… #thankacaregiver
-
Alexion
@AlexionPharma
Today we kick off Nomination November, a chance for our employees to recognize individuals and teams who’ve taken notable action to impact the lives of patients, our stakeholders, and each other. #lifeatalexion
-
Alexion
@AlexionPharma
#dyk...Hypophosphatasia (#hpp) is a rare, genetic, life-threatening metabolic condition that prevents minerals such as calcium and phosphate from being properly deposited in bones. For further advice & support: r.socialstudio.radian6.com/afb4b331-7884-45a0-8b37-ee1816… and r.socialstudio.radian6.com/2a8e4032-f1a6-4c6e-8981-1d9146… #hppaware
-
Alexion
@AlexionPharma
October is American Pharmacists Month and we're proud to partner with @MCPHSfellowship to offer #pharmd Fellowship programs that give Doctor of Pharmacy grads exposure to the biopharmaceutical industry. Apply here: r.socialstudio.radian6.com/e46ca35b-6859-485a-a45f-922555… #mcphsfellows
-
Alexion
@AlexionPharma
We’re #hiring! We are innovators, leaders, and collaborators. And at the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for people living with rare diseases and devastating conditions. Join us! jobs.alexion.com
-
Alexion reposted
AstraZeneca
@AstraZeneca
Inspiring students to pursue a passion for STEM from a young age, like @susanmgalbraith did, is integral to our commitment to STEM education. Explore our #stemed content this week during #scifest, a virtual expo hosted by @USAScienceFest: scifest.vfairs.com?linkId=136508911
-
Alexion
@AlexionPharma
In honor of National Disability Employment Awareness Month, we welcomed David Hertwick, who shared his experience as a blind engineer working to design equipment used to restore vision, and tips for fostering disability inclusion in the workplace. #ndeam
-
Alexion
@AlexionPharma
Tamar Thompson, Head of Corporate Affairs, joins @RareDiseases #nordsummit virtual panel, “Challenges in Access to Genetic Testing for Rare Disease Patients” tomorrow at 1:35 PM ET.
-
Alexion reposted
AstraZeneca
@AstraZeneca
Female representation, particularly in senior leadership positions, is crucial for healthy societies. Join us to show #girlsbelonghere. #younghealthprogramme www.astrazeneca.com/media-centre/articles/2021/girls-belo…
-
Alexion
@AlexionPharma
#pnh is a rare, life-threatening blood disorder in which uncontrolled activation of complement, a component of the normal immune system, leads to chronic hemolysis (destruction of the red blood cells). For further advice and support: r.socialstudio.radian6.com/95b713fe-e345-49a0-9336-80f46f… #pnhweek
-
Alexion
@AlexionPharma
We were proud to host Rohini in our Boston headquarters in honor of #dayofthegirl. Rohini met with Alexion leaders and shared a presentation on the #girlsbelonghere campaign. Thank you, Rohini!
-
Alexion reposted
AstraZeneca
@AstraZeneca
Creating education & employment opportunities for girls and women can improve their health outcomes. To show #girlsbelonghere, see how girls around the world are stepping into AstraZeneca leadership positions. #dayofthegirl #younghealthprogramme @PlanUK
This media couldn't be displayed. See it on the original post. -
Alexion reposted
Alexion Pharmaceuticals U.S.
@AlexionPharmaUS
Best of luck to Christine Rowe, Patient Advocacy, and Michaela Menard, Corporate Affairs, who are running today’s 125th #bostonmarathon!
-
Alexion
@AlexionPharma
We are committed to advancing women’s equality and representation to foster a diverse and inclusive company. #dayofthegirl #girlsbelonghere
-
Alexion
@AlexionPharma
October is #liverawarenessmonth. #lald is a rare, inherited, progressive condition in which people have an uncontrolled buildup of fatty material in their liver and other organs. For further advice and support: laldaware.org or metabolicsupportuk.org
-
Alexion
@AlexionPharma
Thank you to our employees who’ve helped us celebrate #latinxheritagemonth by sharing their stories. We may be different, but we share one purpose: to shine light on rare diseases through the collective power of diversity, inclusion, and belonging.
-
Alexion reposted
Alexion Pharmaceuticals U.S.
@AlexionPharmaUS
Congratulations to Kevin Conway and Tyler Gullbrand on their #pm360trailblazerawards!
-
Alexion reposted
AstraZeneca
@AstraZeneca
Our AZ Forest initiative to plant and maintain 50 million trees worldwide by 2025 is contributing to @WEF’s @1t_org and the #trilliontrees community to help accelerate the sustainable transition. 1tr.org
-
Alexion
@AlexionPharma
We’re excited to be at the 2021 @Prospanica National Conference & Career Expo! Visit our virtual booth at the career fair on 9/28 and video chat with us between 11AM and 4PM ET: r.socialstudio.radian6.com/46a4dccd-5554-42b8-9fcb-91f696… #prospanicaconference
-
Alexion
@AlexionPharma
Atypical hemolytic uremic syndrome (#ahus) is a rare, life-threatening, chronic genetic disease that can progressively damage vital organs that can lead to stroke, heart attack, kidney failure, and death. For more information visit www.ahusallianceaction.org #ahusday
-
Alexion reposted
AstraZeneca
@AstraZeneca
Pascal Soriot, CEO, discusses the importance of urgency, innovation and partnership to tackle climate change in a new @WEF blog post. #sdis21 know.az/2XCR8rr
-
Alexion
@AlexionPharma
We were proud to sponsor @CBCFInc's #alc50 Veterans' Braintrust session on the Biden administration’s efforts to address the challenges and opportunities facing African-American veterans in the aftermath of the COVID-19 pandemic.
-
Alexion
@AlexionPharma
Serving people living with rare diseases and their families is our unwavering mission—they are our guiding star. #worldpatientsafetyday
-
Alexion
@AlexionPharma
We’re looking forward to the National Black MBA Association's 43rd Annual Conference & Career Expo, September 21-22 in Chicago. Visit our virtual booth at the career fair and video chat with us from 12-5 PM ET: nbmbaa21.us2.pathable.com #renewrefreshreset #nbmbaa21 @nbmbaahq
-
Alexion reposted
Alexion Pharmaceuticals U.S.
@AlexionPharmaUS
We are excited to announce that Alexion US is on Twitter! Follow along for the latest updates on how we are working tirelessly to transform the lives of people affected by rare diseases and devastating conditions. www.alexion.com
-
Alexion
@AlexionPharma
We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Want to change the world for people living with rare and devastating diseases? Check out our open positions: r.socialstudio.radian6.com/37a0c851-8ef9-4476-baf3-ec3f31…
-
Alexion
@AlexionPharma
Our CSR-STAR platform supports our mission to transform the lives of people affected by rare diseases and devastating conditions. See how we’re living our mission, every day: r.socialstudio.radian6.com/37b12732-e624-49d8-aae8-46ad67… #csr
-
Alexion
@AlexionPharma
Every day, people living with rare diseases face fears of the unknown with courage, tenacity, and grace that inspire us to continue to strive to do everything we can to transform their lives. Learn more about what drives us: r.socialstudio.radian6.com/bd8d510a-c632-4ece-8830-840567…
-
Alexion
@AlexionPharma
Some opportunities happen only once in a lifetime – like a job where you have the chance to change lives. Learn more about #lifeatalexion: r.socialstudio.radian6.com/52d27a3e-1ca6-4a30-819a-bbe281…
-
Alexion
@AlexionPharma
September is #latinxheritagemonth. Our employees are reflecting on the importance of highlighting diverse voices within our organization and embedding diversity, inclusion, and belonging into our culture. r.socialstudio.radian6.com/c8ed3a02-99e9-4712-bfdd-c02e51…
-
Alexion
@AlexionPharma
Thank you to our global interns for another amazing summer! We are grateful for this year’s cohort who met the challenge of working virtually and maintaining their enthusiasm to deliver life-transforming therapies to people living with rare diseases and devastating conditions.
-
Alexion
@AlexionPharma
Looking to be part of a purpose-driven, rewarding culture? We strive to continuously innovate and create meaningful value in all that we do to help patients and families live their best lives. Join us! r.socialstudio.radian6.com/022aa293-2d30-45c4-bced-310f86…
-
Alexion
@AlexionPharma
We are inspired every day. The work we do is guided by people living with rare diseases and devastating conditions, and we are driven to continuously innovate and create meaningful value in all we do to help patients fully live their best lives. r.socialstudio.radian6.com/5b742daa-f221-4ad2-a95b-759c56…
-
Alexion
@AlexionPharma
Serving our communities has always been integral to who we are and what we stand for, and over the past 18 months, it’s taken on even greater importance. Learn more about our efforts to support the communities where we live and work. r.socialstudio.radian6.com/07e9d847-c6d4-4898-96c6-63c976… #worldhumanitarianday
-
Alexion
@AlexionPharma
People living with rare diseases and devastating conditions endure many obstacles throughout their lives. To better understand those realities and innovate for solutions, we introduced LEAP (Learn, Evolve, Activate, and deliver for Patients). Learn more: r.socialstudio.radian6.com/543abba2-f73d-4c41-a2e2-deaafc…
-
Alexion
@AlexionPharma
We strive to ignite an inclusive environment where people belong because of their uniqueness and unleash their individuality and diversity to spur innovative breakthroughs for patients. Learn more: r.socialstudio.radian6.com/7a01f8b4-28f4-449e-8fdc-bc6425…
-
Alexion
@AlexionPharma
We’re hiring! We are innovators, leaders, and collaborators. At the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for people living with rare diseases and devastating conditions. Join us! r.socialstudio.radian6.com/dcb251b6-b980-4296-955d-673d99…
-
Alexion
@AlexionPharma
Judy Campagnari, Head of Solutions To Accelerate Results (STAR) Strategy & Planning, on our efforts to ensure we develop deep expertise in understanding patient insights and accelerate patient-centered innovation. Read more: r.socialstudio.radian6.com/b610d3ca-6463-4928-846c-9c9541…
-
Alexion
@AlexionPharma
Patient-centricity is at the forefront of all that we do. In our efforts to remain steadfast in this commitment we introduced LEAP (Learn, Evolve, Activate, and deliver for Patients). Learn more about how LEAP aids us in remaining grounded in our mission: www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Tamar Thompson, Vice President, Head of Corporate Affairs, moderates “The Future of Clinical Trials, Minority Communities, and Policy” as part of today’s @WOCIP2015 2021 Think Tank Conference.
wocip.org -
Alexion
@AlexionPharma
Happy #nationalinternday! We are so grateful to our interns who have brought new ideas, fresh perspectives, and a passion for excellence to our organization.
-
Alexion
@AlexionPharma
As part of our commitment to serving our communities, we’ve expanded our local giving efforts to include the donation of IT equipment to non-profit organizations to help increase digital accessibility. Learn more about our IT equipment donation program: r.socialstudio.radian6.com/0fe66196-1272-4a48-ae30-39cf4f…
-
Alexion
@AlexionPharma
Integrating diversity, inclusion & belonging into research & clinical practices is critical to providing optimal care to patients. We were honored to have Dr. Roy Hamilton as our guest for our latest Crucial Exchange, “Building Equity into Clinical Trials.”
-
Alexion
@AlexionPharma
We understand that creating a purpose-driven, rewarding culture is critical to our collective success and our mission to serve the rare disease community. Learn more about our culture transformation story: r.socialstudio.radian6.com/606dff99-3865-42ef-b222-436733…
-
Alexion
@AlexionPharma
.@AstraZeneca announced today the completion of our acquisition, marking the creation of “Alexion, AstraZeneca Rare Disease.” Read more: www.astrazeneca.com/content/astraz/media-centre/press-rel…
-
Alexion
@AlexionPharma
Learn about our ongoing research to build upon our deep expertise in complement biology and hear about our work to advance the next generation of complement inhibitors to help more patients. alexion.com/our-research/our-science #rarescience
-
Alexion
@AlexionPharma
(AL) amyloidosis is a rare disease that creates harmful deposits (amyloids) which accumulate in organs & cause damage. It can be devastating to the heart & kidneys & can ultimately be fatal. Learn more about the science of (AL) amyloidosis: alexion.com/our-research/our-science #rarescience
-
Alexion
@AlexionPharma
Paroxysmal Nocturnal Hemoglobinuria (#pnh) is a rare, chronic, and potentially life-threatening blood disorder characterized by complement-mediated intravascular hemolysis (destruction of red blood cells). Learn more about the science of PNH: alexion.com/our-research/our-science #rarescience
-
Alexion
@AlexionPharma
Today we announced positive topline results from a Phase 3 study of our long-acting C5 inhibitor. Learn more: www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
We are dedicated to building upon our trailblazing science in rare disease to translate emerging science into transformational medicines for even more patients. Learn more about our science: alexion.com/our-research/our-science #rarescience
-
Alexion
@AlexionPharma
We’re proud to be recognized by
@DisabilityIN, the world’s most comprehensive benchmarking tool for disability, inclusion, and equality, among the “Best Places to Work for Disability Inclusion.” www.disabilityin.org/announcements/one-billion-people-wit… -
Alexion
@AlexionPharma
We partner with @MCPHSfellowship to offer #pharmd Fellowship programs that give Doctor of Pharmacy grads exposure to the biopharmaceutical industry and strengthen the impact they can have in the field. We're excited to welcome two new 1st-year fellows! #mcphsfellows
-
Alexion
@AlexionPharma
Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare, autoimmune disorder of the central nervous system that affects the optic nerve and spinal cord. Learn more about the science of NMOSD: alexion.com/our-research/our-science #rarescience
-
Alexion
@AlexionPharma
Wilson disease is a rare and progressive genetic condition in which the body’s pathway for removing excess copper is compromised. Learn more about the science of Wilson disease: r.socialstudio.radian6.com/4c159eba-a8eb-4985-acc0-052972… #rarescience
-
Alexion
@AlexionPharma
Dysregulation of the complement system is a driver of many diseases. We remain focused on innovating to translate the science of complement inhibition into new medicines. Learn more about our science: alexion.com/our-research/our-science #rarescience
-
Alexion
@AlexionPharma
Uzair Qadeer, Chief Diversity Officer, presents “Dialing into Diversity: Creating a Holistic and Purposeful Approach” with @HBAnet. Register here: r.socialstudio.radian6.com/887d2ffb-64d5-4bd0-aa3d-a41d07…
-
Alexion
@AlexionPharma
With 3+ decades of research & nearly 20 years of real-world evidence, we’ve proven what’s possible in a variety of rare diseases & devastating conditions across neurology, hematology, nephrology, & metabolics. Learn more about our science: r.socialstudio.radian6.com/cbdc4316-2cc1-4660-b42b-707462… #rarescience
-
Alexion
@AlexionPharma
The Alexion Charitable Foundation recently made an additional donation to AmeriCares COVID-19 Relief Fund. Read more: r.socialstudio.radian6.com/dd654da0-0904-4b16-8e68-eab354…
-
Alexion
@AlexionPharma
Welcome to our 2021 Summer Interns! We look forward to the unique talent and enthusiasm they will bring as we continue to deliver life-transforming therapies to people living with rare diseases and devastating conditions.
-
Alexion
@AlexionPharma
We loved hearing from our colleagues about what #pridemonth means to them! #pride2021 #pride
-
Alexion
@AlexionPharma
June is Myasthenia Gravis Awareness Month. Myasthenia gravis (MG) is a debilitating, chronic, and progressive autoimmune neuromuscular disease. Learn more: r.socialstudio.radian6.com/bceb5167-de00-47c2-9a4e-6eaaaa… #mgawarenessmonth #raredisease
-
Alexion
@AlexionPharma
Born from a common desire to change lives for the better, we established four key culture values to guide our business: serve patients, empower people, act with integrity, and innovate for solutions. Learn more about our culture transformation journey: r.socialstudio.radian6.com/635cb048-8369-4372-992e-673031…
-
Alexion
@AlexionPharma
We were honored to be among the recipients of the Swiss LGBTI-Label, recognizing companies in Switzerland that are actively fostering a diverse and inclusive workplace culture. #pride2021
-
Alexion
@AlexionPharma
Is R&D your area of expertise? Join us as we continue to discover and deliver transformative medicines, technologies, and healthcare services for people living with rare diseases and devastating conditions. jobs.alexion.com #researchjobs #hiring #rarediseases
-
Alexion
@AlexionPharma
Our culture is rooted in integrity and inclusiveness, and we encourage diversity of ideas to drive innovation. That’s why we’re creating a network of diverse suppliers who believe in our purpose. Learn more about our efforts: alexion.com/-/media/alexion_comredesign/documents/alexion…
-
Alexion
@AlexionPharma
Our pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement system into transformative medicines. Learn more about the complement system: alexion.com/rare-disease-research-and-development #rarescience
-
Alexion
@AlexionPharma
Today we’re celebrating our amazing Alexion dads. Happy #fathersday to fathers everywhere! #fathersday2021
-
Alexion
@AlexionPharma
In honor of #juneteenth, we were joined by @EbonRebel, author of award-winning #bankingonfreedom, whose research focuses on race, gender, and capitalism, for an important discussion on the history of Juneteenth events from the late nineteenth century to the present.
-
Alexion
@AlexionPharma
We strive to foster a culture where speaking up is valued, transparency is expected, and we hold ourselves and each other to the highest standards. Hear from Coleen Glessner, our Chief Quality Officer, on putting our values into practice: www.linkedin.com/posts/coleen-glessner-27bba73_acting-wit… #integritymatters
-
Alexion
@AlexionPharma
We’re excited to attend the 7th Congress of the European Academy of Neurology (EAN) which kicks off tomorrow. @EANeurology
-
Alexion
@AlexionPharma
Paroxysmal nocturnal hemoglobinuria (#pnh) can strike men and women of all races, backgrounds, and ages without warning, with an average age of onset in the early 30s. Learn more: r.socialstudio.radian6.com/b27076c1-417a-40d6-a99d-dd96d7… #eha2021
-
Alexion
@AlexionPharma
This #integritymattersweek, our colleagues are engaging in interactive learning opportunities & exploring strategies to act with integrity so we can continuously deliver on our mission of helping people with rare diseases & devasting conditions. Learn more www.linkedin.com/posts/indrani-franchini-63751473_inspiri…
-
Alexion
@AlexionPharma
We’re proud to partner with the rare disease community to launch the Inspired By book series, a collection of stories that aim to help families with young children talk about rare diseases in an approachable and age-appropriate way. #gmg #mgawarenessmonth www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Our scientists were among the first to take on the bold translational research in complement biology. Hear from those who played a role in translating this research into transformational medicines for rare diseases. www.youtube.com/watch?v=mFYGEtDNmB4 #rarescience
-
Alexion
@AlexionPharma
This week we are reflecting on and celebrating our culture of integrity, one of our four culture values. We are committed to acting with integrity and keeping the patient at the center of all that we do. #integritymatters #integritymattersweek
-
Alexion
@AlexionPharma
In 2019 we introduced LEAP, an experiential learning platform that immerses our team members in the patient journey from multiple perspectives within the rare disease ecosystem. Learn more about our journey to create a patient-centric culture: www.bizjournals.com/boston/news/2021/06/03/putting-the-pa…
-
Alexion
@AlexionPharma
The work we do is guided by people living with rare diseases and devastating conditions. We are driven to continuously follow the science and create meaningful value in all we do to help patients. #eha2021
-
Alexion
@AlexionPharma
Our global colleagues are continuing to celebrate #pridemonth and sharing what this month means to them and to their families. #pride2021 #pride
-
Alexion
@AlexionPharma
Today, in collaboration with Caelum Biosciences, we announced additional data on an innovative compound being studied in AL amyloidosis at #eha2021 (June 9-17). Read more: www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Generalized Myasthenia Gravis typically begins with weakness in the muscles that control the movements of the eyes and eyelids, and often progresses to the more severe and generalized form, known as gMG. Learn more about the science of gMG: alexion.us/conditions/gmg #rarescience
-
Alexion
@AlexionPharma
We’re excited to be attending #eha2021 virtually. We’ll be sharing our research in #pnh, a chronic, progressive, debilitating, and life-threatening rare blood disorder characterized by complement-mediated hemolysis. @EHA_Hematology www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Paroxysmal nocturnal hemoglobinuria (#pnh) is a chronic and life-threatening rare blood disorder. Learn how we're helping patients manage their disease: www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
The @US_FDA approved our long-acting C5 complement inhibitor for children and adolescents with paroxysmal nocturnal hemoglobinuria (#pnh). Read more about our latest approval. www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Our legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into transformative medicines. The complement system is essential to the body’s defense against infection. Learn more: r.socialstudio.radian6.com/f14a5d1c-cf29-4ac1-a4c2-f3b5c1… #rarescience
-
Alexion
@AlexionPharma
We are proud to be named a #fortune500 company by @FortuneMagazine! brand-studio.fortune.com/alexion/people-living-rare-and-d…
-
Alexion
@AlexionPharma
Happy #pridemonth! Our culture is rooted in integrity and inclusiveness, and we proudly stand with the LGBTQ+ community. In celebration, our global colleagues are reflecting on what this month means to them. #pride2021 #pride
-
Alexion
@AlexionPharma
Our Diversity, Inclusion & Belonging (DI&B) mission is to ignite an inclusive environment where people belong because of their uniqueness. Learn more about our efforts in our inaugural DI&B Impact Report: alexion.com/-/media/alexion_comredesign/documents/alexion…
-
Alexion
@AlexionPharma
Most people are familiar with the immune system, but what about the complement system? Learn about this foundational part of the immune system and how our pioneering research in complement inhibition led to transformational medicines for #rarediseases: www.statnews.com/sponsor/2021/05/25/how-unlocking-fundame…
-
Alexion
@AlexionPharma
Today we honor all who have served our country. We are deeply grateful. #memorialday
-
Alexion
@AlexionPharma
#dyk… About 90% of #als cases occur without family history (sporadic ALS) while the remaining 10% are inherited through a mutated gene (familial ALS). Learn more: r.socialstudio.radian6.com/5667420a-0fa7-4015-b830-4a2e75… #alsawarenessmonth #alsmonth #alsawareness #alsinthistogether
-
Alexion
@AlexionPharma
Hear from Camilla Harder Hartvig, SVP, International, on the importance of people-centered and vulnerable leadership and how the #raredisease space could evolve in the near future: pharmaphorum.com/views-and-analysis/alexions-camilla-hard… @pharmaphorum
-
Alexion
@AlexionPharma
Hypophosphatasia is characterized by low alkaline phosphatase (ALP) activity and defective bone mineralization that can lead to destruction and deformity of bones and other skeletal abnormalities. Learn more about the science of #hpp: alexion.us/conditions/hpp #rarescience
-
Alexion
@AlexionPharma
We were honored to be joined by @DrHanRen for a global event celebrating Asian American and Pacific Islander Heritage Month. Dr. Ren discussed the impact of race-related stress and ways to take care of yourself through self and community care. #aapi #apahm2021 #stopasianhate
-
Alexion
@AlexionPharma
Did you miss today’s “Behind the Mystery: Wilson Disease” segment? Tune in on June 1 to @BalancingActTV on the Lifetime TV channel or watch a video replay to learn more about living with Wilson Disease, a rare and progressive genetic condition: www.thebalancingact.com/episodes/behind-the-mystery-wilso…
-
Alexion
@AlexionPharma
We’re excited to virtually attend the 23rd European Congress of Endocrinology and help raise awareness of rare metabolic bone disorders, like hypophosphatasia (#hpp). @ESEndocrinology #eece2021 #ourendocrinecommunity
-
Alexion
@AlexionPharma
Amyotrophic lateral sclerosis (#als) is a neurodegenerative disease characterized by progressive loss of upper & lower motor neurons. This degeneration prevents signal transmission from the brain to the body. Learn more about our pipeline: alexion.com/our-research/pipeline #rarescience
-
Alexion
@AlexionPharma
This #clinicaltrials Day, we are reflecting on the efforts made across the globe to proactively respond to the evolving COVID-19 pandemic and remain focused on supporting patients in clinical trials. #ctd2021
-
Alexion
@AlexionPharma
Hear from Uzair Qadeer, our Chief Diversity Officer, on our journey to create a distinctive diversity, inclusion, and belonging (DI&B) roadmap that has spurred our powerful belonging revolution: www.bizjournals.com/boston/news/2021/05/13/diversity-func…
-
Alexion
@AlexionPharma
About 16,000 people in the U.S. are living with ALS. #alsawarenessmonth #alsmonth #alsawareness #alsinthistogether
-
Alexion
@AlexionPharma
Decades of low awareness and limited scientific research of Wilson disease, a rare genetic condition, have contributed to delayed diagnosis & few treatment options. Tune in on May 24 to @BalancingActTV to learn more about how this disease affects patients www.thebalancingact.com
-
Alexion
@AlexionPharma
“I’ve never been one to back down in a fight, but when I was diagnosed with PNH, the prognosis was overwhelming.” Hear more from Joe about life with paroxysmal nocturnal hemoglobinuria (#pnh). #raredisease alexion.us/patients/joes-story
-
Alexion
@AlexionPharma
In support of #mentalhealthawareness Month, we were joined by Garen Staglin, Chairman and Founder @OneMindOrg, for an important discussion on removing the stigma surrounding mental health and ways we can contribute to a more brain-healthy environment. #mentalhealth #brainhealth
-
Alexion
@AlexionPharma
#dyk… approximately 5,000 people in the U.S. are diagnosed with #als each year. #alsawarenessmonth #alsmonth #alsawareness #alsinthistogether
-
Alexion
@AlexionPharma
Today, in collaboration with Caelum Biosciences, we announced upcoming data presentations on an innovative compound being studied in AL amyloidosis at #eha2021 (June 9-17). www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
We’ll be presenting data from our latest research in #pnh at #eha2021 (June 9-17). www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Congratulations to Lukasz Jarzyna, Head of Global Value Access and Pricing, and to all those nominated by @PharmExec for the 2021 Emerging Pharma Leaders Awards! Learn more about these notable leaders: www.pharmexec.com/view/lukasz-jarzyna
-
Alexion
@AlexionPharma
Wishing our Alexion #supermoms a wonderful #mothersday! We are so grateful for all that you do for your families and for your commitment to transforming the lives of people living with rare diseases and devastating conditions. Happy #mothersday to moms everywhere!
-
Alexion
@AlexionPharma
Happy Asian American and Pacific Islander Heritage Month! Our employees are reflecting on what this month means to them and the importance of celebrating our unique heritage. #aapi #apahm2021
-
Alexion
@AlexionPharma
Paroxysmal nocturnal hemoglobinuria (#pnh) is a chronic, progressive, debilitating, and life-threatening ultra-rare blood disorder. Learn more: r.socialstudio.radian6.com/29911459-eb33-44c0-9d18-0d8682…
-
Alexion
@AlexionPharma
We’re #hiring! We are innovators, leaders, and collaborators. And at the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for people living with rare and devastating diseases. Join us! jobs.alexion.com
-
Alexion
@AlexionPharma
Congratulations to George Llado, SVP & CIO, on being named to @Forbes CIO Next 2021 list! This list recognizes top technology executives who are redefining the CIO role and driving game-changing innovation. www.forbes.com/sites/martingiles/2021/04/29/cio-next-2021…
-
Alexion
@AlexionPharma
May is amyotrophic lateral sclerosis (#als) Awareness Month. #als is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. #alsawarenessmonth #alsinthistogether
-
Alexion
@AlexionPharma
In 2020, we launched our Diversity, Inclusion & Belonging (DI&B) Innovation Factory. This group of over 200 global employees works to innovate and amplify novel DI&B solutions. Learn more about our DI&B efforts in our #csr report: csr.alexion.com
-
Alexion
@AlexionPharma
Chief Diversity Officer, Uzair Qadeer, and General Counsel, Ellen Chiniara, who serves as Executive Champion of our Black Professionals Network (BPN), shared the following with our global workforce today, underscoring our commitment to fostering diversity, inclusion & belonging.
-
Alexion
@AlexionPharma
#dyk… 100% of our plastic waste produced from manufacturing at our Athlone, Ireland, facility, is recycled. That’s the equivalent of approximately two pallets of waste per week. Check out our #csr Report for more fun facts: csr.alexion.com #earthday
-
Alexion
@AlexionPharma
In 2020, we maintained our zero process waste-to-landfill status. Our Ireland-based facilities achieved zero waste-to-landfill for all waste streams. Learn more: csr.alexion.com #csr #earthday
-
Alexion
@AlexionPharma
DYK… by installing a new steam boiler at our New Haven site, we’ve reduced water consumption by 300% a month. Our water savings add up to more than 500,000 gallons a year. Learn more: csr.alexion.com #csr #earthday
-
Alexion
@AlexionPharma
On this #administrativeprofessionalsday, we are especially #grateful for our administrative professionals all over the globe and their continued support during this new way of working together. Thank you!
-
Alexion
@AlexionPharma
#nmosd and #gmg are both rare, neurologic complement-mediated disorders. We’ll be presenting data from our latest research at #aanam. Learn more: www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
#dyk… many #nmosd patients experience repeated attacks, which can occur at weekly, monthly, or yearly intervals. #raredisease #aanam
-
Alexion
@AlexionPharma
#dyk… although myasthenia gravis (#mg) usually becomes apparent during adulthood, symptom onset may occur at any age. #gmg #raredisease #aanam
-
Alexion
@AlexionPharma
“I don’t define myself as having a rare disease. It’s part of my life but it’s certainly not who I am.” Hear from Chelsey about life with #nmosd. r.socialstudio.radian6.com/306f736b-2b8c-4b78-95d4-d0a45d… #nmo #raredisease #aanam
-
Alexion
@AlexionPharma
Myasthenia gravis (MG) is a debilitating, chronic, and progressive autoimmune neuromuscular disease. Learn more: r.socialstudio.radian6.com/aa4970ab-29f2-4836-8827-ce77f8… #gmg #raredisease #aanam
-
Alexion
@AlexionPharma
We’re looking forward to attending this year’s virtual #aanam. We’ll be sharing our research in #nmosd and #gmg. @AANMember r.socialstudio.radian6.com/ebc74f23-6b73-496c-81f8-51c3f3…
-
Alexion
@AlexionPharma
In 2020, we expanded our Global Day of Service to a full week and made it 100% virtual to enable employees to safely give back in the face of a global health crisis. Learn more about our efforts to give back to our communities in our #csr Report. csr.alexion.com
-
Alexion
@AlexionPharma
We’re #hiring! Our passion drives us to continuously innovate and create meaningful value in all we do. Are you devoted to changing the outlook for people affected by rare diseases? Join us! jobs.alexion.com
-
Alexion
@AlexionPharma
Thank you @BostonCares for hosting a great virtual Awards Ceremony and 30th Celebration! We are honored to be recognized with the Boston Cares Corporate Partnership Award and grateful for your partnership and innovation to continue to meet critical community needs.
-
Alexion
@AlexionPharma
This #worldhealthday, we are reflecting on the lessons learned from the #covid19 pandemic. Despite the devastation experienced across the world, this was also a time of great advances in science and public health.
-
Alexion
@AlexionPharma
Brain health helps everyone feel motivated, safe, and empowered to make purposeful and productive choices. In 2020, we joined @OneMindOrg, a global coalition of employers dedicated to workplace brain health. Learn more: csr.alexion.com #csr
-
Alexion
@AlexionPharma
As we wrap up #nmoawarenessmonth, we remain inspired by the patients, caregivers, and loved ones affected by this devastating disease. #nmo #nmosd #raredisease
-
Alexion
@AlexionPharma
Today is #doctorsday and we want to thank all of the #healthcareheroes for their tireless work to keep our communities safe, especially during this global health crisis. #nationaldoctorsday #doctorsday2021
-
Alexion reposted
pharmaphorum
@pharmaphorum
.@AlexionPharma’s Camilla Harder Hartvig discusses the unique considerations that come with being a pharma company focused on #raredisease, and how she sees the space evolving in the near future pharmaphorum.com/views-and-analysis/alexions-camilla-hard…
-
Alexion
@AlexionPharma
Our Corporate Social Responsibility mission is to transform the lives of people affected by rare diseases & devastating conditions while creating value for all stakeholders. We’re pleased to share our 2020 #csr Report, which brings this commitment to life. csr.alexion.com
-
Alexion
@AlexionPharma
Our colleagues took on the challenge of running 100 miles each in support of @TheMaterFoundat and advancing #patientcare. Congrats to our Alexion 100 Milers on this challenge completion! #100milesinamonth
-
Alexion
@AlexionPharma
#dyk… characteristic symptoms of #nmosd are either optic neuritis or myelitis; either may occur as the first symptom. #nmo #nmoawarenessmonth #raredisease
-
Alexion
@AlexionPharma
Each of us has a role to play in combating racial violence, discrimination & prejudice. Today we held our latest Crucial Exchange to listen, learn & show support to our Asian, Asian American & Pacific Islander colleagues, partners & allies. We stand with you to #stopasianhate.
-
Alexion
@AlexionPharma
In honor of #internationalwomensday, our #womeninleadership group hosted an interactive panel celebrating our #hiddengems; women nominated from across the organization who demonstrated collaboration, compassion, commitment, courage, and confidence. #womenshistorymonth #iwd2021
-
Alexion
@AlexionPharma
People living with rare diseases wait a long time to receive a correct diagnosis – 4.8 years on average. @nytimes recently shared a great piece on one woman’s journey to her #myastheniagravis diagnosis. www.nytimes.com/2021/03/04/magazine/myasthenia-gravis-mg-…
-
Alexion
@AlexionPharma
Congratulations to Tsveta Milanova and Tamar Thompson for being recognized by @HBAnet as Luminary and Rising Star! We are grateful to you both for your fearless leadership and commitment to transforming the lives of people living with rare diseases and devastating conditions.
-
Alexion
@AlexionPharma
We join the #raredisease community in recognizing the strength and resiliency of people living with #wilsondisease and celebrating the support provided by caregivers and patient organizations. #wilsondiseaseawarenessmonth
-
Alexion reposted
CBS Evening News with Tony Dokoupil
@CBSEveningNews
STORY OF HOPE: A young student is sharing her experience in battling a rare disease, and her “hospital story” is now giving other children hope.
Chip Reid introduces the young author who’s sharing wisdom, born through adversity. -
Alexion
@AlexionPharma
“Now, more than ever, is a hopeful time to be diagnosed as a rare disease patient”. Hear from Lelainia, living with #nmosd, about moving the science of #raredisease forward. #nmo #nmoawarenessmonth
-
Alexion
@AlexionPharma
Martine Zimmermann, SVP and Head of Global Regulatory Affairs, joined other regulatory experts at the @DrugInfoAssn Europe 2021 and discussed how mechanism of action-driven development can address the COVID-19 challenge. Learn more: r.socialstudio.radian6.com/1217128a-4801-4a70-866d-820c3c…
-
Alexion
@AlexionPharma
Thank you to @frederickruberg for joining our recent Chat With an Expert session celebrating Amyloidosis Awareness Month! Dr. Ruberg discussed #amyloidosis, the path to diagnosis, and the connection to heart failure.
-
Alexion
@AlexionPharma
#wilsondisease is something you are born with, but diagnosis typically happens decades later. Greater awareness and continued research are essential to helping us understand this #raredisease and transforming the patient experience. #wilsondiseaseawarenessmonth
-
Alexion
@AlexionPharma
Looking to be part of a purpose-driven, rewarding culture? We strive to continuously innovate and create meaningful value in all that we do to help patients and families live their best lives. Join us! jobs.alexion.com
-
Alexion
@AlexionPharma
We’re so pleased to share that we have been reaccredited with the @IbecKeepWell Mark, a testament to our commitment to #employeewellbeing. Congratulations to all our colleagues in Ireland! #corporatewellness
-
Alexion
@AlexionPharma
Simu Thomas, VP, Global Health Economics and Outcomes Research, reflects on the critical role of real-world evidence in the #raredisease community. Access the full roundtable discussion with other industry leaders in @PharmExec: cdn.sanity.io/files/0vv8moc6/pharmexec/4178b4a818edca64b4…
-
Alexion
@AlexionPharma
#dyk… Patients with #nmosd can experience unpredictable attacks, also referred to as relapses, which can lead to long-term disability. #nmo #nmoawarenessmonth
-
Alexion
@AlexionPharma
#wilsondisease is a rare and progressive genetic disorder in which the body’s pathway for removing excess copper is broken or disabled. People living with this #raredisease often face a long and complicated road to diagnosis. #wilsondiseaseawarenessmonth
-
Alexion
@AlexionPharma
At Alexion, hate of any kind has no home. Our Chief Corporate Affairs Officer, @TanishaCarino, shared the following with our global workforce today. #stopasianhate
-
Alexion
@AlexionPharma
Happy #internationalwomensday! We asked some of our #womeninleadership to share the best advice they’ve ever received. #womenshistorymonth #iwd2021
-
Alexion
@AlexionPharma
Today is #employeeappreciationday and we are deeply grateful for the dedication and resilience of our 3,000+ employees worldwide. Each plays a critical role in accomplishing our mission to transform the lives of people living with rare diseases and devastating conditions.
-
Alexion
@AlexionPharma
We’ll be presenting data from our latest research in #nmosd and #gmg at #aanam (April 17-22). www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Thank you to @DrCHebertWDSU for joining our recent Crucial Exchange session, “COVID-19: The Impact on Black America.” Dr. Hébert shared his thoughts on how we can overcome inequities in our healthcare system and his advice to #washupmaskupseparatevaccinate
-
Alexion
@AlexionPharma
We strive to ignite an inclusive environment where people belong because of their uniqueness and unleash their individuality and diversity to spur innovative breakthroughs for patients. Learn more: r.socialstudio.radian6.com/0b8f0b22-bdcf-47c4-badf-6a035e…
-
Alexion
@AlexionPharma
March is Neuromyelitis Optica Spectrum Disorder Awareness Month. #nmosd is a rare and devastating disorder that affects the central nervous system. Learn more: r.socialstudio.radian6.com/2264f8a4-8534-4f3d-8ff9-2db3ec… #raredisease
-
Alexion
@AlexionPharma
People living with rare and devastating diseases are our inspiration and our Guiding Star. Hear messages from our employees to the #raredisease community. Rare is many. Rare is strong. Rare is proud. #rarediseaseday
-
Alexion
@AlexionPharma
#dyk…There are more than 7,000 known rare diseases, but only 5% have an approved treatment. Learn more: rarediseaseday.org #rarediseaseday
-
Alexion
@AlexionPharma
We’re so proud to join the #raredisease community in shining a light on rare diseases by lighting up our New Haven office. @RareDiseases #lightupforrare
-
Alexion
@AlexionPharma
#dyk… 80% of rare diseases are genetic in origin and are often chronic and life-threatening. Learn more: rarediseaseday.org #rarediseaseday
-
Alexion
@AlexionPharma
It has been one year since we launched the Alexion Charitable Foundation to offer promise and cultivate a sense of belonging, particularly for people affected by #rarediseases. We’re proud to share the impact made this past year: alexion.com/our-commitment/csr-star-in-action/csr-stories… #rarediseaseday
-
Alexion
@AlexionPharma
Thank you, @TheHillEvents, for an excellent discussion today around race, equity, and the lack of diversity in the pharma industry, and the steps we’re taking at Alexion to address systemic racism and to better understand and serve diverse patients. #thehillbhm #blackhistorymonth
-
Alexion
@AlexionPharma
#dyk…It takes an average of 4.8 years for a person living with a rare disease to receive an accurate diagnosis. Learn more: rarediseaseday.org #rarediseaseday
-
Alexion
@AlexionPharma
People living with rare diseases wait a long time to receive a correct diagnosis. Rare Answers™ is a group of innovative tools designed to help shorten the diagnostic journey and time to initiating treatment of children with a #raredisease www.astrazeneca.com/investor-relations.html #rarediseaseday
-
Alexion
@AlexionPharma
#dyk…50% of people affected by rare diseases are children. Learn more: rarediseaseday.org #rarediseaseday
-
Alexion
@AlexionPharma
There are over 400 million people around the world affected by a rare disease. Rare is many. Rare is strong. Rare is proud. Learn more: rarediseaseday.alexion.com #rarediseaseday #eurordisawards2021
-
Alexion
@AlexionPharma
LEAP is an immersive experience that engages cross-functional team members, patients, and other stakeholders to challenge our assumptions, deepen our understanding, and identify value-added solutions. #rarediseaseday
-
Alexion
@AlexionPharma
Our “Rare Inspiration. Changing Lives.” session on health equity featured Sarah White of @MRCTCenter, Dr. Anne Pariser of @ORDR, Adrian Palau-Tejeda of @EveryLifeOrg, and @Durhane of @raredisorders. Watch: arediseaseday.alexion.com #rarediseaseday
-
Alexion
@AlexionPharma
#dyk…3 in 10 children with a rare disease will not live to see their 5th birthday. Learn more: rarediseaseday.org #rarediseaseday
-
Alexion
@AlexionPharma
The COVID-19 pandemic has had a tremendous impact on society, including the rare disease community. Dr. Marshall Summar, Division Chief, Genetics & Metabolism @ChildrensNatl, shares what we can learn from them. #rarediseaseday @genedocrare
-
Alexion
@AlexionPharma
We’re so excited to launch rarediseaseday.alexion.com to kick off the #rarediseaseday celebrations this week! Create a postcard for patients, check out the video message wall, learn about rare diseases, and more.
-
Alexion
@AlexionPharma
Jethro Ekuta, Vice President, Global Regulatory Affairs, reflects on how #blackhistory is #morethanamonth. #blackhistorymonth
-
Alexion
@AlexionPharma
Next week we’ll be celebrating #rarediseaseday all week long, joining the rare disease community in raising awareness for patients, families, and caregivers around the world. Rare is many. Rare is strong. Rare is proud.
-
Alexion
@AlexionPharma
Uzair Qadeer, Chief Diversity Officer, and other industry thought leaders share their perspectives on the work being done within the pharmaceutical industry to foster diversity, inclusion, and belonging. Read more: r.socialstudio.radian6.com/33fabeda-a814-496b-891b-d5c450…
-
Alexion
@AlexionPharma
Today is the fifth annual International Day of Women and Girls in Science. Hear how our colleagues are celebrating and what this day means to them. #stem #womeninscience @WomenScienceDay
-
Alexion
@AlexionPharma
Bentley Williams, Regional Account Manager, US Neurology, shares what #blackhistorymonth means to him and how he is celebrating.
-
Alexion
@AlexionPharma
Are you driven by innovation, motivated by excellence, and passionate about changing the lives of people living with rare diseases and devastating conditions around the world? So are we. Learn about our career opportunities in research and development. r.socialstudio.radian6.com/814ad8e1-f36a-40e2-bd50-5025e3…
-
Alexion
@AlexionPharma
Congratulations to our colleagues in Ireland on the @NISOIreland Healthy Workplace and Biopharmaceutical awards! This recognition is a testament to the best-in-class safety standards we have adopted and implemented during these unprecedented times.
-
Alexion
@AlexionPharma
Lysosomal Acid Lipase Deficiency (#lald) is a rare, inherited, progressive condition in which people have an uncontrolled buildup of fatty material in their liver & other organs. Learn more: r.socialstudio.radian6.com/0c404907-c63f-46c9-9484-f623ae…
-
Alexion
@AlexionPharma
Our quality mindset is woven into the work we do every day. We recently participated in the Gartner Culture of Quality Diagnostic, a survey that evaluates the strengths and weaknesses of a company’s quality culture. We are proud to have achieved a ranking in the top quintile.
-
Alexion
@AlexionPharma
Thank you to Yann le Cam, founder & CEO of @eurordis, for joining us to discuss our shared goal of supporting continued research and innovation to address the significant unmet needs of people living with rare diseases around the world. #rareinspirationchanginglives
-
Alexion
@AlexionPharma
This #blackhistorymonth, we are reflecting on the profound legacy that African Americans have had on our history. Rachell Hill, Director, US Government Affairs, reflects on celebrating as a child and today as a black woman.
-
Alexion
@AlexionPharma
Our annual Global Culture Forum brings together our 60+ Culture Champions and Connectors from around the world. In 2020, we gathered virtually to share ideas and inspire each other in our culture transformation efforts. Learn more: r.socialstudio.radian6.com/7dfefef8-289f-42a7-9641-9f8db8…
-
Alexion
@AlexionPharma
We are inspired every day. The work we do is guided by people living with rare and devastating diseases, and we are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. www.alexion.com
-
Alexion
@AlexionPharma
Uzair Qadeer, Chief Diversity Officer, reflects on leading Alexion’s DI&B efforts and nurturing a culture of Inclusivity in an article from @EOPublications. Check out the full CAREERS & the disABLED issue here: r.socialstudio.radian6.com/49cb10f6-3163-445b-a022-612ac2…
-
Alexion
@AlexionPharma
The Guiding Star Award is our highest employee recognition, given to those whose contributions have a significant and lasting impact on Alexion and the lives of people living with rare diseases. We were proud to present this award to over 160 incredible employees!
-
Alexion
@AlexionPharma
#dyk…Neuromyelitis Optica Spectrum Disorder (#nmosd) is a rare and devastating disease that affects the central nervous system. Learn more: r.socialstudio.radian6.com/e176370b-e17d-47d8-b508-af112e… #raredisease
-
Alexion
@AlexionPharma
We’re hiring! We are innovators, leaders, and collaborators. And at the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for people living with rare and devastating diseases. Join us! jobs.alexion.com
-
Alexion
@AlexionPharma
Today marks the 26th anniversary of the day of service that celebrates Dr. Martin Luther King Jr who devoted his life to advancing equality and opportunity for all. Kimberly Marshall, Regional Account Manager, reflects on how his legacy impacts her today.
-
Alexion
@AlexionPharma
The global pandemic has changed the way we operate in the workplace, but our Global Security Team has remained vigilant to keep patients and our employees safe. Learn more about how we celebrated Security Awareness Month r.socialstudio.radian6.com/3454aca5-bd4d-4d7f-a4e8-751a2f…
-
Alexion
@AlexionPharma
Today we provided an update on our Phase 3 study in hospitalized patients with severe COVID-19: www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
Our mission is to transform the lives of people living with rare diseases through the development and delivery of innovative medicines. alexion.com
-
Alexion
@AlexionPharma
Martine Zimmermann, SVP, Global Regulatory Affairs attended the first @DrugInfoAssn Regulatory Affairs Leadership Forum. This panel came together to publish “Regulatory Leadership in the Time of COVID-19 and Beyond”. Read more: globalforum.diaglobal.org/issue/december-2020/regulatory-…
-
Alexion
@AlexionPharma
-
Alexion
@AlexionPharma
We are so pleased to be named to Newsweek Magazine's America's Most Responsible Companies 2021 list. Our commitment to CSR continues to evolve and reflect the nature of our business. r.socialstudio.radian6.com/459080ba-b0d1-4195-b6c5-6c93a1…
-
Alexion
@AlexionPharma
Looking to make a change in the new year? Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. Learn more: r.socialstudio.radian6.com/ab2495e1-280c-4ada-8315-a49989…
-
Alexion
@AlexionPharma
To meet the diverse needs of our colleagues and to celebrate our uniqueness, we’re introducing an Annual Diversity, Inclusion & Belonging Flex Holiday beginning in 2021, for employees to celebrate diversity in ways meaningful to them.
-
Alexion
@AlexionPharma
In these unprecedented times, our ability to collaborate and innovate virtually is more important than ever. We were proud to support the 2020 @AAN Leadership Program which provides unique leadership experience to early-career neurologists. Learn more: r.socialstudio.radian6.com/e3d33d18-cc4c-40d1-84f8-01d073…
-
Alexion
@AlexionPharma
Thank you to everyone who liked and shared our #momentsthatmattered2020! Wishing you all a healthy and happy new year. #happynewyear
-
Alexion
@AlexionPharma
The Guiding Star Award is our highest employee recognition, given to those whose contributions have a significant impact on Alexion & on the lives of people living with rare diseases. This year, we were proud to present this award to 120 employees! #momentsthatmattered2020
-
Alexion
@AlexionPharma
In response to the constantly evolving healthcare landscape, we launched the “Rare Inspiration. Changing Lives.” virtual speaker series to bring in critical stakeholder perspectives & engage in conversations on topics that matter most to our industry. #momentsthatmattered2020
-
Alexion
@AlexionPharma
During this global health crisis, our International team has remained #strongertogetherevenwhenfarapart. We’re grateful for the collaborative spirit and commitment to keeping the patient at the center as we navigate through new, virtual times. #momentsthatmattered2020
-
Alexion
@AlexionPharma
We were very proud to accept the Germany Prix Galien Award in the category “Specialist Care”. The prize is awarded for outstanding drug innovation. #prixgalien #galenus20 #momentsthatmattered2020
-
Alexion
@AlexionPharma
During this global health crisis, we are filled with gratitude for our colleagues in labs and manufacturing sites that have done an amazing job adapting to unprecedented circumstances. #momentsthatmattered2020
-
Alexion
@AlexionPharma
Our Manager Development Program was launched in February, but quickly pivoted to a fully virtual experience due to the COVID-19 pandemic. #momentsthatmattered2020
-
Alexion
@AlexionPharma
We were grateful to receive a letter from Julen, living with PNH, who shared his disease journey. “Stories can be a bridge between the technical world of scientific practice and the experiential world of patients.” Wendy Erler, Head of Patient Experience #momentsthatmattered2020
-
Alexion
@AlexionPharma
We know that a strong sense of connection is key to successfully navigating this time of #remotework. That is why we launched CEO Chats, where our CEO, Ludwig Hantson, and other leaders from around Alexion keep us all informed and engaged. #momentsthatmattered2020
-
Alexion
@AlexionPharma
In February, we were honored to be recognized by S&P Global as one of three S&P 500 companies where women hold the majority of executive positions. r.socialstudio.radian6.com/3b4107eb-f6e6-4b31-a6c1-c6830e… #momentsthatmattered2020
-
Alexion
@AlexionPharma
Our colleagues around the globe enjoyed celebrating disease awareness days this year! The work we do is guided by people living with rare diseases and devastating conditions and they inspire us every day. #momentsthatmattered2020
-
Alexion
@AlexionPharma
During one of our #bewell sessions, a series focused on mental and physical wellbeing, CFO, Aradhana Sarin, hosted a virtual story time for employees and their kids. Aradhana shared photos of animals she encountered during her travels around the world! #momentsthatmattered2020
-
Alexion
@AlexionPharma
Earlier this year, the collaborative work of our Data Sciences, Genomics & Bioinformatics team was honored by @genome_gov as one of the 10 most significant advances for genomic medicine in 2019. r.socialstudio.radian6.com/c466dc5f-d2d7-4c4d-8191-8f07cf… #momentsthatmattered2020
-
Alexion
@AlexionPharma
In 2020 we virtualized LEAP, an immersive experience that engages cross-functional team members, patients, and other stakeholders to challenge our assumptions, deepen our understanding, and identify value-added solutions. #momentsthatmattered2020
-
Alexion
@AlexionPharma
Patients are our Guiding Star and as we embark on a new chapter in our journey, they will continue to guide every decision we make. To the patients we serve, thank you for being our steadfast partners and entrusting us with your care.
-
Alexion
@AlexionPharma
Our internship programs are designed to ensure students gain valuable industry experience and build partnerships within their professional networks. We were pleased to continue our programs this summer, welcoming students in the U.S. and across the E.U. #momentsthatmattered2020
-
Alexion
@AlexionPharma
Another year, another incredible #masswomen conference! Thank you, @MassWomen, for working so hard to make this virtual event such a success.
-
Alexion
@AlexionPharma
In 2020, more than 1,480 Alexion employees contributed 3,400+ hours of service in support of 85 projects throughout 20+ countries worldwide. Our virtual efforts included STEM workshops, mentoring students, at-home care kit making, and more. #momentsthatmattered2020
This media couldn't be displayed. See it on the original post. -
Alexion
@AlexionPharma
The mission of the Alexion Charitable Foundation is to offer promise and cultivate a sense of belonging, particularly for people affected by a rare disease. This year, we were proud to announce the Foundation’s launch. Learn more: r.socialstudio.radian6.com/cdd3554b-8417-4aec-9a3b-a94023… #momentsthatmattered
-
Alexion
@AlexionPharma
.@AstraZeneca to acquire @AlexionPharma to advance our shared mission to bring science-driven innovation to patients globally: www.astrazeneca.com/investor-relations.html
-
Alexion
@AlexionPharma
We were honored to be joined virtually this year by patients and caregivers to hear about their #raredisease journeys. Thank you all for generously sharing your stories with us! #momentsthatmattered2020
-
Alexion
@AlexionPharma
In October, we celebrated the approval of a new formulation of our long-acting C5 complement inhibitor. Read more about this approval: r.socialstudio.radian6.com/ebf9a900-56f6-4733-adbf-077438… #momentsthatmattered2020
-
Alexion
@AlexionPharma
We were excited to welcome @JoanneOR_Ox as we celebrated International Day of Persons with Disabilities. One of only seven people in the world living with tetra-amelia, Joanne spoke about her life and ways we can learn from and support others. #idpd2020
-
Alexion
@AlexionPharma
We were so pleased to announce the appointment of Uzair Qadeer as Chief Diversity Officer, accelerating our efforts to embed diversity, inclusion, and belonging across our organization and advance a unique culture of belonging for patients and employees. #momentsthatmattered2020
-
Alexion
@AlexionPharma
Advancing the emotional well-being of the rare disease community, our employees & communities is a core commitment. In May we were pleased to join a global coalition of employers dedicated to workplace brain health through our partnership with @OneMindOrg #momentsthatmattered2020
-
Alexion
@AlexionPharma
Thank you to @ASH_Hematology for an innovative, inspiring virtual conference. #ash20 #ashfromhome
-
Alexion
@AlexionPharma
This summer we launched our MOSAIC series, an internal monthly event that aims to shine a light on the many distinct ethnicities and origin groups that make up our global community. #momentsthatmattered2020
-
Alexion
@AlexionPharma
Atypical hemolytic uremic syndrome (#ahus) is a genetic, chronic, ultra-rare disease that can progressively damage vital organs, such as the kidneys. Learn more: r.socialstudio.radian6.com/3308cdd4-3fb1-45eb-a0f8-761dfd… #ash20
-
Alexion
@AlexionPharma
Paroxysmal nocturnal hemoglobinuria (#pnh) is a chronic, debilitating, and life-threatening #ultrarare blood disorder that may cause thrombosis (blood clotting). Learn more: r.socialstudio.radian6.com/270bb5f0-e24d-4022-be99-676b7b… #ash20
-
Alexion
@AlexionPharma
In response to the COVID-19 pandemic, we launched our virtual volunteering program. Earlier this year, our Japanese colleagues spent time entertaining nursing home residents. Learn more: r.socialstudio.radian6.com/c7267261-bae2-40b7-b480-a82a17… #momentsthatmattered
-
Alexion
@AlexionPharma
To change the systems around us, we must first change the conversation. We’re excited to participate in @MilkenInstitute’s Future of Health Summit this week. Read more: www.astrazeneca.com/investor-relations.html #mihealthsummit
-
Alexion
@AlexionPharma
This year, we were thrilled to virtually welcome 450+ new employees around the globe—and we’re still growing! We’re building a rewarding place to work that’s focused on serving people living with #rarediseases. Join us! r.socialstudio.radian6.com/75099d66-530f-4565-923e-097077… #momentsthatmattered2020
-
Alexion
@AlexionPharma
Looking forward to #ash20! We’ll be sharing our research in atypical hemolytic uremic syndrome (#ahus) and paroxysmal nocturnal hemoglobinuria (#pnh), two rare blood disorders. #ashfromhome #ashtogether
r.socialstudio.radian6.com/dd202180-9139-414a-b499-02b05a…




























































































































































































































































































































































































































































































































































































































































